<SEC-DOCUMENT>0001654954-20-000289.txt : 20200110
<SEC-HEADER>0001654954-20-000289.hdr.sgml : 20200110
<ACCEPTANCE-DATETIME>20200110164512
ACCESSION NUMBER:		0001654954-20-000289
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20200110
DATE AS OF CHANGE:		20200110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			cbdMD, Inc.
		CENTRAL INDEX KEY:			0001644903
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				473414576
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-228773
		FILM NUMBER:		20521565

	BUSINESS ADDRESS:	
		STREET 1:		8845 RED OAK BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28217
		BUSINESS PHONE:		704-445-3060

	MAIL ADDRESS:	
		STREET 1:		8845 RED OAK BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Level Brands, Inc.
		DATE OF NAME CHANGE:	20170202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEVEL BEAUTY GROUP, INC.
		DATE OF NAME CHANGE:	20150611
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ycbd_424.htm
<DESCRIPTION>PRELIMINARY PROSPECTUS
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<font style="font-weight: bold">Filed Pursuant to Rule
424(b)(5)</font></font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0; <font style="font-weight: bold">Registration No. 333-228773</font></font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: middle; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">PROSPECTUS
SUPPLEMENT</font></div>
</td>
<td style="vertical-align: middle; width: 33%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; color: #ff0000"><br></font></font></div>
</td>
<td style="vertical-align: middle; width: 33%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; color: #ff0000"><br></font></font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">(To the Prospectus
dated April 9, 2019)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">
16,000,000 Shares</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Common
Stock</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<img src="ycbd_424000.jpg"></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 24px; font-family: Times New Roman">cbdMD,
Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: auto; margin-right: auto; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--line--><br></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">We are offering
16,000,000 shares of our common stock in this offering
<font style="color: #000000">pursuant to this prospectus supplement
and the accompanying prospectus.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">Our common stock is
listed on the NYSE American under the symbol &#x201C;YCBD.&#x201D; On
January 9, 2020, the last reported sale price of our
common stock was $1.51 per share.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">As of the date of
this prospectus supplement, the aggregate market value of our
outstanding common stock held by non-affiliates was $55,784,142,
based on 27,777,856 shares of outstanding common stock, of which
14,641,507 shares are held by non-affiliates and 13,136,349 shares
are held by affiliates, and a per share price of $3.81 per share,
the closing price of our common stock on November 12, 2019, which
is the highest closing sale price of our common stock on the NYSE
American within the prior 60 days. As of the date of this
prospectus supplement, we have not offered and sold any shares of
our common stock pursuant to General Instruction I.B.6 to Form S-3
during the 12 calendar month period that ends on and includes the
date hereof. Pursuant to General Instruction I.B.6 of Form S-3, in
no event will we sell securities in a public primary offering with
a value exceeding more than one-third of our &#x201C;public
float&#x201D;, or approximately $18,594,713 as of the date hereof
(the market value of our common stock held by our non-affiliates)
in any 12-month period so long as our public float remains below
$75,000,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman"><font style="color: #000000">
Investing in our common stock involves a high degree of risk.
&#xA0;See &#x201C;</font><font style="font-style: italic; color: #000000">Risk
Factors</font><font style="color: #000000">&#x201D; beginning on
page S-5 of this prospectus supplement and on page 5 of the
accompanying prospectus for a discussion of information that should
be considered in connection with an investment in our common
stock.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Neither
the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any
representation to the contrary is a criminal offense.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">We are an &#x201C;emerging growth company&#x201D; as
that term is used in the Jumpstart Our Business Startups Act of
2012, or the JOBS Act, and, as such, have elected to comply with
certain reduced public company reporting requirements. Please see
&#x201C;</font><font style="font-style: italic; color: #000000">Prospectus
Summary&#x2014;Implications of Being an Emerging Growth
Company</font><font style="color: #000000">.&#x201D;</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;">Per
Share</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;">Total</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">Public offering
price</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1.00</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">16,000,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">Underwriting
discounts and commissions (1)</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">0.075</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,200,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">Proceeds, before
expenses, to us</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">0.925</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">14,800,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: top; font-size: 70%; font-family: Times New Roman">
(1)</font> <font style="font-size: 13px; font-family: Times New Roman">In addition, we
have agreed to issue the representative of the underwriters as a
portion of the underwriting compensation warrants to purchase
shares of common stock and to reimburse the underwriters for
certain expenses. Please see &#x201C;<font style="font-style: italic">Underwriting</font> &#x201D; beginning on page
S-14 of this prospectus supplement for additional
information.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">We have granted the
representative of the underwriters an option to purchase up to an
additional 2,400,000 shares of common stock from us at
the public offering price, less the underwriting discounts and
commissions, within 45 days from the date of this prospectus to
cover over-allotments, if any.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="color: #000000; background-color: #ffffff; font-size: 13px; font-family: Times New Roman">
Eight of our executive officers and directors have
indicated an interest in purchasing up to 455,000
shares of our common stock in the offering at the public offering
price. However, because indications of interest are not binding
agreements or commitments to purchase, the underwriters may
determine to sell more, less or no shares in this offering to these
executive officers and directors or these executive officers and
directors may determine to purchase more, less, or no shares in
this offering.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">The underwriters
expect to deliver the shares of common stock to the purchasers on
or about January 14, 2020.</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 24px; font-family: Times New Roman">ThinkEquity</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">a
division of Fordham Financial Management, Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 19px"><font style="font-weight: bold">Benchmark
Company</font></font><br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">The date of this
prospectus supplement is January 9, 2020</font> </div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424001.jpg"></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0; <font style="font-size: 13px; font-family: Times New Roman"><br>
</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424002.jpg"></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0; <font style="font-size: 13px; font-family: Times New Roman"><img src="ycbd_424003.jpg"></font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">TABLE
OF CONTENTS</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Prospectus
Supplement</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">ABOUT THIS
PROSPECTUS SUPPLEMENT</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-ii</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">CAUTIONARY
STATEMENTS REGARDING FORWARD-LOOKING INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-iii</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">PROSPECTUS
SUPPLEMENT SUMMARY</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-1</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">THE
OFFERING</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-4</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">RISK
FACTORS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-5</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">USE OF
PROCEEDS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-10</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">CAPITALIZATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-11</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DIVIDEND
POLICY</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-12</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DILUTION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-13</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">UNDERWRITING</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-14</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">LEGAL
MATTERS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-19</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">EXPERTS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-19</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">WHERE YOU CAN FIND
MORE INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-19</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">INFORMATION
INCORPORATED BY REFERENCE</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-20</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Prospectus</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">ABOUT THIS
PROSPECTUS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">2</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">AVAILABLE
INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">2</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">OUR
COMPANY</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">3</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">CAUTIONARY
STATEMENTS REGARDING FORWARD-LOOKING INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">4</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">RISK
FACTORS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">5</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">USE OF
PROCEEDS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">16</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DESCRIPTION OF
CAPITAL STOCK</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">17</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DESCRIPTION OF
WARRANTS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">18</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">MATERIAL FEDERAL
INCOME TAX CONSEQUENCES</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">19</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">PLAN OF
DISTRIBUTION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">19</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">LEGAL
MATTERS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">21</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">EXPERTS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">21</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">INFORMATION
INCORPORATED BY REFERENCE</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">21</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">ABOUT
THIS PROSPECTUS SUPPLEMENT</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">This document is in
two parts. The first part is the prospectus supplement, including
the documents incorporated by reference, which describes the
specific terms of this offering. The second part, the accompanying
prospectus, including the documents incorporated by reference,
provides more general information. Before you invest, you should
carefully read this prospectus supplement, the accompanying
prospectus, all information incorporated by reference herein and
therein, as well as the additional information described under
&#x201C;<font style="font-style: italic">Where You Can Find More
Information</font>&#x201D; of this prospectus supplement. These
documents contain information you should consider when making your
investment decision. This prospectus supplement may add, update or
change information contained in the accompanying prospectus. To the
extent there is a conflict between the information contained in
this prospectus supplement, on the one hand, and the information
contained in the accompanying prospectus or any document
incorporated by reference therein filed prior to the date of this
prospectus supplement, on the other hand, you should rely on the
information in this prospectus supplement. If any statement in one
of these documents is inconsistent with a statement in another
document having a later date &#x2014; for example, a document filed
after the date of this prospectus supplement and incorporated by
reference in this prospectus supplement and the accompanying
prospectus &#x2014; the statement in the document having the later
date modifies or supersedes the earlier statement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">You should rely
only on the information contained or incorporated by reference in
this prospectus supplement, the accompanying prospectus and in any
free writing prospectuses we may provide to you in connection with
this offering. We have not, and ThinkEquity, a division of Fordham
Financial Management, Inc., or ThinkEquity, has not, authorized any
other person to provide you with any information that is different.
If anyone provides you with different or inconsistent information,
you should not rely on it. We are offering to sell, and seeking
offers to buy, shares of our common stock only in jurisdictions
where offers and sales are permitted. The distribution of this
prospectus supplement and the offering of the common stock in
certain jurisdictions may be restricted by law. Persons outside the
United States who come into possession of this prospectus
supplement must inform themselves about, and observe any
restrictions relating to, the offering of the common stock and the
distribution of this prospectus supplement outside the United
States. This prospectus supplement does not constitute, and may not
be used in connection with, an offer to sell, or a solicitation of
an offer to buy, any securities offered by this prospectus
supplement by any person in any jurisdiction in which it is
unlawful for such person to make such an offer or
solicitation.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We further note
that the representations, warranties and covenants made by us in
any agreement that is filed as an exhibit to any document that is
incorporated by reference in the accompanying prospectus were made
solely for the benefit of the parties to such agreement, including,
in some cases, for the purpose of allocating risk among the parties
to such agreements, and should not be deemed to be a
representation, warranty or covenant to you. Moreover, such
representations, warranties or covenants were accurate only as of
the date when made. Accordingly, such representations, warranties
and covenants should not be relied on as accurately representing
the current state of our affairs.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">When
used herein, the terms &#x201C;cbdMD,&#x201D; &#x201C;we,&#x201D;
&#x201C;us, &#x201C;our&#x201D; and similar terms refer to cbdMD,
Inc., a North Carolina corporation formerly known as Level Brands,
Inc., and our subsidiaries CBD Industries, LLC, a North Carolina
limited liability company formerly known as cbdMD LLC which we
refer to as &#x201C;CBDI&#x201D;, Paw CBD, Inc., a recently formed
North Carolina corporation which we refer to as &#x201C;Paw
CBD&#x201D;, Beauty and Pinups, LLC, a North Carolina limited
liability company which we refer to as &#x201C;BPU&#x201D;, I | M 1,
LLC, a California limited liability company, which we refer to as
&#x201C;IM1&#x201D;, Encore Endeavor 1 LLC, a California limited
liability company which we refer to as &#x201C;EE1,&#x201D; and Level
H&amp;W, LLC, a North Carolina limited liability company which we
refer to as &#x201C;Level H&amp;W.&#x201D; In addition, "fiscal 2018"
refers to the year ended September 30, 2018, &#x201C;fiscal
2019&#x201D; refers to the year ended September 30, 2019, and
&#x201C;fiscal 2020&#x201D; refers to the year ending September 30,
2020.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-ii</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING
INFORMATION</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The information
included or incorporated by reference into this prospectus
supplement and the accompanying prospectus contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, or Securities Act, and Section 21E of the
Securities Exchange Act of 1934, as amended, or Exchange Act. These
<font style="color: #000000">forward-looking statements that relate
to future events or our future financial performance and involve
known and unknown risks, uncertainties and other factors that may
cause our actual results, levels of activity, performance or
achievements to differ materially from any future results, levels
of activity, performance or achievements expressed or implied by
these forward-looking statements. Words such as, but not limited
to, &#x201C;believe,&#x201D; &#x201C;expect,&#x201D;
&#x201C;anticipate,&#x201D; &#x201C;estimate,&#x201D;
&#x201C;intend,&#x201D; &#x201C;plan,&#x201D; &#x201C;targets,&#x201D;
&#x201C;likely,&#x201D; &#x201C;aim,&#x201D; &#x201C;will,&#x201D;
&#x201C;would,&#x201D; &#x201C;could,&#x201D; and similar expressions
or phrases identify forward-looking statements. We have based these
forward-looking statements largely on our current expectations and
future events and financial trends that we believe may affect our
financial condition, results of operation, business strategy and
financial needs. Actual results may differ materially from those
expressed or implied in such forward-looking statements as a result
of various factors. We do not undertake, and we disclaim, any
obligation to update any forward-looking statements or to announce
any revisions to any of the forward-looking statements, except as
required by law. Certain factors that could cause results to be
materially different from those projected in the forward-looking
statements include, but are not limited to, statements
about:</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">management&#x2019;s
broad discretion as to the use of proceeds from this
offering;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">immediate dilution
to purchasers of shares of our common stock in this
offering;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks for failing
to comply with the continued listing standards of the NYSE
American;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the impact of fair
value accounting on our results of operations in future
periods;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the dilution to our
shareholders upon the possible future issuance of the Earnout
Shares, the conversion of Series A Convertible Preferred Stock
and/or the exercise of outstanding options and
warrants;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the superior rights
of holders of our Series A Convertible Preferred
Stock;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with control by our executive officers, directors and
affiliates;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">expected lack of
dividends on our common stock;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our history of
losses and limited operating history;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the impact of fair
value accounting on the contingent liabilities associated with the
Earnout Shares;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our possible need
for additional capital;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our inability to
liquidate securities we have accepted as compensation;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">reliance on third
party manufacturers; and risks associated with the manufacture of
our products;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">possible
undisclosed liabilities related with our discontinued operations;
and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the regulatory
environment in which we operate.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We urge you to
consider these factors before investing in our common stock. The
forward-looking statements included in this prospectus supplement,
the accompanying prospectus and any other offering material, or in
the documents incorporated by reference into this prospectus
supplement, the accompanying prospectus and any other offering
material, are made only as of the date of the prospectus
supplement, the accompanying prospectus, any other offering
material or the incorporated document. For more detail on these and
other risks, please see &#x201C;<font style="font-style: italic">Risk Factors</font>&#x201D; in this prospectus
supplement, the accompanying prospectus, our Annual Report on Form
10-K for our fiscal year ended September 30, 2019 as filed with the
Securities and Exchange Commission, or SEC, on December 18, 2019
and our subsequent filings with the SEC.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-iii</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">PROSPECTUS
SUPPLEMENT SUMMARY</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
The following information below is only a summary of more detailed
information included elsewhere in, or incorporated by reference in,
this prospectus supplement and the accompanying prospectus, and
should be read together with the information contained or
incorporated by reference in other parts of this prospectus
supplement and the accompanying prospectus. This summary highlights
selected information about us and this offering. This summary may
not contain all of the information that may be important to you.
Before making a decision to invest in our common stock, you should
read carefully all of the information contained in or incorporated
by reference into this prospectus supplement and the accompanying
prospectus, including the information set forth under the caption
&#x201C;Risk Factors&#x201D; in this prospectus supplement and the
accompanying prospectus as well as the documents incorporated
herein by reference, which are described under &#x201C;Where You Can
Find More Information&#x201D; and &#x201C;Information Incorporated by
Reference&#x201D; in this prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Our Company</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">cbdMD was
originally founded in 2015 as an <font style="color: #000000">innovative branding and marketing company with a
focus on lifestyle-based brands. In December 2018 pursuant to a
two-step merger, or the Mergers, we acquired Cure Based Development
LLC, or Cure Based Development, following the</font> approval of
the United States of the Agricultural Improvement Act of 2018,
commonly known as the Farm Bill, which contained a declassification
of cannabidiol (CBD) as a controlled substance under federal
law<font style="color: #000000">. As a result of that transaction,
we</font> own and operate the nationally recognized CBD brand cbdMD
which now represents our focus and all of our
revenues.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424004.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Through our CBDI
subsidiary which succeeded to the business of Cure Based
Development, we produce <font style="color: #222222; background-color: #ffffff">and distribute</font>
various high-grade, premium CBD products, including tinctures,
capsules, gummies, bath bombs and topical creams. In the third
quarter of fiscal 2019, we launched a line of pet related CBD
products under our Paw CBD brand which includes tinctures, treats,
and balms, with additional products under development. In October
2019, following the initial positive response to the Paw CBD brand
from retailers and consumers, we organized Paw CBD as a separate
wholly-owned subsidiary in an effort to take advantage of its early
mover status in the CBD animal health industry. With over 40
SKU&#x2019;s of premium pet CBD products for dogs, cats and horses,
we are seeking to grow Paw CBD into a leading brand. We also
anticipate that Paw CBD will also partner with existing pet brands
seeking to leverage our experience in sales, marketing and
distribution in the CBD industry.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We either
manufacture our premium line of products at our Charlotte, NC
facility or work with third party manufacturers.&#xA0; We only
source cannabinoids, including CBD,&#xA0;which are extracted
from&#xA0;non-GMO&#xA0;hemp grown on farms in the United
States.&#xA0;&#xA0;We utilize a manufacturing&#xA0;process which
creates hybrid broad-spectrum concentrations including CBD, other
cannabinoids, and various other compounds, which we believe creates
a superior product, while eliminating&#xA0;tetrahydrocannabinol
(THC) content.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-1</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424005.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Since December
2018, we have <font style="color: #000000">increased the number of
locations cbdMD products are available in significantly, and with
the building momentum of retailer acceptance subsequent to the
passage of the Farm Bill, we are pursuing multiple opportunities to
expand our product distribution as we continue to work to build
cbdMD into a top recognized brand in the industry. We are also
utilizing partnerships and sponsorships with professional athletes
as a way to gain brand recognition. During the third quarter of
fiscal 2019 we signed several significant sponsorships, including,
but not limited to, professional golfer and 12-time PGA Tour winner
Bubba Watson, Ice Cube&#x2019;s Big 3 basketball league, Bellator
MMA, and Nitro Circus.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424006.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Discontinued operations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Historically
our operations included our BPU, EE1, IM1 and Level H&amp;W
subsidiaries.&#xA0;These subsidiaries accounted for our licensing,
entertainment, and products segments prior to fiscal 2019.&#xA0;As
revenues from the operations of these subsidiaries continued to
decline in fiscal 2019 from fiscal 2018 levels, and the revenues
associated with CBDI began to represent substantially all of our
revenues, effective&#xA0;September 30, 2019, we discontinued
operations of EE1, IM1, BPU and Level H&amp;W.&#xA0;The decision to
exit these businesses has resulted in these businesses being
accounted for as discontinued operations in our audited
consolidated financial statements incorporated by reference into
this prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Risk
Factors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">An investment in
our common stock involves risk. Before deciding whether to
participate in this offering, you should carefully consider the
risk factors beginning on page S-5 of this prospectus supplement
and the risk factors contained in the documents incorporated by
reference in this prospectus supplement and the accompanying
prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-2</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Corporate
Information</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
company was formed under the laws of the state of North Carolina in
March 2015 under the name Level Beauty Group, Inc. In November 2016
we changed the name of our company to Level Brands, Inc. Effective
May 1, 2019, we changed our name to cbdMD, Inc. in connection with
the Mergers with Cure Based Development.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Our principal executive offices are located at
8845 Red Oak Boulevard, Charlotte, NC 28217. Our telephone number
at this location is (704) 445-3060. Our corporate website address
is</font> <font style="color: #0000ff; text-decoration: underline">www.cbdmd.com</font><font style="color: #000000">.
We make our periodic and current reports that are filed with the
SEC available, free of charge, on our website as soon as reasonably
practicable after such material is electronically filed with, or
furnished to, the SEC. The information contained in, and that can
be accessed through, our website is not incorporated into and is
not a part of this prospectus supplement.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Please see our
Annual Report on Form 10-K for the fiscal year ended September 30,
2019 as filed with the SEC on December 18, 2019 for additional
information about our business, operations and financial
condition.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold">Implications of Being an Emerging Growth
Company</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We qualify as an
&#x201C;emerging growth company&#x201D; as defined in the JOBS Act.
As an emerging growth company, we intend to take advantage of
specified reduced disclosure and other requirements that are
otherwise applicable generally to public companies. These
provisions include:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td colspan="4" style="vertical-align: middle; width: 94%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">allowance to
provide only two years of audited financial statements in addition
to any required unaudited interim financial statements with
correspondingly reduced Management&#x2019;s Discussion and Analysis
of Financial Condition and Results of Operations
disclosures;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td colspan="3" style="vertical-align: middle; width: 94%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">reduced disclosure
about our executive compensation arrangements;</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td colspan="2" style="vertical-align: middle; width: 93%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">no non-binding
advisory votes on executive compensation or golden parachute
arrangements; and</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td colspan="2" style="vertical-align: top">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">exemption from
auditor attestation requirements in the assessment of our internal
control over financial reporting.</font> <font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We may take
advantage of these provisions for up to five years or such earlier
time that we are no longer an emerging growth company. We would
cease to be an emerging growth company on the date that is the
earliest of: (i) the last day of the fiscal year in which we have
total annual gross revenues of $1.07 billion or more; (ii) the last
day of our fiscal year following the fifth anniversary of the date
of the completion of our initial public offering; (iii) the date on
which we have issued more than $1.0 billion in nonconvertible debt
during the previous three years; or (iv) the date on which we are
deemed to be a large accelerated filer under the rules of the SEC.
We have taken advantage of reduced reporting requirements in this
prospectus. Accordingly, the information contained herein may be
different than the information you receive from other public
companies in which you have beneficial ownership.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-3</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
THE OFFERING</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The following
summary contains basic information about this offering. The summary
is not intended to be complete. You should read the full text and
more specific details contained elsewhere in this prospectus
supplement.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Issuer</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">cbdMD,
Inc.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Common stock offered by us</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">
16,000,000 shares at a purchase price of $1.00
per share.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Over-allotment option</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
have granted to the representative of the underwriters the option,
exercisable for 45 days from the date of this prospectus
supplement, to purchase up to 2,400,000 additional
shares of common stock to cover over-allotments.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; color: #000000">Common stock to be outstanding
after</font>&#xA0;<font style="font-weight: bold; color: #000000">this
offering</font><font style="font-weight: bold">&#xA0;</font><font style="font-weight: bold; vertical-align: top; color: #000000; font-size: 70%">(1)</font></font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">43,777,856 shares.</font> If the
representative&#x2019;s over-allotment option is exercised in full,
the total number of shares of common stock outstanding immediately
after this offering would be 46,177,856
shares.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Representative&#x2019;s Warrants</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">At closing we will issue warrants to purchase
480,000 shares of our common stock to the
representative of the underwriters, or the Representative&#x2019;s
Warrant, as a portion of the underwriting compensation payable to
the underwriters in connection with this offering. The warrants
will be exercisable for a period commencing 180 days following the
closing of this offering and ending on the fifth anniversary of the
closing date at an exercise price equal to $1.25 per
share, or 125% of the initial public offering price of the common
stock. It is not anticipated that the Representative&#x2019;s
Warrants will be registered and included in the registration
statement of which this prospectus supplement is a part. Please see
&#x201C;</font><font style="font-style: italic; color: #000000">Underwriting &#x2014;
Representative&#x2019;s Warrants</font><font style="color: #000000">&#x201D; for a description of these
warrants.</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
NYSE American symbol</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">YCBD</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Use of proceeds</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">We intend to use the net proceeds from this
offering for working capital. Please see &#x201C;</font><font style="font-style: italic; color: #000000">Use of
Proceeds</font><font style="color: #000000">."</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Risk factors</font></div>
</td>
<td style="vertical-align: top; width: 50%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">This investment involves a high degree of risk.
Please see &#x201C;</font><font style="font-style: italic; color: #000000">Risk
Factors</font><font style="color: #000000">&#x201D; and other
information included or incorporated by reference in this
prospectus supplement and the accompanying prospectus for a
discussion of certain factors you should carefully consider before
deciding to invest in shares of our common
stock.</font></font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">____________________</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000"><font style="vertical-align: top; font-size: 70%">(1)</font></font>
<font style="color: #000000">The number of shares outstanding after
this offering is based on 27,777,856 shares of common stock
outstanding on January 1, 2020. The number of shares of common
stock to be outstanding after this offering excludes the following
as of January 1, 2020:</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">833,500 shares issuable upon the
conversion of 500,000 shares of our 8.0% Series A Cumulative
Convertible Preferred Stock, or Series A Convertible Preferred
Stock;</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">1,499,650 shares issuable upon the
exercise of outstanding options with a weighted average exercise
price of $5.52 per share;</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">471,528 shares issuable upon the
exercise of outstanding warrants with a weighted average exercise
price of $6.36 per share;</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">480,000 shares of our
common stock issuable upon the exercise of the
Representative&#x2019;s Warrants to be issued upon the closing of
this offering at an exercise price equal to $1.25 per
share, or 125% of the initial public offering price of the common
stock;</font> </div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">782,955 shares reserved for future
issuances under our equity compensation plan; and</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px"><font style="font-size: 19px"><font style="font-size: 13px">up to 15,250,000
Earnout Shares which may be issued subject to the satisfaction of
earnout targets pursuant to the rights granted as consideration for
the mergers with Cure Based Development which closed on December
20, 2018.</font></font></font></div>
</div>
</div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-4</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">RISK
FACTORS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
<font style="color: #000000">Investing in our securities involves a
high degree of risk. You should carefully consider and evaluate all
of the information contained in this prospectus supplement, the
accompanying prospectus and in the documents we incorporate by
reference into this prospectus supplement and the accompanying
prospectus before you decide to purchase our securities. In
particular, you should carefully consider and evaluate the risks
and uncertainties described under the heading &#x201C;Risk
Factors&#x201D; in this prospectus supplement and the accompanying
prospectus.</font> You should also consider the risks,
uncertainties and assumptions discussed under Item 1A, &#x201C;Risk
Factors,&#x201D; in Part I of our Annual Report on Form 10-K for the
year ended September 30, 2019 as filed with the SEC on December 18,
2019 together with any updates or other risks contained in other
filings that we may make with the SEC after the date of this
prospectus, all of which are incorporated herein by reference, and
may be amended, supplemented or superseded from time to time by
other reports we file with the SEC in the future and any additional
prospectus supplement. <font style="color: #000000">Any of the
risks and uncertainties set forth in this prospectus supplement and
the accompanying prospectus, as updated by annual, quarterly and
other reports and documents that we file with the SEC and
incorporate by reference into this prospectus supplement or the
accompanying prospectus could materially and adversely affect our
business, results of operations and financial condition, which in
turn could materially and adversely affect the value of our common
stock. As a result, you could lose all or part of your investment.
&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO THIS OFFERING</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We have broad discretion in determining how to use the proceeds
from this offering and we cannot assure you that we will be
successful in spending the proceeds in ways that increase our
profitability or market value, or otherwise yield favorable
returns.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We plan to utilize
net proceeds of this offering for general working capital.
Nevertheless, we will have broad discretion in determining specific
expenditures. You will be entrusting your funds to our management,
upon whose judgment you must depend, with limited information
concerning the purposes to which the funds will ultimately be
applied. We may not be successful in spending the proceeds of this
offering in ways which increase our profitability or market value,
or otherwise yield favorable returns.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
If you purchase shares of our common stock sold in this offering,
you will experience immediate and substantial dilution in the net
tangible book value of your shares. In addition, we may issue
additional shares of common stock in the future which may result in
additional dilution to common shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">After giving effect
to the sale of 16,000,000 shares of our common stock
in this offering at a price of $1.00 per share for
aggregate gross proceeds to us of approximately
$14,600,000, and after deducting commissions and
estimated offering expenses payable by us, but giving no effect to
the exercise of the over-allotment option, purchasers of our common
stock in this offering will incur immediate dilution of
$1.45 per share of common stock in the pro forma as
adjusted net tangible book value of the common stock they acquire.
<font style="color: #000000">For a more detailed discussion of the
foregoing, please see the section entitled
&#x201C;</font><font style="font-style: italic; color: #000000">Dilution</font><font style="color: #000000">&#x201D; below. To the extent outstanding shares of
Series A Convertible Preferred Stock are converted into common
stock or outstanding stock options or warrants are exercised or the
Earnout Shares are issued, there will be further dilution to new
investors.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR COMPANY</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">
We are subject to the continued listing standards of the NYSE
American and our failure to satisfy these criteria may result in
delisting of our securities</font>.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Both our common
stock and our Series A Convertible Preferred Stock are listed on
the NYSE American. In order to maintain these listings, we must
maintain certain share prices, financial and share distribution
targets, including maintaining a minimum amount of
shareholders&#x2019; equity and a minimum number of public
shareholders. In addition to these objective standards, the NYSE
American may delist the securities of any issuer (i) if, in its
opinion, the issuer&#x2019;s financial condition and/or operating
results appear unsatisfactory; (ii) if it appears that the extent
of public distribution or the aggregate market value of the
security has become so reduced as to make continued listing on the
NYSE American inadvisable; (iii) if the issuer sells or disposes of
principal operating assets or ceases to be an operating company;
(iv) if an issuer fails to comply with the NYSE American&#x2019;s
listing requirements; (v) if an issuer&#x2019;s securities sell at
what the NYSE American considers a &#x201C;low selling price&#x201D;
and the issuer fails to correct this via a reverse split of shares
after notification by the NYSE American; or (vi) if any other event
occurs or any condition exists which makes continued listing on the
NYSE American, in its opinion, inadvisable. If the NYSE American
delists either our common stock and/or our Series A Convertible
Preferred Stock, investors may face material adverse consequences,
including, but not limited to, a lack of trading market for our
securities, reduced liquidity, decreased analyst coverage of our
securities, and an inability for us to obtain any additional
financing to fund our operations that we may need.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-5</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The impact of changes in the fair value of our contingent
liabilities associated with the Earnout Shares may materially
impact our results of operations in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
December 2018 we closed the Mergers with Cure Based Development. As
consideration for the Mergers, we had a contractual obligation,
after approval by our shareholders, to issue 15,250,000 shares of
our common stock, or the &#x201C;Initial Shares,&#x201D; to the
members of Cure Based Development of which 8,750,000 of the shares
will vest over a five year period and are subject to a voting proxy
agreement, as well as to issue another 15,250,000 shares of our
common stock, or the &#x201C;Earnout Shares,&#x201D; in the future
upon meeting certain earnout goals within the next five years. Our
shareholders approved the issuance of the both the Initial Shares
and the Earnout Shares at our 2019 annual shareholder meeting and
the Initial Shares were issued to members of Cure Based Development
on April 19, 2019. Under U.S. GAAP we are required to record a
non-cash contingent liability associated with both the Initial
Shares and the Earnout Shares. As of September 30, 2019, the
Initial Shares have been issued and have been reclassified from
contingent liability to additional paid in capital. At September
30, 2019, the total of this contingent liability increased
$32,461,680 and is reflective of the value of the Earnout Shares.
We are obligated to reassess the obligations associated with the
Earnout Shares and, in the event our estimate of the fair value of
the contingent consideration changes, we will record increases or
decreases in the fair value as an adjustment to earnings, which
could have a material impact on our results of operations, our
shareholders&#x2019; equity and the market price of our securities.
In particular, changes in the market price of our common stock,
which is one of the inputs used in determining the amount of the
non-cash contingent liability, will result in increases or
decreases in this liability and positively or negatively impact our
net loss or profit for the period. Investors should not place undue
reliance on the impact of these non-cash changes when evaluating
our results of operations in future periods, as they have no impact
on the operations of the business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We are unable at this time to predict the amount of our net income
(loss) for the three months ended December 31, 2019. Any change in
the contingent liability of the Earnout Shares at December 31, 2019
from September 30, 2019 could materially impact our net income
(loss).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Under
U.S. GAAP we were required to record a non-cash contingent
liability associated with both the Initial Shares and the Earnout
Shares. We are obligated to reassess the obligations associated
with the Earnout Shares and, in the event our estimate of the fair
value of the contingent consideration changes, we will record
increases or decreases in the fair value as an adjustment to
earnings, which could have a material impact on our results of
operations, our shareholders&#x2019; equity and the market price of
our securities. In particular, changes in the market price of our
common stock, which is one of the inputs used in determining the
amount of the non-cash contingent liability, will result in
increases or decreases in this liability and positively or
negatively impact our net loss or profit for the period, which
could be material.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The issuance of the Earnout Shares, the issuance of shares of our
common stock upon the conversion of outstanding shares of Series A
Convertible Preferred Stock and/or the exercise of outstanding
options and warrants may cause immediate and substantial dilution
to our existing shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Upon
the terms of the Mergers, we are obligated to issue up to an
additional 15,250,000 Earnout Shares to the former members of Cure
Based Development upon the satisfaction of certain aggregate net
revenue criteria within 60 months following the closing date. In
addition, we presently have outstanding shares of Series A
Convertible Preferred Stock that if converted would result in the
issuance of an additional 833,500 shares of common stock, together
with outstanding options and warrants that if exercised would
result in the issuance of an additional 1,971,178 shares of our
common stock. The issuance of the Earnout Shares, the conversion of
the Series A Convertible Preferred Stock and/or the issuance of
shares of our common stock upon exercise of warrants and options
will result in dilution to the interests of other
shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Holders of our shares of Series A Convertible Preferred Stock have
superior rights to our common shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have designated
5,000,000 shares of our preferred stock as Series A Convertible
Preferred Stock. In October 2019 we closed a firm commitment
underwritten public offering in which we sold 500,000 of these
shares and we may seek to sell additional shares of Series A
Convertible Preferred Stock in the future. The designations, rights
and preferences of the Series A Convertible Preferred Stock provide
the holders of those shares with rights with respect to the payment
of dividends, conversion rights, liquidation preferences and
redemption rights, including a mandatory redemption upon a board
approved change of control of our company. These designations,
rights and preferences provide the holders of Series A Convertible
Preferred Stock superior rights to those of our common
shareholders, including purchasers of shares in this
offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Our executive officers, directors and their affiliates may exert
control over us and may exercise influence over matters subject to
shareholder approval.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
executive officers and directors beneficially own and/or control
approximately 54% of our outstanding common stock as of January 1,
2020. Accordingly, these shareholders, if they act together, may
exercise substantial influence over matters requiring shareholder
approval, including the election of directors and approval of
corporate transactions. This concentration of ownership could have
the effect of delaying or preventing a change in control or
otherwise discourage a potential acquirer from attempting to obtain
control over us, which in turn could have a material adverse effect
on the market value of our securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Because we do not anticipate paying any cash dividends on our
common stock in the foreseeable future, capital appreciation, if
any, will be your sole source of potential gain.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
have never declared or paid cash dividends on our common stock. Our
ability to pay declare and pay cash dividends on our common stock
is limited by the designations, rights and preferences of our
Series A Convertible Preferred Stock. We do not expect to declare
dividends on our common stock in the foreseeable future. As a
result, capital appreciation, if any, of our shares of common stock
will be your sole source of gain for the foreseeable
future.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-6</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR OVERALL BUSINESS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We have a
history of losses and there are no assurances we will report
profitable operations in future periods</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
reported net losses attributable to common shareholders of
$50,428,226 and $412,075 for fiscal 2019 and fiscal 2018,
respectively. Included in our net loss for fiscal 2019 is
$5,927,773 associated with losses from our discontinued operations,
and an expense reflecting an increase of $32,461,680 in the
non-cash contingent liability associated with the Earnout Shares
primarily as a result of the change in the market price of our
common stock. Until such time, if ever, that we are successful in
generating profits which are sufficient to pay our operating
expenses it is likely we will continue to report losses in future
periods. There are no assurances we will generate substantial
revenues from our CBD operations or that we will ever generate
sufficient revenues to report profitable operations or a net
profit.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We have a limited operating history in a new market segment that
could impede our ability to achieve our goals for future
performance and brand strategy.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our wholly-owned
subsidiary, CBDI, succeeded to the operations of Cure Based
Development following the closing of the Mergers in December 2018.
We formed this subsidiary in connection with the Mergers and it had
no operating history prior to the Mergers. Cure Based Development
was formed in 2017 and did not begin reporting any meaningful
revenues until mid-2018. We are operating in a market segment that
has experienced significant growth and competition since the
passage of the Farm Bill in December 2018. We are experiencing all
of the challenges of a company with a limited operating history in
its current business seeking to effectively develop a brand in a
market segment with growing competition. These challenges make it
difficult for investors to evaluate our future business prospects
and make decisions based on estimates of our future performance. To
address these risks and uncertainties, we must do the
following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">successfully
execute our business strategy to offer the highest quality CBD in
the industry;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">introduce new,
differentiated botanical products;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">respond to
competitive business developments;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">effectively and
efficiently market and sell our line of CBD products;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">improve the
distribution of our CBD products; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">attract, integrate,
retain and motivate qualified personnel.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">During fiscal 2019
we spent approximately $7,831,000 on brand development and
marketing. In order to continue to develop brand recognition and
grow our sales, we will need to continue to invest in our brand
development and marketing strategies which may require us to raise
additional capital. Even with our focus on brand development in an
effort to increase our sales, our business strategy may not be
successful and we may not successfully address these risks. In the
event that we do not successfully address these risks, our
business, prospects, financial condition and results of operations
may be materially and adversely affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We may require additional capital to finance operations or for
potential acquisitions, and if we are unable to raise such capital
on beneficial terms this could restrict our growth.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may, in the future, require additional capital to help fund all or
part of our operations or for potential acquisitions. If, at the
time required, we do not have sufficient cash to finance those
additional capital needs, we will need to raise additional funds
through equity and/or debt financing. We cannot guarantee that, if
and when needed, additional financing will be available to us on
acceptable terms or at all. Further, if additional capital is
needed and is either unavailable or cost prohibitive, our growth
may be limited as we may need to change our business strategy to
slow the rate of our expansion plans. In addition, any additional
financing we undertake could impose additional covenants upon us
that restrict our operating flexibility, and, if we issue equity
securities to raise capital or as acquisition consideration, our
existing shareholders may experience dilution or the new securities
may have rights senior to those of our Series A Convertible
Preferred Stock, assuming the holders of the Series A Convertible
Preferred Stock approve the issuance of such senior
securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-7</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The issuances of the Earnout Shares to the Cure Based Development
members will significantly dilute our existing
shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon the terms set
forth in the merger agreement, on the closing date of the Mergers
the members of Cure Based Development received the right to receive
15,250,000 Initial Shares, representing approximately 60% of our
outstanding common stock following such issuance at the time, as
the consideration for the Mergers. The merger agreement also
provides that we are obligated to issue up to an additional
15,250,000 Earnout Shares as part of the Mergers consideration upon
the satisfaction of certain aggregate net revenue criteria by cbdMD
within 60 months following the closing date. As of January 1, 2020,
there were 27,777,856 shares of our common stock issued and
outstanding, which includes the 15,250,000 Initial Shares which
were issued in April 2019. Assuming the possible issuance of an
additional 15,250,000 Earnout Shares, but giving effect to no other
change to the number of shares of our common stock issued and
outstanding, the members of Cure Based Development, which includes
Mr. R. Scott Coffman, our co-CEO and member of our board of
directors, would own approximately 64% of our then outstanding
shares of common stock. Therefore, the ownership and voting rights
of our existing shareholders will be proportionally
reduced.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
We may be unable to liquidate securities we accept as partial
compensation under consulting agreements which could adversely
impact our liquidity in future periods.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
ability to sell any securities we had accepted as partial
compensation under consulting agreements is dependent upon a number
of factors, including the existence of a liquid market for the
securities and our compliance with the resale provisions of federal
securities laws which require us to hold the shares for at least
six months, among other factors. If we accept securities, we expect
to generally accept securities from issuers who are publicly traded
or who are expecting to become a publicly traded company. There are
no assurances a liquid market will exist in such securities at such
time as we are able to resell the shares, or that the price we may
receive will be commensurate with the value of the services we are
providing. In that event, we would not benefit from the expected
rise in the market price of the securities we own as a result of
our efforts on behalf of the client company. In addition, depending
upon the terms of our business relationship with the issuer of the
securities, it is possible that from time to time we could be in
possession of non-public information regarding the issuer which
could prohibit us from disposing of the shares at a time when it is
advantageous to us to do so. If we are unable to readily liquidate
any securities we accept as compensation, we could be deprived of
the cash value of those services and we would be required to
write-off the carrying value of the securities which could
adversely impact our results of operations in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We rely on third-parties to manufacture and to compound some of our
products, we have no control over these manufacturers and may not
be able to obtain quality products on a timely basis or in
sufficient quantity.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Some
of our products are manufactured or compounded by unaffiliated
third parties. We do not have any long-term contracts with any of
these third parties, and we expect to compete with other companies
for raw materials, production and import capacity. If we experience
significant increased demand, or need to replace an existing
manufacturer, there can be no assurance that additional
manufacturing capacity will be available when required on terms
that are acceptable to us, or at all, or that any manufacturer or
compounder would allocate sufficient capacity to us in order to
meet our requirements. In addition, even if we are able to expand
existing or find new sources, we may encounter delays in production
and added costs as a result of the time it takes to engage third
parties. Any delays, interruption or increased costs in the
manufacturing or compounding of our products could have an adverse
effect on our ability to meet retail customer and consumer demand
for our products and result in lower revenues and net income both
in the short and long-term.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
We face risks associated with the manufacture of our products which
could adversely affect our business and financial
results.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are subject to the risks inherent in manufacturing our products,
including industrial accidents, environmental events, strikes and
other labor disputes, disruptions in supply chain or information
systems, loss or impairment of key manufacturing sites or
suppliers, product quality control, safety, increase in commodity
prices and energy costs, licensing requirements and other
regulatory issues, as well as natural disasters and other external
factors over which we have no control. If such an event were to
occur, it could have an adverse effect on our business and
financial results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We could experience losses related to undisclosed liabilities of
EE1 and I&#x2019;M1.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Effective September
30, 2019 we discontinued the operations of EE1 and
I&#x2019;M1.&#xA0; In November 2019 we entered into a settlement and
release agreement with the minority holders of EE1 and I&#x2019;M1
and other related parties.&#xA0; The terms of this agreement
provided, in part, that the parties agreed to transfer the accounts
receivable of EE1 and the minority interest of both EE1 and IM1 to
us and we agreed to have all rights to certain past contracts or
customers for those entities assigned to the minority
holders.&#xA0; As a result, we are now the sole member of these
entities.&#xA0; While the settlement and release agreement contains
an indemnification provision, if we should discover in the future
that there are undisclosed liabilities in one or both of these
entities, we could be liable for the payment of these undisclosed
liabilities, which could be material, until such time, if ever,
that we were able to recoup any such amounts from the indemnifying
parties.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-8</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">RISKS
RELATED TO THE REGULATORY ENVIRONMENT</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Changes to state laws pertaining to industrial hemp could slow the
use of industrial hemp which would materially impact our revenues
in future periods.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">As of the date of
this prospectus supplement, approximately 40 states authorized
industrial hemp programs pursuant to the Farm Bill. Continued
development of the industrial hemp industry will be dependent upon
new legislative authorization of industrial hemp at the state
level, and further amendment or supplementation of legislation at
the federal level. Any number of events or occurrences could slow
or halt progress all together in this space. While progress within
the industrial hemp industry is currently encouraging, growth is
not assured. While there appears to be ample public support for
favorable legislative action, numerous factors may impact or
negatively affect the legislative process(es) within the various
states where we have business interests. Any one of these factors
could slow or halt use of industrial hemp, which could negatively
impact the business up to possibly causing us to discontinue
operations as a whole.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Costs associated with compliance with numerous laws and regulations
could impact our financial results. In addition, we have become and
could in the future become subject to increased litigation risks
associated with the CBD industry.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The manufacture,
labeling and distribution by us of the CBD products is regulated by
various federal, state and local agencies. These governmental
authorities may commence regulatory or legal proceedings, which
could restrict the permissible scope of our product claims or the
ability to sell products in the future. The U.S. Food and Drug
Administration, or FDA, may regulate our products to ensure that
the products are not adulterated or misbranded. We are subject to
regulation by the federal government and other state and local
agencies as a result of our CBD products. The shifting compliance
environment and the need to build and maintain robust systems to
comply with different compliance in multiple jurisdictions
increases the possibility that we may violate one or more of the
requirements. If our operations are found to be in violation of any
of such laws or any other governmental regulations that apply to
our company, we may be subject to penalties, including, without
limitation, civil and criminal penalties, damages, fines, the
curtailment or restructuring of our operations, any of which could
adversely affect the ability to operate our business and our
financial results. Failure to comply with FDA requirements may
result in, among other things, injunctions, product withdrawals,
recalls, product seizures, fines and criminal prosecutions. Our
advertising is subject to regulation by the U.S. Federal Trade
Commission, or FTC, under the Federal Trade Commission Act.
Additionally, some states also permit advertising and labeling laws
to be enforced by attorneys general who may seek relief for
consumers, seek class-action certifications, seek class-wide
damages and product recalls of products sold by us. For example, in
November 2019 the FDA issued warning letters to <font style="color: #333333; background-color: #ffffff">15 companies for
illegally selling products containing CBD in ways that violate
the</font> <font style="background-color: #ffffff">Federal Food,
Drug, and Cosmetic Act</font><font style="color: #333333; background-color: #ffffff">. Notwithstanding that
we were not a recipient of a warning letter, and we believe our
products are properly labeled as required under federal law, cbdMD,
along with other of our competitors who also did not receive FDA
warning letters, have been named in a class action lawsuit which we
believe is without merit.</font> Any actions against our company by
governmental authorities or private litigants could be time
consuming, costly to defend, could result in significant payments
if we were to be found to be liable and could have a material
adverse effect on our business, financial condition and results of
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Uncertainty caused by potential changes to legal regulations could
impact the use of CBD products.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">There is
substantial uncertainty and different interpretations among
federal, state and local regulatory agencies, legislators,
academics and businesses as to the scope of operation of Farm
Bill-compliant hemp programs relative to the emerging regulation of
cannabinoids. These different opinions include, but are not limited
to, the regulation of cannabinoids by the U.S. Drug Enforcement
Administration, or DEA, and/or the FDA and the extent to which
manufacturers of products containing Farm Bill-compliant
cultivators and processors may engage in interstate commerce. The
uncertainties cannot be resolved without further federal, and
perhaps even state-level, legislation, regulation or a definitive
judicial interpretation of existing legislation and rules. If these
uncertainties continue, they may have an adverse effect upon the
introduction of our products in different markets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-9</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">USE
OF PROCEEDS</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We will have broad
discretion in the use of the net proceeds from the sale of the
shares of common stock offered under this prospectus supplement. We
presently intend to use the net proceeds from the sale of our
shares of common stock for general working capital. We reserve the
right, however, to use the net proceeds from this offering for any
proper corporate purpose as determined by our board of
directors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pending our use of
the net proceeds from this offering, we intend to invest the net
proceeds in a variety of capital preservation investments,
including short-term, investment grade, interest bearing
instruments and U.S. government securities.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-10</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
CAPITALIZATION</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
following table sets forth our capitalization as of September 30,
2019:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">on an actual
basis;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">on a pro forma
basis to give effect to the issuance and sale of 500,000 shares of
our Series A Convertible Preferred Stock in October 2019 and the
receipt of $4,270,000 of net proceeds and 57,500 shares of our
common stock issued in January 1, 2020; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">on
a pro forma as adjusted basis to give effect to the sale of
16,000,000 shares of common stock in this offering at
the public offering price of $1.00 per share, after
deducting underwriting discounts and commissions and other
estimated offering expenses payable by us, but giving no effect to
the exercise of the over-allotment option</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
capitalization table should be read in conjunction with
Management&#x2019;s Discussion and Analysis of Financial Condition
and Results of Operations and our consolidated financial statements
and related notes included in our Annual Report on Form 10-K for
the year ended September 30, 2019 as filed with the SEC on December
18, 2019, and other financial information included and incorporated
by reference in this prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; margin-left: 0px; padding-bottom: 2px;"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:36%;">
<div><font style="text-align: left; vertical-align: bottom; width: 3%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 94%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">As of September 30,
2019</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 3%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; margin-left: 0px; padding-bottom: 2px;"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Actual</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Pro
Forma</font></font></div>
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">(unaudited)</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Pro Forma As
Adjusted</font></font></div>
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">(unaudited)</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:48px;"><font style="font-size: 13px; font-family: Times New Roman">Cash and cash
Equivalents</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,689,966</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">8,959,966</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">23,529,996<br></font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:48px;"><font style="font-size: 13px; font-family: Times New Roman">Preferred stock,
authorized 50,000,000 shares, $0.001 par value; no shares issued
and outstanding; 500,000 shares and 500,000 shares of Series A
Convertible Preferred Stock issued and outstanding,
respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">500</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">500<br></font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:48px;"><font style="font-size: 13px; font-family: Times New Roman">Common stock,
authorized 150,000,000 shares, $0.001 par value; 27,720,356 shares,
27,777,856 shares and 43,777,856 shares, issued and
outstanding, respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">27,720</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">27,777</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">43,777<br></font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:48px;"><font style="font-size: 13px; font-family: Times New Roman">Additional paid-in
capital</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,186,524</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">101,593,967</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">116,147,967<br></font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;padding-bottom:2px;margin-left:48px;"><font style="font-size: 13px; font-family: Times New Roman">Accumulated
deficit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(59,610,260</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<br></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(59,610,260</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<br></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(59,610,260</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:48px;"><font style="font-size: 13px; font-family: Times New Roman">Total
shareholders&#x2019; equity</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">37,603,984</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">42,011,984</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">56,581,984<br></font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:48px;"><font style="font-size: 13px; font-family: Times New Roman">Total
capitalization</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">37,603,984</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">42,011,984</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">56,581,984<br></font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">All
information in this Capitalization section excludes:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font>
<font><br></font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">833,500 shares issuable upon the
conversion of 500,000 shares of our Series A Convertible Preferred
Stock;</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">1,219,650 shares issuable upon the
exercise of outstanding options with a weighted average exercise
price of $6.07 per share (actual) or 1,499,650 shares issuable upon
the exercise of outstanding options with a weighted average
exercise price of $5.52 per share (pro forma and pro forma as
adjusted);</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">423,605 shares issuable upon the
exercise of outstanding warrants with a weighted average exercise
price of $6.64 per share (actual) or 471,528 shares issuable upon
the exercise of outstanding warrants with a weighted average
exercise price of $6.36 per share (pro forma);</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">480,000 shares of our
common stock issuable upon the exercise of the
Representative&#x2019;s Warrants to be issued upon the closing of
this offering at an exercise price equal to $1.25 per
share, or 125% of the initial public offering price of the common
stock;</font> </div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">962,955 shares reserved for future
issuance under our equity compensation plan (actual) or 782,955
shares reserved for future issuances under our equity compensation
plan (pro forma and pro forma as adjusted);</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px">up to 15,250,000 Earnout Shares which
may be issued subject to the satisfaction of earnout targets;
and</font></div>
</div>
</div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="font-size: 13px"><font style="font-size: 16px"><font style="font-size: 13px">the future impact
of changes in the fair value of the contingent liabilities
associated with the Earnout Shares.</font></font></font></div>
</div>
</div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-11</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
DIVIDEND POLICY</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">We do not currently intend to pay dividends on our
common stock. Our ability to declare and pay dividends on our
common stock is limited by the designations, rights and preferences
of the Series A Convertible Preferred Stock.</font> Unless full
cumulative dividends on all shares of Series A Convertible
Preferred Stock have been or contemporaneously are declared and
paid or declared and a sum sufficient for the payment thereof has
been or contemporaneously is set apart for payment for all past
dividend periods, no dividends (other than in shares of our common
stock or in shares of any junior stock we may issue as to dividends
and upon liquidation) may be declared or paid or set aside for
payment on our shares of our common stock. Even if we meet these
conditions, t<font style="color: #000000">he declaration, amount
and payment of any future dividends on shares of our common stock,
if any, will be at the sole discretion of our board of directors,
which may take into account general and economic conditions, our
financial condition and results of operations, our available cash
and current and anticipated cash needs, capital requirements,
contractual, legal, tax and regulatory restrictions, the
implications of the payment of dividends by us to our shareholders
or by our subsidiaries to us, and any other factors that our board
of directors may deem relevant.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-12</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">DILUTION</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">A purchaser of our
shares of our common stock in this offering will be diluted
immediately to the extent of the difference between the offering
price per share and the pro forma as adjusted net book value per
share of our common stock upon the closing of this offering. Our
historical net tangible book value per common share as of September
30, 2019, was $(38,701,013), or approximately $(1.40) per share of
outstanding common stock, based on 27,720,356 shares of common
stock outstanding as of September 30, 2019. Net tangible book value
per share of our common stock is determined at any date by
subtracting total liabilities from the amount of total tangible
assets, and dividing this amount by the number of shares of common
stock deemed to be outstanding as of that date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">Our pro forma net
tangible book value as of September 30, 2019 was $(34,431,013) or
approximately $(1.24) per share of common stock, based upon
27,777,856 shares outstanding after giving effect to (i) the
issuance and sale in October 2019 of 500,000 shares of our Series A
Convertible Preferred Stock, and (ii) the issuance in January 2020
of 57,500 shares of our common stock. After giving effect to (x)
these pro form issuances, and (y) the sale of
16,000,000 shares of our common stock at the offering
price of $1.00 per share in this offering, but giving
no effect to the possible exercise of the over-allotment option,
our pro forma as adjusted net tangible book value of our common
stock as of September 30, 2019 would have been approximately
$(19,861,013), or approximately $(0.45)
per share of outstanding common stock. This amount represents an
immediate increase in net tangible book value of $0.95
per share of our common stock to our existing common shareholders
and an immediate dilution of $1.45 per share of our
common stock to new investors purchasing common stock in this
offering, as illustrated in the following table:</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr style="background-color:#cceeff;">
<td rowspan="1" style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Public
offering price per common share</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.00<br></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Pro
forma net tangible book value per share of common stock before this
offering as of September 30, 2019</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1.24</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Increase
in pro forma net tangible book value per share of common stock
attributable to this offering</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">0.95<br></font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Pro
forma as adjusted net tangible book value per share of common stock
after giving effect to this offering</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(0.45</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)<br></font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Dilution
per share of common stock to new investors in this
offering</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1.45</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<br></font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The foregoing table
does not take into account further dilution to new investors that
could occur upon the conversion of the outstanding shares of Series
A Convertible Preferred Stock or the exercise of outstanding
options or warrants having a per share exercise price less than the
per common share offering price to the public in this
offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The foregoing table
excludes the following as of September 30, 2019:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">833,500 shares
issuable upon the conversion of 500,000 shares of our Series A
Convertible Preferred Stock which were issued and sold in October
2019;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">1,219,650 shares
issuable upon the exercise of outstanding options with a weighted
average exercise price of $6.07 per share;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">423,605 shares
issuable upon the exercise of outstanding warrants with a weighted
average exercise price of $6.64 per share;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">480,000
shares of our common stock issuable upon the exercise of the
Representative&#x2019;s Warrants to be issued upon the closing of
this offering at an exercise price equal to $1.25 per
share, or 125% of the initial public offering price of the common
stock;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">962,955 shares
reserved for future issuances under our equity compensation plan;
and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">up to 15,250,000
Earnout Shares which may be issued subject to the satisfaction of
earnout targets.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-13</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">UNDERWRITING</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">ThinkEquity, a
division of Fordham Financial Management, Inc., is acting as the
representative of the underwriters of this offering, or the
Representative, or ThinkEquity. We have entered into an
underwriting agreement dated January 9, 2020 with the
Representative. Subject to the terms and conditions of the
underwriting agreement, we have agreed to sell to each underwriter
named below and each underwriter named below has severally and not
jointly agreed to purchase from us, at the public offering price
per share less the underwriting discounts set forth on the cover
page of this prospectus supplement, the number of shares of common
stock listed next to its name in the following table:</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent: 0px; margin-right: 0px; margin-left: 0px; padding-bottom: 2px;"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<font style="font-weight: bold">Underwriters</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;">Number
of Shares</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">ThinkEquity, a
division of Fordham Financial Management, Inc.</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">12,480,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="padding-bottom: 2px;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="font-size: 13px; font-family: Times New Roman">The
Benchmark Company, LLC</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">3,520,000</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="padding-bottom: 4px;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Total</font>
&#xA0;</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block; padding-bottom: 4px;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block; border-bottom: 4px double rgb(0, 0, 0);">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block; border-bottom: 4px double rgb(0, 0, 0);">16,000,000</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block; padding-bottom: 4px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">All of the shares
to be purchased by the underwriters will be purchased from
us.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The underwriting
agreement provides that the obligations of the underwriters to pay
for and accept delivery of the shares of common stock offered by
this prospectus supplement are subject to various conditions and
representations and warranties, including the approval of certain
legal matters by their counsel and other conditions specified in
the underwriting agreement. The shares of common stock are offered
by the underwriters, subject to prior sale, when, as and if issued
to and accepted by them. The underwriters reserve the right to
withdraw, cancel or modify the offer to the public and to reject
orders in whole or in part. The underwriters are obligated to take
and pay for all of the shares of common stock offered by this
prospectus supplement if any such shares of common stock are taken,
other than those shares of common stock covered by the
over-allotment option described below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Over-Allotment
Option</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">We have granted to
the underwriters an option, exercisable no later than 45 calendar
days after the closing of this offering, to purchase up to
2,400,000 additional shares of common stock (15% of
the shares of common stock sold in this offering) from us to cover
over-allotments, if any, at a price per share of common stock equal
to the public offering price, less the underwriting discounts and
commissions. The underwriters may exercise this option only to
cover over-allotments made in connection with this offering. If the
underwriters exercise this option in whole or in part, then the
underwriters will be severally committed, subject to the conditions
described in the underwriting agreement, to purchase these
additional shares of common stock. If any additional shares of
common stock are purchased, the underwriters will offer the
additional shares of common stock on the same terms as those on
which the shares of common stock are being offered
hereby.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0; <font style="font-size: 13px; font-family: Times New Roman"><br>
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Discounts
and Commissions</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="background-color: #ffffff; font-size: 13px; font-family: Times New Roman">
The Representative has advised us that the underwriters propose to
offer the shares of common stock to the public at the public
offering price per share set forth on the cover page of this
prospectus supplement. The underwriters may offer shares to
securities dealers at that price less a concession of not more than
$0.04 per share. After the initial offering to the
public, the public offering price and other selling terms may be
changed by the Representative.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The following table
summarizes the public offering price, underwriting discounts and
commissions and proceeds before expenses to us assuming both no
exercise and full exercise by the underwriters of their
over-allotment option:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font><br></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;">Per
Share</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;">Total
Without Over-allotment Option</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;">Total
With Over-allotment Option</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">Public offering
price</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1.00</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">16,000,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">18,400,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:64%;">
<div>
<div style="padding-bottom: 2px;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">Underwriting
discounts and commissions (7.5%)</font></div>
</div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block;">0.075</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block;">1,200,000</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block;">1,380,000</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div>
<div style="padding-bottom: 4px;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 13px; font-family: Times New Roman">Proceeds, before
expenses, to us</font></div>
</div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block;">0.925</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block;">14,800,000</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; font-size: 13px; font-family: Times New Roman; display: inline-block;">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; font-size: 13px; font-family: Times New Roman; display: inline-block;">17,020,000</font><font style="text-align: left; vertical-align: bottom; width: 10%; font-size: 13px; font-family: Times New Roman; display: inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="background-color: #ffffff">We</font> have agreed to reimburse the
underwriters for all of their reasonable and actual accountable
out-of-pocket fees and costs incurred by the underwriters in
connection with this offering, including the fees and expenses of
the underwriters&#x2019; legal counsel, up to a maximum of one-half
of 1.0% (0.5%) of the total gross proceeds raised in this
offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">We estimate the
expenses of this offering payable by us, not including underwriting
discounts and commissions, will be approximately
$230,000.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-14</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Representative&#x2019;s
Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-size: 13px; font-family: Times New Roman">Upon closing of
this offering, we have agreed to issue to the Representative as
compensation the Representative&#x2019;s Warrants, which are
warrants to purchase a number of shares of common stock equal to 3%
of the aggregate number of shares of common stock sold in this
offering (excluding the over-allotment option), which equals
480,000 shares. The Representative&#x2019;s Warrants will be
exercisable at a per share exercise price equal to 125% of the
public offering price per share in this offering. The
Representative&#x2019;s Warrants are exercisable at any time and
from time to time, in whole or in part, during the four and
one-half year period commencing 180 days from the &#x201C;effective
date&#x201D; <font style="color: #000000">(pursuant to Rule
430B(f)(2) of the Securities Act)</font> of <font style="color: #000000">the registration statement of which this
prospectus supplement is a part, which we refer to as the effective
date of</font> this offering.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The
Representative&#x2019;s Warrants have been deemed compensation by
FINRA and are therefore subject to a 180-day lock-up pursuant to
Rule 5110(g)(1) of FINRA. The Representative (or permitted
assignees under Rule 5110(g)(1)) will not sell, transfer, assign,
pledge, or hypothecate these warrants or the securities underlying
these warrants, nor will they engage in any hedging, short sale,
derivative, put, or call transaction that would result in the
effective economic disposition of the warrants or the underlying
securities for a period of 180 days from the effective date of this
offering. <font style="color: #000000">It is not anticipated that
the Representative&#x2019;s Warrants will be registered and included
in the registration statement of which this prospectus supplement
is a part.</font> However, the Representative&#x2019;s Warrants
provide for registration rights of the underlying shares of common
stock upon request, in certain cases. The one demand registration
right provided will not be greater than five years from the
effective date of this offering in compliance with FINRA Rule
5110(f)(2)(G)(iv). The piggyback registration rights provided will
not be greater than seven years from the effective date of this
offering in compliance with FINRA Rule 5110(f)(2)(G)(v). We will
bear all fees and expenses attendant to registering the securities,
including only one demand registration right and unlimited
piggyback registration rights granted by us to the Representative,
issuable on exercise of the Representative&#x2019;s Warrants other
than underwriting commissions incurred and payable by the holders
of the warrants. The exercise price and number of shares issuable
upon exercise of the warrants may be adjusted in certain
circumstances including in the event of a stock dividend or our
recapitalization, reorganization, merger or consolidation. However,
the exercise price of the Representative&#x2019;s Warrants or
underlying shares will not be adjusted for issuances of shares of
common stock at a price below the warrant exercise
price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Right
of First Refusal</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">From the date of
the executed underwriting agreement entered into in connection with
this offering until June 30, 2020, the Representative will have,
subject to certain exceptions, an irrevocable right of first
refusal to act as sole investment banker, sole book-runner and/or
sole placement agent, at the Representative&#x2019;s discretion, for
each and every future public and private equity financing,
including equity-linked financings, during such period, for us, or
any successor to or any subsidiary of us, on terms customary for
the Representative. The Representative will have the sole right to
determine whether or not any other broker-dealer shall have the
right to participate in any such offering and the economic terms of
any such participation.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Discretionary
Accounts</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The underwriters do
not intend to confirm sales of the securities offered hereby to any
accounts over which they have discretionary authority.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Other</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">From time to time, certain of the underwriters
and/or their affiliates have provided, and may in the future
provide, various investment banking and other financial services
for us for which</font> services <font style="color: #000000">they
have received and, may in the future receive, customary fees.
&#xA0;In the course of their businesses, the underwriters and their
affiliates may actively trade our securities or loans for their own
account or for the accounts of customers, and, accordingly, the
underwriters and their affiliates may at any time hold long or
short positions in such securities or loans.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Except for services provided in connection with
this offering and our underwritten public offering of our 8.0%
Series A Cumulative Convertible Preferred Stock in October 2019 in
which ThinkEquity acted as lead underwriter, no underwriter has
provided any investment banking or other financial services to us
during the 180-day period preceding the date of this prospectus
supplement and we do not expect to retain any underwriter to
perform any investment banking or other financial services for at
least 90 days after the date of this prospectus
supplement.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-15</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Lock-Up
Agreements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pursuant to
&#x201C;lock-up&#x201D; agreements, we and our executive officers and
directors and greater than 5% stockholders have agreed, subject to
limited exceptions, without the prior written consent of the
Representative not to directly or indirectly, offer to sell, sell,
pledge or otherwise transfer or dispose of any of shares of (or
enter into any transaction or device that is designed to, or could
be expected to, result in the transfer or disposition by any person
at any time in the future of) our common stock, enter into any swap
or other derivatives transaction that transfers to another, in
whole or in part, any of the economic benefits or risks of
ownership of shares of our common stock, make any demand for or
exercise any right or cause to be filed a registration statement,
including any amendments thereto, with respect to the registration
of any shares of common stock or securities convertible into or
exercisable or exchangeable for common stock or any of our other
securities or publicly disclose the intention to do any of the
foregoing, subject to customary exceptions, for a period of 45 days
from the date of this prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">NYSE
American Listing</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our common stock is
listed on the NYSE American under the symbol
&#x201C;YCBD.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Transfer
Agent</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our transfer agent
is <font style="color: #000000">VStock Transfer, LLC, 18 Lafayette
Place, Woodmere, New York 11598.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Price
Stabilization, Short Positions and Penalty Bids</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In connection with
this offering, the underwriters may engage in transactions that
stabilize, maintain or otherwise affect the price of our common
stock. Specifically, the underwriters may over-allot in connection
with this offering by selling more shares than are set forth on the
cover page of this prospectus supplement. This creates a short
position in our common stock for its own account. The short
position may be either a covered short position or a naked short
position. In a covered short position, the number of shares of
common stock over-allotted by the underwriters is not greater than
the number of shares of common stock that they may purchase in the
over-allotment option. In a naked short position, the number of
shares of common stock involved is greater than the number of
shares common stock in the over-allotment option. To close out a
short position, the underwriters may elect to exercise all or part
of the over-allotment option. The underwriters may also elect to
stabilize the price of our common stock or reduce any short
position by bidding for, and purchasing, common stock in the open
market.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The underwriters
may also impose a penalty bid. This occurs when a particular
underwriter or dealer repays selling concessions allowed to it for
distributing shares of common stock in this offering because the
underwriter repurchases the shares of common stock in stabilizing
or short covering transactions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Finally, the
underwriters may bid for, and purchase, shares of our common stock
in market making transactions, including &#x201C;passive&#x201D;
market making transactions as described below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">These activities
may stabilize or maintain the market price of our common stock at a
price that is higher than the price that might otherwise exist in
the absence of these activities. The underwriters are not required
to engage in these activities, and may discontinue any of these
activities at any time without notice. These transactions may be
effected on the national securities exchange on which our shares of
common stock are traded, in the over-the-counter market, or
otherwise.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-16</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Indemnification</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have agreed to
indemnify the underwriters against liabilities relating to this
offering arising under the Securities Act and the Exchange Act,
liabilities arising from breaches of some or all of the
representations and warranties contained in the underwriting
agreement, and to contribute to payments that the underwriters may
be required to make for these liabilities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Electronic
Distribution</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">This prospectus supplement in electronic format
may be made availa</font>b<font style="color: #000000">le on
websites or through other online services maintained by one or more
of the underwriters, or by their affiliates. &#xA0;Other than this
prospectus supplement in electronic format, the information on any
underwriters&#x2019; website and any information contained in any
other website maintained by an underwriter is not part of this
prospectus supplement or the registration statement of which this
prospectus forms a part, has not been approved and/or endorsed by
us or any underwriter in its capacity as underwriter, and should
not be relied upon by investors.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Selling
Restrictions</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">No action has been
taken in any jurisdiction (except in the United States) that would
permit a public offering of our common stock, or the possession,
circulation or distribution of this prospectus supplement, the
accompanying prospectus or any other material relating to us or our
common stock in any jurisdiction where action for that purpose is
required. Accordingly, our common stock may not be offered or sold,
directly or indirectly, and none of this prospectus supplement, the
accompanying prospectus or any other offering material or
advertisements in connection with our common stock may be
distributed or published, in or from any country or jurisdiction,
except in compliance with any applicable rules and regulations of
any such country or jurisdiction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
European Economic Area</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In relation to each
Member State of the European Economic Area which has implemented
the Prospectus Directive, each a &#x201C;Relevant Member
State&#x201D;, with effect from and including the date on which the
Prospectus Directive is implemented in that Relevant Member State,
or the &#x201C;Relevant Implementation Date&#x201D;, our securities
will not be offered to the public in that Relevant Member State
prior to the publication of a prospectus in relation to our
securities that has been approved by the competent authority in
that Relevant Member State or, where appropriate, approved in
another Relevant Member State and notified to the competent
authority in that Relevant Member State, all in accordance with the
Prospectus Directive, except that, with effect from and including
the Relevant Implementation Date, an offer of our securities may be
made to the public in that Relevant Member State at any
time:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 48px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">to any legal entity
that is a qualified investor as defined in the Prospectus
Directive;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 48px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">to fewer than 100
or, if the Relevant Member State has implemented the relevant
provision of the 2010 PD Amending Directive, 150 natural or legal
persons (other than qualified investors as defined in the
Prospectus Directive), as permitted under the Prospectus Directive,
subject to obtaining the prior consent of the manager for any such
offer; or</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 48px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">in any other
circumstances which do not require the publication by the issuer of
a prospectus pursuant to Article 3(2) of the Prospectus Directive,
provided that no such offer of the securities shall require the
issuer or any underwriter to publish a prospectus pursuant to
Article 3 of the Prospectus Directive.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">For the purposes of
this provision, the expression an &#x201C;offer of securities to the
public&#x201D; in relation to any securities in any Relevant Member
State means the communication in any form and by any means of
sufficient information on the terms of the offer and securities to
be offered so as to enable an investor to decide to purchase or
subscribe securities, as the same may be varied in that Relevant
Member State by any measure implementing the Prospectus Directive
in that Relevant Member State and the expression &#x201C;Prospectus
Directive&#x201D; means Directive 2003/71/EC (and amendments
thereto, including the 2010 PD Amending Directive, to the extent
implemented in the Relevant Member State), and includes any
relevant implementing measure in each Relevant Member State and the
expression &#x201C;2010 PD Amending Directive&#x201D; means Directive
2010/73/EU.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-17</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
United Kingdom</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In the United
Kingdom, this document is being distributed only to, and is
directed only at, and any offer subsequently made may only be
directed at persons who are &#x201C;qualified investors&#x201D; (as
defined in the Prospectus Directive) (i) who have professional
experience in matters relating to investments falling within
Article 19 (5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (the Order), and/or
(ii) who are high net worth companies (or persons to whom it may
otherwise be lawfully communicated) falling within Article 49(2)(a)
to (d) of the Order (all such persons together, the relevant
persons). This document must not be acted on or relied on in the
United Kingdom by persons who are not relevant persons. In the
United Kingdom, any investment or investment activity to which this
document relates is only available to, and will be engaged in with,
relevant persons.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Canada</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The offering of our
common stock in Canada is being made on a private placement basis
in reliance on exemptions from the prospectus requirements under
the securities laws of each applicable Canadian province and
territory where our common stock may be offered and sold, and
therein may only be made with investors that are purchasing, or
deemed to be purchasing, as principal and that qualify as both an
&#x201C;accredited investor&#x201D; as such term is defined in
National Instrument 45-106 <font style="font-style: italic">Prospectus Exemptions</font> or subsection
73.3(1) of the <font style="font-style: italic">Securities
Act</font> (Ontario) and as a &#x201C;permitted client&#x201D; as
such term is defined in National Instrument 31-103 <font style="font-style: italic">Registration Requirements, Exemptions and
Ongoing Registrant Obligations.</font> Any offer and sale of our
common stock in any province or territory of Canada may only be
made through a dealer that is properly registered under the
securities legislation of the applicable province or territory
wherein our common stock is offered and/or sold or, alternatively,
where such registration is not required.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any resale of our
common stock by an investor resident in Canada must be made in
accordance with applicable Canadian securities laws, which require
resales to be made in accordance with an exemption from, or in a
transaction not subject to, prospectus requirements under
applicable Canadian securities laws. These resale restrictions may
under certain circumstances apply to resales of the common stock
outside of Canada.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Securities
legislation in certain provinces or territories of Canada may
provide a purchaser with remedies for rescission or damages if this
prospectus (including any amendment thereto) contains a
misrepresentation, provided that the remedies for rescission or
damages are exercised by the purchaser within the time limit
prescribed by the securities legislation of the purchaser&#x2019;s
province or territory. The purchaser should refer to any applicable
provisions of the securities legislation of the purchaser&#x2019;s
province or territory for particulars of these rights or consult
with a legal advisor.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pursuant to section
3A.3 (or, in the case of securities issued or guaranteed by the
government of a non-Canadian jurisdiction, section 3A.4) of
National Instrument 33-105 <font style="font-style: italic">Underwriting Conflicts</font> (&#x201C;NI
33-105&#x201D;), the underwriters are not required to comply with
the disclosure requirements of NI 33-105 regarding underwriter
conflicts of interest in connection with this
offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon receipt of
this prospectus supplement, each Qu&#xE9;bec investor hereby
confirms that it has expressly requested that all documents
evidencing or relating in any way to the sale of the securities
described herein (including for greater certainty any purchase
confirmation or any notice) be drawn up in the English language
only. <font style="font-style: italic">Par la r&#xE9;ception de ce
document, chaque investisseur qu&#xE9;becois confirme par les
pr&#xE9;sentes qu&#x2019;il a express&#xE9;ment exig&#xE9; que tous
les documents faisant foi ou se rapportant de quelque mani&#xE8;re
que ce soit &#xE0; la vente des valeurs mobili&#xE8;res
d&#xE9;crites aux pr&#xE9;sentes (incluant, pour plus de certitude,
toute confirmation d&#x2019;achat ou tout avis) soient
r&#xE9;dig&#xE9;s en anglais seulement</font>.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-18</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
LEGAL MATTERS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pearlman Law Group
LLP, Fort Lauderdale, Florida will provide us with an opinion as to
certain legal matters in connection with the securities offered
hereby. <font style="color: #000000">Certain matters under North
Carolina law have been passed upon for us by Gavigan Law PLLC,
Charlotte, North Carolina. Gracin &amp; Marlow, LLP, New York, New
York</font> is representing the underwriter.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
EXPERTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
consolidated balance sheets as of September 30, 2019 and 2018 and
the related consolidated statements of operations, comprehensive
income (loss), shareholders&#x2019; equity and cash flows for the
fiscal years ended September 30, 2019 and 2018 incorporated by
reference in the registration statement of which this prospectus
supplement is a part have been audited by Cherry Bekaert LLP,
independent registered public accounting firm, as indicated in
their report with respect thereto, and have been so included in
reliance upon the report of such firm given on their authority as
experts in accounting and auditing.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">WHERE
YOU CAN FIND MORE INFORMATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We file annual,
quarterly and other reports, proxy statements and other information
with the SEC. The SEC maintains a website at <font style="color: #0000ff; text-decoration: underline">www.sec.gov</font>
that contains reports, proxy and information statements, and other
information regarding issuers such as our company that file
electronically with the SEC.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our corporate
website address is <font style="color: #0000ff; text-decoration: underline">www.cbdmd.com</font>.
We make available free of charge, through the Investor section of
our website, annual reports on Form 10-K, quarterly reports on Form
10-Q and current reports on Form 8-K and amendments to those
reports filed or furnished pursuant to Section 13(a) or 15(d) of
the Exchange Act as soon as reasonably practicable after we
electronically file such material with, or furnish it to, the
SEC.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-19</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
INFORMATION INCORPORATED BY REFERENCE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
SEC allows us to incorporate by reference the information we file
with them, which means that we can disclose important information
to you by referring you to those documents. The information
incorporated by reference is considered to be part of this
prospectus supplement, and later information filed with the
Securities and Exchange Commission will update and supersede this
information. We incorporate by reference the documents listed below
that we have previously filed with the SEC, except that information
furnished under Item 2.02 or Item 7.01 of our Current Reports on
Form 8-K or any other filing where we indicate that such
information is being furnished and not filed under the Exchange
Act, is not deemed to be filed and not incorporated by reference
herein:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font>
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Annual Report on Form 10-K for the fiscal year ended September 30,
2019 as filed with the SEC on December 18, 2019;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;
our Current Reports on Form 8-K as filed with the SEC on October
16, 2019, October 22, 2019, October 23, 2019, November 20, 2019,
December 16, 2019, and January 10, 2020;</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; background-color: #ffffff; font-size: 13px; font-family: Times New Roman">
&#x25CF; our definitive proxy statement on Schedule 14A as filed
with the SEC on March 21, 2019; and</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font>
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
description of our common stock contained in our Registration
Statement on Form 8-A as filed with the SEC on November 15, 2017
and any further amendment or report filed hereafter for the purpose
of updating such description.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
also incorporate by reference into this prospectus supplement
additional documents that we may file with the SEC under Sections
13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the
completion or termination of the offering, including all such
documents we may file with the SEC after the date of the initial
registration statement and prior to the effectiveness of the
registration statement, but excluding any information deemed
furnished and not filed with the SEC. Any statements contained in a
previously filed document incorporated by reference into this
prospectus supplement is deemed to be modified or superseded for
purposes of this prospectus supplement to the extent that a
statement contained in this prospectus supplement, or in a
subsequently filed document also incorporated by reference herein,
modifies or supersedes that statement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus supplement may contain information that updates,
modifies or is contrary to information in one or more of the
documents incorporated by reference in this prospectus supplement.
You should rely only on the information incorporated by reference
or provided in this prospectus supplement. We have not authorized
anyone else to provide you with different information. You should
not assume that the information in this prospectus supplement is
accurate as of any date other than the date of this prospectus
supplement or the date of the documents incorporated by reference
in this prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
will provide to each person, including any beneficial owner, to
whom this prospectus supplement is delivered, upon written or oral
request, at no cost to the requester, a copy of any and all of the
information that is incorporated by reference in this prospectus
supplement. You may request a copy of these filings, at no cost to
you, by telephoning us at (704) 445-3060 or by writing us at the
following address:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">cbdMD,
Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">8845
Red Oak Boulevard</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Charlotte,
NC 28217</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Attention:
Investor Relations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">You
may also access the documents incorporated by reference in this
prospectus supplement through our website at www.cbdmd.com. The
reference to our website is an inactive textual reference only and,
except for the specific incorporated documents listed above, no
information available on or through our website shall be deemed to
be incorporated in this prospectus supplement, the accompanying
prospectus or the registration statement of which it forms a
part.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-20</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #ff0000; font-size: 13px; font-family: Times New Roman">
The information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these securities
and we are not soliciting offers to buy these securities in any
state where the offer or sale is not permitted.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">SUBJECT
TO COMPLETION, DATED APRIL 4, 2019</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
PROSPECTUS</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424007.jpg"></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
$100,000,000</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Level Brands, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
COMMON STOCK</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
PREFERRED STOCK</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
WARRANTS</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
UNITS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">We may offer and
sell, from time to time in one or more offerings, any combination
of common stock, preferred stock, warrants or units having a
maximum aggregate offering price of $100,000,000. When we decide to
sell a particular class or series of securities, we will provide
specific terms of the offered securities in a prospectus
supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">The prospectus
supplement may also add, update or change information contained in
or incorporated by reference into this prospectus. However, no
prospectus supplement shall offer a security that is not registered
and described in this prospectus at the time of its effectiveness.
You should read this prospectus and any prospectus supplement, as
well as the documents incorporated by reference or deemed to be
incorporated by reference into this prospectus, carefully before
you invest.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">This prospectus may
not be used to offer or sell our securities unless accompanied by a
prospectus supplement relating to the offered
securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our common stock is
listed on the NYSE American under the symbol &#x201C;LEVB.&#x201D;
The last reported sale price of our common stock on April 3, 2019
was $4.63 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">The aggregate
market value of our outstanding common stock held by non-affiliates
is $51,390,150 based on 10,170,356 shares of common stock
outstanding, of which 7,732,983 shares are held by non-affiliates,
and a per share value of $5.23 based on the closing price of our
common stock on the NYSE American on February 19, 2019. We have not
offered any securities pursuant to General Instruction I.B.6 of
Form S-3 during the prior 12 calendar month period that ends on and
includes the date of this prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">These securities
may be sold directly by us, through dealers or agents designated
from time to time, to or through underwriters or through a
combination of these methods. See &#x201C;Plan of
Distribution&#x201D; beginning on page 18. We may also describe the
plan of distribution for any particular offering of our securities
in a prospectus supplement. If any agents, underwriters or dealers
are involved in the sale of any securities in respect of which this
prospectus is being delivered, we will disclose their names and the
nature of our arrangements with them in a prospectus supplement.
The net proceeds we expect to receive from any such sale will also
be included in a prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Investing
in our securities involves various risks. See &#x201C;Risk
Factors&#x201D; on page 5 for more information on these risks.
Additional risks, if any, will be described in the prospectus
supplement related to a potential offering under the heading
&#x201C;Risk Factors&#x201D;. You should review that section of the
related prospectus supplement for a discussion of matters that
investors in such securities should consider.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Neither
the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities, or
passed upon the adequacy or accuracy of this prospectus or any
accompanying prospectus supplement. Any representation to the
contrary is a criminal offense.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The date of this
prospectus is April 9, 2019</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
ABOUT THIS PROSPECTUS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus is part of a registration statement on Form S-3 that we
filed with the Securities and Exchange Commission utilizing a
&#x201C;shelf&#x201D; registration, or continuous offering, process.
Under the shelf registration process, we may issue and sell any
combination of the securities described in this prospectus in one
or more offerings with a maximum offering price of up to
$100,000,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus provides you with a general description of the
securities we may offer. Each time we sell securities under this
shelf registration, we will provide a prospectus supplement that
will contain certain specific information about the terms of that
offering, including a description of any risks related to the
offering, if those terms and risks are not described in this
prospectus. A prospectus supplement may also add, update or change
information contained in this prospectus. If there is any
inconsistency between the information in this prospectus and the
applicable prospectus supplement, you should rely on the
information in the prospectus supplement. The registration
statement we filed with the Securities and Exchange Commission
includes exhibits that provide more details on the matters
discussed in this prospectus. You should read this prospectus and
the related exhibits filed with the Securities and Exchange
Commission and the accompanying prospectus supplement together with
additional information described under the headings
&#x201C;Available Information&#x201D; and &#x201C;Information
Incorporated by Reference&#x201D; before investing in any of the
securities offered.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may sell securities to or through underwriters or dealers, and also
may sell securities directly to other purchasers or through agents.
To the extent not described in this prospectus, the names of any
underwriters, dealers or agents employed by us in the sale of the
securities covered by this prospectus, the principal amounts or
number of shares or other securities, if any, to be purchased by
such underwriters or dealers and the compensation, if any, of such
underwriters, dealers or agents will be set forth in the
accompanying prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
information in this prospectus is accurate as of the date on the
front cover. Information incorporated by reference into this
prospectus is accurate as of the date of the document from which
the information is incorporated. You should not assume that the
information contained in this prospectus is accurate as of any
other date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Unless the context otherwise indicates, when used
herein, the terms &#x201C;Level Brands,&#x201D; &#x201C;we,&#x201D;
&#x201C;us&#x201D;, &#x201C;our&#x201D; and similar terms refer to
Level Brands, Inc., a North Carolina corporation formerly known as
Level Beauty Group, Inc., and our subsidiaries</font> <font style="color: #000000">cbdMD, LLC, a North Carolina limited liability
company which we refer to as &#x201C;cbdMD&#x201D;,</font> Beauty and
Pinups, LLC, a North Carolina limited liability company which we
refer to as &#x201C;Beauty &amp; Pin-Ups&#x201D;, I | M 1, LLC, a
California limited liability company, which we refer to as
&#x201C;I&#x2019;M1&#x201D;, Encore Endeavor 1 LLC, a California
limited liability company which we refer to as &#x201C;EE1,&#x201D;
Level H&amp;W, LLC, a North Carolina limited liability company
which we refer to as &#x201C;Level Health &amp; Wellness&#x201D;,
AcqCo, LLC, a newly organized North Carolina limited liability
company and cbdMD LLC, a newly organized North Carolina limited
liability company. In addition, &#x201C;fiscal 2017&#x201D; refers to
the year ended September 30, 2017, "fiscal 2018" refers to the year
ended September 30, 2018, "fiscal 2019" refers to the year ending
September 30, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
AVAILABLE INFORMATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
file annual, quarterly and other reports, proxy statements and
other information with the Securities and Exchange Commission. You
may read and copy any materials that we file at the Securities and
Exchange Commission&#x2019;s Public Reference Room, 100 F Street,
N.E., Washington, D.C. 20549. You may obtain information on the
operation of the Public Reference Room by calling the Securities
and Exchange Commission at 1-800-SEC-0330. The Securities and
Exchange Commission also maintains a website at www.sec.gov that
contains reports, proxy and information statements, and other
information regarding issuers such as our company that file
electronically with the Securities and Exchange
Commission.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
have filed a registration statement under the Securities Act of
1933 with the Securities and Exchange Commission with respect to
the securities to be sold by pursuant to this prospectus. This
prospectus has been filed as part of the registration statement.
This prospectus does not contain all of the information set forth
in the registration statement because certain parts of the
registration statement are omitted in accordance with the rules and
regulations of the Securities and Exchange Commission. You should
refer to the registration statement, including the exhibits, for
further information about us and the securities being offered
pursuant to this prospectus. Statements in this prospectus
regarding the provisions of certain documents filed with, or
incorporated by reference in, the registration statement are not
necessarily complete and each statement is qualified in all
respects by that reference.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
Internet address is www.levelbrands.com. We make available free of
charge, through the investor section of our website, annual reports
on Form 10-K, quarterly reports on Form 10-Q and current reports on
Form 8-K and amendments to those reports filed or furnished
pursuant to Section 13(a) or 15(d) of the Securities Exchange Act
of 1934 as soon as reasonably practicable after we electronically
file such material with, or furnish it to, the Securities and
Exchange Commission.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">2</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
OUR COMPANY</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Level Brands
strives to be an innovative licensing, marketing and brand
management company with a focus on lifestyle-based products. We
champion a bold, unconventional image, and social consciousness for
our company and our brands. Working closely with our Chairman
Emeritus and Chief Brand Strategist, Kathy Ireland, the Chairman,
CEO and Chief Designer of <font style="font-style: italic">kathy
ireland</font>&#xAE; Worldwide, we seek to secure strategic
licenses and joint venture partnerships for our brands, as well as
to grow the portfolio of brands through strategic
acquisitions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">We operate our
business in four business units, including:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td rowspan="3" style="vertical-align: top; width: 23%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424008.jpg"></div>
</td>
<td rowspan="3" style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td rowspan="3" style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Level H&amp;W was established in September
2017</font> and has an exclusive license to the <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness&#x2122; brand. Its goal is to create a brand which will
include a wide variety of licensed products and services, targeted
to both Baby Boomers as well as millennials. This unit began
operating in fiscal 2018.</font></font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 23%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424009.jpg"></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Founded in early
2017 <font style="color: #000000">and first conceptualized
by</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide</font>,
I'M1 is a men&#x2019;s lifestyle brand established to capitalize on
potentially lucrative licensing and co-branding opportunities with
products focused on millennials.</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 23%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424010.jpg"></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Also founded in
2017, EE1 was established to serve as a producer and marketer of
experiential entertainment including recordings, film, TV, web and
live events, and entertainment experiences. EE1 also provides brand
management services including creative development and marketing,
brand strategy, and distribution support.</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 23%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424011.jpg"></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">"<font style="font-style: italic">Beauty belongs to
everyone</font>"</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Beauty &amp;
Pin-Ups, our first business unit is a professional hair care line
with a social conscience and launched its products in 2015. We
offer quality hair care products, including shampoos, conditioners,
styling aides and a patented styling tool, through retailers and
online outlets and are expanding into licensing
opportunities.</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 23%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0; <font style="font-style: italic">&#xA0;</font> &#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 23%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424012.jpg"></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our newest business
unit was established in December 2018 in connection with the
mergers with Cure Based Development LLC. In conjunction with the
mergers, we acquired the cbdMD brand. cbdMD produces <font style="color: #222222; background-color: #ffffff">and distributes</font>
various high-grade, premium cannabidiol ("CBD") products under the
cbdMD brand, including: tinctures, capsules, gummies, bath bombs,
vape oils, topical creams and animal treats and
oils.&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our business model
is designed with the goal of maximizing the value of our brands
through entry into license agreements with partners that are
responsible for the design, manufacturing and distribution of our
licensed products. We promote our brands across multiple channels,
including print, television and social media. We believe that this
&#x201C;omnichannel&#x201D; (or multi-channel) approach, which we
expect will allow our customers to interact with each of our
brands, in addition to the products themselves, will be critical to
our success.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Corporate
information</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
company was formed under the laws of the state of North Carolina in
March 2015 under the name Level Beauty Group, Inc. In November 2016
we changed the name of our company to Level Brands,
Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Our principal executive offices are located at
4521 Sharon Road, Suite 450, Charlotte, NC 28211. Our telephone
number at this location is (704</font>) 362-6286. T<font style="color: #000000">he information which appears on our website at
www.levelbrands.com is not part of this
prospectus.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">3</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING
INFORMATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">This prospectus
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors which may cause actual results,
performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by
such forward-looking statements. These forward-looking statements
were based on various factors and were derived utilizing numerous
assumptions and other factors that could cause our actual results
to differ materially from those in the forward-looking statements.
These factors include, but are not limited to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our ability to
successfully integrate the operations of Cure Based Development
following the mergers;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our material
dependence on our relationships with <font style="font-style: italic">kathy ireland&#xAE;</font> Worldwide and
certain of its affiliates;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the significant
dilution to our shareholders of the issuance of the shares of our
common stock as the consideration for the mergers;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our limited
operating history;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the limited
operating histories of our subsidiaries;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our history of
losses;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the evolving and
highly competitive market in which cbdMD operates;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">laws and
regulations impacting cbdMD</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with any failure by us to maintain an effective system of internal
control over financial reporting;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the terms of
various agreements with <font style="font-style: italic">kathy
ireland&#xAE;</font> Worldwide and possible impacts on our
management's abilities to make certain decisions regarding the
operations of our company;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our dependence on
consumer spending patterns;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our history on
reliance on sales from a limited number of customers, including
related parties;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with our failure to effectively promote our brands;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our ability to
identify and successfully acquire additional brands and
trademarks;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the operating
agreements of our I'M1 and EE1 subsidiaries;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the accounting
treatment of securities we accept as partial compensation for
services;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our ability to
liquidate securities we accept as partial compensation for services
and the possible impact of the Investment Company Act of
1940;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the possible need
to raise additional capital in the future;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">terms of the
contracts with third parties in each of our divisions;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">possible conflicts
of interest with <font style="font-style: italic">kathy
ireland&#xAE;</font> Worldwide;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">possible litigation
involving our licensed products;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our ability to
effectively compete and our dependence on market acceptance of our
brands;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the lack of
long-term contracts for the purchase of products from our
professional products division;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">our ability to
protect our intellectual property;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">additional
operational risks associated with our professional products
division;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with developing a liquid market for our common stock and possible
future volatility in its trading price;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with any future failure to satisfy the NYSE American LLC continued
listing standards;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">dilution to our
shareholders from the exercise of outstanding options and warrants
and the vesting of restricted stock awards;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with our status as an emerging growth company;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with control by our executive officers, directors and
affiliates;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with unfavorable research reports;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with our status as a public company; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with articles of incorporation, bylaws and North Carolina
law.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Most of these
factors are difficult to predict accurately and are generally
beyond our control. You should consider the areas of risk described
in connection with any forward-looking statements that may be made
herein. Readers are cautioned not to place undue reliance on these
forward-looking statements and readers should carefully review our
Annual Report on Form 10-K for the fiscal year ended September 30,
2018 as filed with the Securities and Exchange Commission on
December 12, 2018, including the risk factors described therein,
our Quarterly Report on Form 10-Q for the period ended December 31,
2018 as filed with the Securities and Exchange Commission on
February 14, 2019, as well as our other filings with the Securities
and Exchange Commission. Except for our ongoing obligations to
disclose material information under the Federal securities laws, we
undertake no obligation to release publicly any revisions to any
forward-looking statements, to report events or to report the
occurrence of unanticipated events. These forward-looking
statements speak only as of the date of this prospectus, and you
should not rely on these statements without also considering the
risks and uncertainties associated with these statements and our
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">4</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISK FACTORS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">An
investment in our securities involves a significant degree of risk.
You should not invest in our securities unless you can afford to
lose your entire investment. You should consider carefully the
following risk factors and other information in this prospectus
before deciding to invest in our securities. If any of the
following risks and uncertainties develops into actual events, our
business, financial condition or results of operations could be
materially adversely affected and you could lose your entire
investment in our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR OVERALL BUSINESS</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
THERE ARE NO ASSURANCES WE WILL SUCCESSFULLY INTEGRATE THE CURE
BASED DEVELOPMENT BUSINESSES INTO OUR BUSINESS, WHICH WOULD
ADVERSELY AFFECT THE COMBINED COMPANY&#x2019;S FUTURE
RESULTS.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">In December 2018 we
closed the mergers with Cure Based Development. The success of this
transaction will depend, in large part, on the ability of the
combined company to realize anticipated benefits from combining the
businesses of the companies. The failure to successfully integrate
and to successfully manage the challenges presented by the
integration process may result in the failure to achieve some or
all the anticipated benefits of the transaction, which may have a
material adverse effect on our operations and financial condition.
Potential difficulties that may be encountered in the integration
process include the following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">the potential
disruption of, or the loss of momentum in, each company&#x2019;s
ongoing business;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">using the combined
company&#x2019;s assets efficiently to develop the business of the
combined company;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">potential unknown
or currently unquantifiable liabilities associated with the mergers
and the operations of the combined company;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">potential unknown
and unforeseen expenses and delays associated with the mergers and
the possibility that integration costs may be
material;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">performance
shortfalls at one or both companies as a result of the diversion of
management&#x2019;s attention caused by integrating the
companies&#x2019; operations;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">necessary changes
in the operations and culture of the acquired company post-closing
in order to accommodate the changes from a privately-held company
with a limited operating history to a subsidiary of a public
company;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">complexities
associated with managing the combined businesses, including
difficulty addressing possible differences in corporate cultures
and management philosophies;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">significant
increases in our operating expenses; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">additional
business, financial and operating risks we have yet to
identify.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">There are no
assurances that the mergers will ultimately result in the
realization of the anticipated economic benefits and other expected
synergies, or that such anticipated economic benefits and other
expected synergies will take longer than excepted to be realized.
If we are unable to fully realize the perceived benefits from the
mergers on a timely basis, we may be required to in the future
impair some or all of the goodwill associated with this transaction
which would materially adversely impact our results of operations
in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">5</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
CBDMD LLC HAS A LIMITED OPERATING HISTORY THAT IMPEDES OUR ABILITY
TO EVALUATE ITS POTENTIAL FUTURE PERFORMANCE AND
STRATEGY.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our wholly-owned
subsidiary, cbdMD, succeeded to the operations of Cure Based
Development following the closing of the mergers in December 2018.
We formed cbdMD in connection with the mergers and it had no
operating history prior to the mergers. Cure Based Development was
formed in 2017 and did not begin reporting any meaningful revenues
until mid-2018. Its limited operating history makes it difficult
for us to evaluate cbdMD&#x2019;s future business prospects and make
decisions based on estimates of its future performance. To address
these risks and uncertainties, we must do the
following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">successfully
execute our business strategy to offer the highest quality CBD in
the industry;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">introduce new,
differentiated botanical products;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">respond to
competitive business developments;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">effectively and
efficiently market and sell our line of CBD products;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">improve the
distribution of our CBD products; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">attract, integrate,
retain and motivate qualified personnel.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our business
strategy may not be successful and we may not successfully address
these risks. In the event that we do not successfully address these
risks, our business, prospects, financial condition and results of
operations may be materially and adversely affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
THE MARKET FOR CBD PRODUCTS IS HIGHLY COMPETITIVE, AND IF WE ARE
UNABLE TO COMPETE EFFECTIVELY AGAINST OUR COMPETITORS, OUR BUSINESS
AND OPERATING RESULTS COULD BE ADVERSELY AFFECTED.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">cbdMD operates in a
competitive and rapidly evolving market. While we believe that the
industry is fragmented at the present time, there are numerous
competitors, including Green Roads, PlusCBD, and Select CBD in the
retail of CBD-based products, and in the digital selling space
Diamond CBD, CBDistillery, and Lazarus Naturals, some of whom are
larger and have a longer operating history and may have greater
financial resources than cbdMD does. Moreover, we expect
competition in the CBD industry to intensify following the passage
of the Farm Bill in December 2018. In the future we may also face
competition with larger, better capitalized companies who elect to
enter the market given the relatively low barriers to entry. cbdMD
believes that it competes effectively with its competitors because
of the quality of its products and customer service. However, no
assurance can be given that cbdMD will effectively compete with its
existing or future competitors. In addition, competition may drive
the prices of our products down, which may have a materially
adverse effect on our results of operations in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
LAWS AND REGULATIONS AFFECTING OUR INDUSTRY ARE EVOLVING UNDER THE
FARM BILL, FDA AND OTHER REGULATORY AUTHORITIES AND CHANGES TO ANY
REGULATION MAY MATERIALLY EFFECT OUR CBD OPERATIONS.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">In conjunction with
the enactment of the Farm Bill, the United States Food and Drug
Administration (&#x201C;FDA&#x201D;) released a statement about the
status of CBD as a nutritional supplement, and the agency&#x2019;s
actions in the short term with regards to CBD will guide the
industry. The statement noted that the Farm Bill explicitly
preserved the FDA&#x2019;s authority to regulate products containing
cannabis or cannabis-derived compounds under the Federal Food,
Drug, and Cosmetic Act (FD&amp;C Act) and Section 351 of the Public
Health Service Act. As a nutritional supplement manufacturer, cbdMD
LLC is also striving to meet or exceed the FDAs Good Manufacturing
Practice (GMP) guidelines. Any difficulties in compliance with
existing government regulation could increase our operating costs
and adversely impact our results of operations in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">In addition, as a
result of the Farm Bill&#x2019;s recent passage, we expect that
there will be a constant evolution of laws and regulations
affecting the CBD industry which could affect cbdMD&#x2019;s
operations. Local, state and federal hemp laws and regulations may
be broad in scope and subject to changing interpretations. These
changes may require us to incur substantial costs associated with
legal and compliance fees and ultimately require us to alter our
business plan. Furthermore, violations of these laws, or alleged
violations, could disrupt our business and result in a material
adverse effect on our operations. In addition, we cannot predict
the nature of any future laws, regulations, interpretations or
applications, and it is possible that regulations may be enacted in
the future that will be directly applicable to our
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">6</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
THE ISSUANCES OF THE SHARES OF OUR COMMON STOCK TO THE CURE BASED
DEVELOMENT MEMBERS WILL SIGNIFICATLY DILUTE OUR EXISTING
SHAREHOLDERS. WE ARE REQUIRED TO MEET THE INITIAL LISTING STANDARDS
OF THE NYSE AMERICAN IN CONNECTION WITH SUCH
ISSUANCES.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Upon the terms set
forth in the merger agreement, on the closing date the members of
Cure Based Development received contractual rights to receive
15,250,000 shares of our common stock, representing approximately
60% of our outstanding common stock following such issuance, as the
consideration for the mergers. The merger agreement also provides
that we may issue up to an additional 15,250,000 shares of our
common stock as part of the merger consideration upon the
satisfaction of certain aggregate net revenue criteria by cbdMD
within 60 months following the closing date. As of the closing
date, there were 10,095,396 shares of our common stock issued and
outstanding. Our ability to issue these shares must be approved by
our shareholders at our upcoming 2019 annual meeting of
shareholders in accordance with the rules and regulations of NYSE
American. Assuming the approval of such issuances at the
shareholder meeting, the issuance of the first 15,250,000 shares,
but giving effect to no other change to the number of shares of our
common stock issued and outstanding or the possible issuance of
additional 15,250,000 shares in future periods, the members of Cure
Based Development would own 60.2% of our then outstanding shares of
common stock. Therefore, the ownership and voting rights of our
existing shareholders will be proportionally reduced.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Kathy
Ireland is not an officer or director of our company. We are
materially dependent upon our relationships with kathy
ireland&#xAE; Worldwide and certain of its affiliates. If these
advisory agreements or license rights should be terminated or
expire, we would be deprived of the services and our business could
be materially adversely impacted</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">While affiliates of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide are
minority owners of both I&#x2019;M1 and EE1, the terms of the
operating agreements for those subsidiaries do not require them to
provide any services to us. We have entered into a non-exclusive
advisory agreement with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide, as
amended, which expires in February 2025 under which we engaged it
to provide various consulting and advisory services to us. Ms.
Ireland serves in the non-executive role of Chairman Emeritus and
Chief Brand Strategist to us under this agreement. Ms. Ireland is
not a member of our management or board of directors, the title
Chairman Emeritus is an honorary title and she is not a founder or
co-founder of our company. Ms. Ireland provides services to us
solely under the terms of the non exclusive advisory agreement. We
have also entered into advisory agreements with additional
affiliates of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide,
including Messrs. Roseberry, Carrasco, Meharey and Mendoza,
pursuant to which they provide various management and advisory
services to us, including key operational roles at I&#x2019;M1 and
EE1. These agreements will expire in February 2019 and at that
point extend on a month to month basis unless cancelled by either
party. None of these services are provided on an exclusive basis,
each of these individuals may have a conflict of interest in that
they have a long term relationship with Kathy Ireland and have
derived substantial income from</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide and
there is no minimum number of hours which are required to be
devoted to us. In addition we have obtained a royalty free right to
license the intellectual property related to</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness. Our business model is materially dependent upon our
continued relationship with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide, Ms.
Ireland and her affiliates, including Messrs. Roseberry, Carrasco,
Meharey and Mendoza. If we should lose access to those
relationships or if the reputation of Ms. Ireland and/or</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide were to
be damaged, our results would suffer and there are no assurances we
would be able to continue to operate our company and develop our
brands as presently planned.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Our limited operating history does not afford investors a
sufficient history on which to base an investment
decision.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Level Brands was formed in March 2015. Until
fiscal 2017, our net sales were solely from our products division.
We began reporting revenues from our licensing division and our
entertainment division during the second quarter of fiscal 2017. In
September 2017, we entered into wholesale license agreements for
three new brands, including</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness, a newly created brand. There are no assurances we will be
successful in generating any significant net sales in future
periods based upon these new agreements. Our operations are subject
to all the risks inherent in the establishment of a new business
enterprise. The likelihood of success must be considered in light
of the problems, expenses, difficulties, complications and delays
that are frequently encountered in a newly-formed company. There
can be no assurance that at this time that we will successfully
implement our business plan, operate profitably or will have
adequate working capital to meet our obligations as they become
due. Prospective investors must consider the risks and difficulties
frequently encountered by early stage companies, particularly in
rapidly evolving markets. We cannot be certain that our business
strategy will be successful or that we will successfully address
these risks. In the event that we do not successfully address these
risks, our business, prospects, financial condition, and results of
operations could be materially and adversely affected and we may
not have the resources to continue or expand our business
operations.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Our subsidiaries I&#x2019;M1, EE1 and Level H&amp;W are new entities
with a limited operating history and we recently entered into a
license agreement licensing the rights to certain intellectual
property related to kathy ireland &#xAE; Health &amp; Wellness, a
newly created brand with no previous operating history, which does
not afford investors a sufficient history on our company which to
base an investment decision.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">I&#x2019;M1, EE1, and Level H&amp;W are entities
formed in September 2016, March 2016, and September 2017
respectively. We acquired membership interests in I&#x2019;M1 and
EE1 in January 2017. In September 2017 we entered into an exclusive
license agreement to license the trademark and intellectual
property rights for</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness, a newly created brand with no previous operations. All of
these entities are in the early stages of their businesses and we
began reporting revenues from I&#x2019;M1 and EE1 operations in the
second quarter of fiscal 2017 and reported revenues from Level
H&amp;W in the second quarter of fiscal 2018. Our operations are
subject to all the risks inherent in the establishment of a new
business enterprise. The likelihood of success must be considered
in light of the problems, expenses, difficulties, complications and
delays that are frequently encountered in a newly-formed company.
There can be no assurance that at this time that we will operate
profitably or will have adequate working capital to meet our
obligations as they become due. Prospective investors must consider
the risks and difficulties frequently encountered by early stage
companies, particularly in rapidly evolving markets. We cannot be
certain that our business strategy will be successful or that we
will successfully address these risks. In the event that we do not
successfully address these risks, our business, prospects,
financial condition, and results of operations could be materially
and adversely affected and we may not have the resources to
continue or expand our business operations.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">7</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We have a
history of losses and there are no assurances we will report
profitable operations in future periods</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
reported net losses to common shareholders of $584,385, $412,075
and $1,738,734 for the first quarter of fiscal 2019, fiscal 2018
and fiscal 2017, respectively. Until such time, if ever, that we
are successful in generating profits which are sufficient to pay
our operating expenses it is likely we will continue to report
losses in future periods. Further, historically our revenues have
been attributable to sales from our products division and we did
not begin reporting revenues from either our licensing division or
our entertainment division until the second quarter of fiscal 2017.
There are no assurances we will generate substantial revenues from
the new businesses or that we will ever generate sufficient
revenues to report profitable operations or a net
profit.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">The terms
of the various agreements between our company and kathy
ireland&#xAE; Worldwide contain termination provisions which may
impact management's ability to make certain decisions regarding the
operation of our company</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">The master advisory and consulting agreement
with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide on
which we are materially dependent provides that the agreement is
immediately terminable by</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide if any
officers are terminated or resign, including Mr. Roseberry in his
role as President and co-Managing Director of I'M1 and EE1, or if
additional officers are appointed for each I'M1 and EE1 without the
consent of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. The
wholesale license agreement for</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness&#x2122; contains the right of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide to
immediately terminate it if any officers are terminated or removed
or additional officers are appointed with respect to either I'M1 or
EE1, or if we compete with or invest in business that compete
with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. It is
possible, however, that our management's ability to make certain
operational decisions which it believes are otherwise in the best
interests of our company could be restricted in future periods if
these decisions could result in triggering the rights of</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide to
terminate any agreement.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Our
business depends on consumer spending patterns</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
business is sensitive to a number of factors that influence the
levels of consumer spending, including political and economic
conditions such as recessionary environments, the levels of
disposable consumer income, consumer debt, interest rates and
consumer confidence. Reduced consumer spending on beauty products
could have an adverse effect on our operating results in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Substantially
all of our net sales historically have been to a limited number of
customers, the loss of any of which would be materially adverse to
our company</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Prior
to the close of the mergers in December 2018, substantially all of
our net sales in fiscal 2018 and 2017 were attributable to sales to
a limited number of customers. There are no assurances sales to
these customers will continue. While we expect to add additional
customers to our distribution network in the future for our
products division, and expand our licensing and consulting clients
in our other divisions, until such time as we are successful in
these efforts, of which there is no assurance, any significant
decrease in sales to any of our customers would have a material
adverse financial effect on our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
A significant amount of our net sales were from customers who are
identified as related parties, the loss of any of which would be
materially adverse to our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">A
significant amount of our net sales in fiscal 2018 and 2017,
totaling $1,992,046 and $1,731,238 respectively, were from
customers who are identified as related parties. There are no
assurances sales to these customers will continue. While we expect
to add additional customers in all of our businesses as we expand
our licensing and consulting clients, until such time as we are
successful in these efforts, of which there is no assurance, any
significant decrease in sales to any of our customers would have a
material adverse financial effect on our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
If we fail to promote and maintain our brands in the market, our
businesses, operating results, financial condition, and our ability
to attract customers will be materially adversely
affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
success depends on our ability to create and maintain brand
awareness for our product offerings. This may require a significant
amount of capital to allow us to market our products and establish
brand recognition and customer loyalty. Additionally, many of the
companies offering similar products have already established their
brand identity within the marketplace. We can offer no assurances
that we will be successful in establishing awareness of our brands
allowing us to compete in this market. The importance of brand
recognition will continue to increase because low barriers of entry
to the industries in which we operate may result in an increased
number of direct competitors. To promote our brands, we may be
required to continue to increase our financial commitment to
creating and maintaining brand awareness. We may not generate a
corresponding increase in revenue to justify these
costs.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">8</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
If we are unable to identify and successfully acquire additional
brands and trademarks, our growth may be limited, and, even if
additional trademarks are acquired, we may not realize anticipated
benefits due to integration or licensing difficulties.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">A
component of our growth strategy is the acquisition of additional
brands and trademarks. We generally compete with traditional
apparel and consumer brand companies, other brand management
companies and private equity groups for brand acquisitions.
However, as more of our competitors continue to pursue our brand
management model, competition for specific acquisition targets may
become more acute, acquisitions may become more expensive and
suitable acquisition candidates could become more difficult to
find. In addition, even if we successfully acquire additional
trademarks or the rights to use additional trademarks, we may not
be able to achieve or maintain profitability levels that justify
our investment in, or realize planned benefits with respect to,
those additional brands.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Although we seek to temper our acquisition risks by following
acquisition guidelines relating to the existing strength of the
brand, its diversification benefits to us, its potential licensing
scale and credit worthiness of the licensee base, acquisitions,
whether they be of additional intellectual property, or
&#x201C;IP,&#x201D; assets or of the companies that own them, entail
numerous risks, any of which could detrimentally affect our results
of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Acquisition
of brands or trademarks transactions involve a number of risks and
present financial, managerial and operational challenges,
including: diversion of management&#x2019;s attention from running
our existing business; unanticipated costs associated with the
target acquisition, appropriately valuing the target acquisition
and analyzing its marketability, increased expenses, including
legal and administrative expenses; integration costs related to the
customer base and business practices of the acquired company with
our own; and adverse effects on our reported operating results due
to possible write-down of goodwill and/or identifiable intangibles
associated with acquisitions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">When
we acquire IP assets or the companies that own them, our due
diligence reviews are subject to inherent uncertainties and may not
reveal all potential risks. Although we generally attempt to seek
contractual protections through representations, warranties and
indemnities, we cannot be sure that we will obtain such provisions
in our acquisitions or that such provisions will fully protect us
from all unknown, contingent or other liabilities or costs.
Finally, claims against us relating to any acquisition may
necessitate our seeking claims against the seller for which the
seller may not, or may not be able to, indemnify us or that may
exceed the scope, duration or amount of the seller&#x2019;s
indemnification obligations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
No assurance can be given with respect to the timing, likelihood or
financial or business effect of any possible transaction. As a
result, there is no guarantee that our shareholders will achieve
greater returns as a result of any future acquisitions we
complete.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Each
of our I'M1 and EE1 subsidiaries are governed by operating
agreements that require us to distribute amounts to minority
members in certain circumstances. These distributions could reduce
the amount of operating capital we have in future periods. Under
the terms of the operating agreements for each of I&#x2019;M1 and
EE1, Level Brands as the manager of these entities is responsible
for the operations, including the payment of the operating costs.
These costs are then deducted from the &#x201C;profits&#x201D; of the
entity and a portion of those amounts, as determined by the
particular operating agreement, will then be distributed to the
members. We own all of the voting interests in I'M1 and EE1. During
fiscal 2017 EE1 made a distribution to its members, no additional
distributions have been made or are currently planned.
Distributions to the members of I'M1 and EE1 will reduce the amount
of working capital available to us and could adversely impact our
liquidity in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
The value of the equity securities we may accept as compensation
under consulting agreements will be subject to adjustment which
could result in losses to us in future periods. By accepting equity
securities as partial compensation for our services, we may be
adversely impacting our working capital in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">From time to time we have entered into several
agreements with third parties under which we accepted shares of its
common stock as partial compensation for the services to be
provided. For fiscal 2018 and fiscal 2017, the value of these
securities represented 60.6% and 43.2%, respectively, of our total
net revenues, and for the first quarter of fiscal 2019 was 37.6% of
total net revenues. By accepting equity securities as partial
compensation for our services in lieu of cash, we incur expenses to
deliver the services without the corresponding cash payments from
our clients. As such, we utilize a greater portion of our working
capital to provide services with the hope that we may benefit from
an increase in the market value of the equity securities we have
received in future periods. In addition, these securities will be
reflected on our balance sheets in future periods as
&#x201C;marketable securities&#x201D; or &#x201C;investment other
securities&#x201D;. At the end of each quarter, we will evaluate the
carrying value of the marketable securities or investment other
securities for a decrease in value. We will evaluate the company
underlying these marketable securities or investment other
securities to determine whether a decline in fair value below the
amortized cost basis is other than temporary. If the decline in
fair value is judged to be &#x201C;other- than- temporary&#x201D;,
the cost basis of the individual security will be written down to
fair value as a new cost basis and the amount of the write-down is
charged to earnings. During fiscal 2018 we recognized an other
comprehensive loss of $2,512,539 for loss on these securities, net
of taxes.</font> Subsequent to our most recently Form 10Q being
filed, we have liquidated certain positions in accordance with our
intention to avoid being classified as an Investment Company under
the 1940 Act. As a result of this liquidation, we recognized a
significant other than temporary impairment expense. As we continue
to divest ourselves of such positions in future quarters, such
continued losses are probable. <font style="color: #000000">It is
possible that we may continue to recognize impairments on the
carrying value of these securities in future periods. Any future
impairments would adversely affect our operating results for the
corresponding periods in that we would be required to reduce the
carrying value of these investments.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">9</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
We may be unable to liquidate securities we accept as partial
compensation under consulting agreements which could adversely
impact our liquidity in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
ability to sell any securities we accept as partial compensation
under consulting agreements is dependent upon a number of factors,
including the existence of a liquid market for the securities and
our compliance with the resale provisions of Federal securities
laws which require us to hold the shares for at least six months,
among other factors. While we expect to generally accept securities
from issuers who are publicly traded or who are expecting to become
a publicly traded company, there are no assurances a liquid market
will exist in such securities at such time as we are able to resell
the shares, or that the price we may receive will be commensurate
with the value of the services we are providing. In that event, we
would not benefit from the expected rise in the market price of the
securities we own as a result of our efforts on behalf of the
client company. In addition, depending upon the terms of our
business relationship with the issuer of the securities, it is
possible that from time to time we could be in possession of
non-public information regarding the issuer which could prohibit us
from disposing of the shares at a time when it is advantageous to
us to do so. If we are unable to readily liquidate any securities
we accept as compensation, we would be deprived of the cash value
of those services and we would be required to write-off the
carrying value of the securities which could adversely impact our
results of operations in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We are
subject to the risk of possibly becoming an investment company
under the Investment Company Act of 1940</font><font style="color: #000000">.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
Investment Company Act of 1940 regulates certain companies that
invest in, hold or trade securities. Although we do not believe we
are engaged in the business of investing, reinvesting or trading in
securities, and we do not currently hold ourselves out to the
public as being engaged in those activities, in the past we have
accepted securities of our client companies as partial
compensation. At December 31, 2018, we do not exceed the exemptive
asset and revenue thresholds under Section 3(a)(1)(C) of Investment
Company Act of 1940. So that we do not become an inadvertent
investment company, we will continue to limit the amount of equity
we accept as compensation for services provided so as to stay under
the income threshold as indicated in the Investment Company Act of
1940 going forward. As a result, we may structure transactions in a
less advantageous manner than if we did not have Investment Company
Act of 1940 concerns, or we may avoid otherwise economically
desirable transactions due to those concerns.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
We may require additional capital to finance the acquisition of
additional brands and if we are unable to raise such capital on
beneficial terms or at all this could restrict our
growth.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may, in the future, require additional capital to help fund all or
part of potential acquisitions. If, at the time required, we do not
have sufficient cash to finance those additional capital needs, we
will need to raise additional funds through equity and/or debt
financing. We cannot guarantee that, if and when needed, additional
financing will be available to us on acceptable terms or at all.
Further, if additional capital is needed and is either unavailable
or cost prohibitive, our growth may be limited as we may need to
change our business strategy to slow the rate of our expansion
plans. In addition, any additional financing we undertake could
impose additional covenants upon us that restrict our operating
flexibility, and, if we issue equity securities to raise capital or
as acquisition consideration, our existing shareholders may
experience dilution or the new securities may have rights senior to
those of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">10</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR LICENSING AND ENTERTAINMENT
DIVISIONS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">The failure
of our licensees to adequately produce, market, import and sell
products bearing our brand names in their license categories,
continue their operations, renew their license agreements or pay
their obligations under their license agreements could result in a
decline in our results of operations</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
future revenues from our licensing division will be substantially
dependent on royalty payments made to us under our license
agreements, in addition to compensation under any consulting
agreements we may enter into with the third parties for services by
either our licensing division, our entertainment division, or both.
The failure of our licensees to satisfy their obligations under
these agreements, or their inability to operate successfully or at
all, could result in their breach and/or the early termination of
such agreements, their non-renewal of such agreements or our
decision to amend such, thereby eliminating some or all of that
stream of revenue. It is possible that the milestones to be met
under the terms of licensing agreements may never be achieved which
also could deprive us of additional revenues. There can be no
assurances that we will not lose the licensees under our license
agreements due to their failure to exercise the option to renew or
extend the term of those agreements or the cessation of their
business operations (as a result of their financial difficulties or
otherwise) without equivalent options for replacement. Any of such
failures could reduce the anticipated revenue stream to be
generated by the license agreements. In addition, the failure of
our licensees to meet their production, manufacturing and
distribution requirements, or to be able to continue to import
goods (including, without limitation, as a result of labor strikes
or unrest), could cause a decline in their sales and potentially
decrease the amount of royalty payments (over and above any
guaranteed minimums) due to us. Further, the failure of our
licensees and/or their third party manufacturers, which we do not
control, to adhere to local laws, industry standards and practices
generally accepted in the United States in areas of worker safety,
worker rights of association, social compliance, and general health
and welfare, could result in accidents and practices that cause
disruptions or delays in production and/or substantial harm to the
reputation of our brands, any of which could have a material
adverse effect on our business, financial position, results of
operations and cash flows. A weak economy or softness in certain
sectors including apparel, consumer products, retail and
entertainment could exacerbate this risk. This, in turn, could
decrease our potential revenues and cash flows.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">From time
to time we may compete with kathy ireland Worldwide&#xAE; in
securing advisory or representation agreements with potential
clients for EE1 which may create a conflict of interests for the
managing directors of EE1</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide is an
established company which has significant experience in assisting
companies in the promotion and management of their brands through
licensing and advisory agreements. Affiliates of</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide are
responsible for the day to day operations of EE1 and</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. Part
of EE1's business competes with</font> <font style="font-style: italic; color: #000000">kathy ireland</font>
<font style="color: #000000">&#xAE;Worldwide in identifying and
securing clients for its advisory services. For example, both EE1
and</font> <font style="font-style: italic; color: #000000">kathy
ireland</font> <font style="color: #000000">&#xAE;Worldwide are
parties to substantial identical representation agreements with
Dada Media, Inc. and David Tutera. These affiliates will be able to
determine which entity, either</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide or EE1,
is referred to the potential client.</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide has
more experience and resources and there are no assurances that
conflicts of interest which may arise will be resolved in our
favor. As a result, it is possible that we may lose out on
potential business opportunities.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We could
become a party to litigation involving our licensed products which
could result in additional costs to us. Certain licensed products
may be more likely to lead to product liability lawsuits than
others, which could expose us to additional unknown
risks</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Although
we are not responsible for the manufacturing, sale or distribution
of licensed products, it is possible our company could be named as
a defendant in litigation related to licensed products. Certain
licensed products may, by virtue of the industry in which they are
sold and the governmental regulations to which they are subject,
such as vaping products, could be more likely to be the subject of
litigation than others. Notwithstanding that our standard form of
license agreements requires the licensee to indemnify us against
ligation involving the licensed products and to maintain product
liability insurance policies, it is possible that a licensee may
fail to maintain this coverage during the term of the license
agreement. While we would then have a right to terminate the
license agreement as a result of this breach of its terms, there
are no assurances we would not be required to expend significant
funds and management time defending our company in any potential
product liability insurance claim. There are no assurances that we
would prevail in any such litigation, which could subject us to
judgments and costs of settlements which could adversely impact our
liquidity and results of operations in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">As a result
of the intense competition within our targeted licensees&#x2019;
markets and the strength of some of their competitors, we and our
licensees may not be able to compete
successfully</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Many
of our targeted trademark licenses are for products in the apparel,
fashion accessories, footwear, beauty and fragrance, home products
and d&#xE9;cor, consumer electronics and entertainment industries
in which licensees face intense competition from third party brands
and licensees. In general, competitive factors include quality,
price, style, name recognition and service. In addition, various
fads and the limited availability of shelf space could affect
competition for our licensees&#x2019; products. Many of our
licensees&#x2019; competitors have greater financial, importation,
distribution, marketing and other resources than our licensees and
have achieved significant name recognition for their brand names.
Our licensees may be unable to compete successfully in the markets
for their products, and we may not be able to compete successfully
with respect to our licensing arrangements.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">11</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Our business is dependent on market acceptance of our brands and
the potential future products of our licensees bearing these
brands.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Although
some of our targeted licensees might have guaranteed minimum net
sales and minimum royalties to us, a failure of our brands or of
products bearing our brands to achieve or maintain market
acceptance could cause a reduction of our licensing revenue and
could further cause existing licensees not to renew their
agreements. Such failure could also cause the devaluation of our
trademarks, which are our primary intellectual property, or
&#x201C;IP&#x201D;, assets, making it more difficult for us to renew
our current licenses upon their expiration or enter into new or
additional licenses for our trademarks. In addition, if such
devaluation of our trademarks were to occur, a material impairment
in the carrying value of one or more of our trademarks could also
occur and be charged as an expense to our operating
results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
industries in which we target to compete, including the apparel
industry, are subject to rapidly evolving trends and competition.
In addition, consumer tastes change rapidly. The licensees under
our licensing agreements may not be able to anticipate, gauge or
respond to such changes in a timely manner. Failure of our
licensees to anticipate, identify and capitalize on evolving trends
could result in declining sales of our brands and devaluation of
our trademarks. Continued and substantial marketing efforts, which
may, from time to time, also include our expenditure of significant
additional funds to keep pace with changing consumer demands, are
required to maintain market acceptance of the licensees&#x2019;
products and to create market acceptance of new products and
categories of products bearing our trademarks; however, these
expenditures may not result in either increased market acceptance
of, or licenses for, our trademarks or increased market acceptance,
or sales, of our licensees&#x2019; products. Furthermore, while we
believe that we currently maintain sufficient control over the
products our licensees&#x2019; produce under our brand names through
the provision of trend direction and our right to preview and
approve a majority of such products, including their presentation
and packaging, we do not actually design or manufacture products
bearing our marks, and therefore, have more limited control over
such products&#x2019; quality and design than would a traditional
product manufacturer.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR PRODUCTS DIVISION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Our
revenues from our products division have been declining. We
recognized asset impairments of $502,000 in fiscal 2018 related to
this division</font><font style="color: #000000">.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Net sales from our products division were lower in
each period in fiscal 2018 as compared to the same periods in
fiscal 2017, with an overall reduction in fiscal 2018 of 126.3%
from fiscal 2017. This decline continued into the first quarter of
fiscal 2019, with a 10% decline as compared to the first quarter of
2018.</font>&#xA0; As a result, during the fourth quarter of fiscal
2018 we recognized an impairment of $502,000, including an
inventory and prepaid marketing supplies write off of $262,000 and
an intangible asset impairment of $240,000. In addition, 78% of our
net sales in this division occurred in September 2018 and were made
to an entity affiliated with <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. cbdMD
will also be reporting under the products division and it is
unknown if there will continue to be impairments, similar to what
we have had historically in future periods.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The majority of our net sales to date in our products division are
generated on the basis of purchase orders, rather than long term
purchase commitments; which could adversely affect our financial
position and results of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
operating history is not long enough to evaluate the likelihood of
future cancellations or deferments of customer orders related to
product sales in our products division. Manufacturers and
distributors are currently contracted on a per order basis. The
lack of long-term purchase commitments creates a risk that product
demand may be reduced if orders are canceled or deferred or, in the
event of unanticipated demand, an inability to timely produce and
deliver our products. We do not have long-term agreements with our
distributors, manufacturers or suppliers and these parties may
disrupt or cancel a purchase order or defer or delay shipments of
our products at any time. Furthermore, because of our inability to
rely on enforceable purchase contracts, and our limited visibility
into future customer demand, actual net sales may be different from
our forecasts, which could adversely affect our financial position
and results of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">12</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We may be
unable to protect our intellectual property rights and/or
intellectual property rights licensed to us, and may be subject to
intellectual property litigation and infringement claims by third
parties</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
intend to protect our intellectual property through limited patents
and our unpatented trade secrets and know-how through
confidentiality or license agreements with third parties, employees
and consultants, and by controlling access to and distribution of
our proprietary information. However, this method may not afford
complete protection, particularly in foreign countries where the
laws may not protect our proprietary rights as fully as in the
United States and unauthorized parties may copy or otherwise obtain
and use our products, processes or technology. Additionally, there
can be no assurance that others will not independently develop
similar know-how and trade secrets. We are also dependent upon the
owners of intellectual property rights licensed to us under various
wholesale license agreements to protect and defend those rights
against third party claims. If third parties take actions that
affect our rights, the value of our intellectual property, similar
proprietary rights or reputation or the licensors who have granted
us certain rights under wholesale license agreements, or we are
unable to protect the intellectual property from infringement or
misappropriation, other companies may be able to offer competitive
products at lower prices, and we may not be able to effectively
compete against these companies. We also face the risk of claims
that we have infringed third parties&#x2019; intellectual property
rights. Any claims of intellectual property infringement, even
those without merit, may require us to:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">defend
against infringement claims which are expensive and time
consuming;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">cease
making, licensing or using products that incorporate the challenged
intellectual property;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">re-design,
re-engineer or re-brand our products or packaging; or</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">enter
into royalty or licensing agreements in order to obtain the right
to use a third party&#x2019;s intellectual property.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
the event of claims by third parties for infringement of
intellectual property rights we license from third parties under
wholesale license agreements, we could be liable for costs of
defending allegations of infringement and there are no assurances
the licensors will either adequately defend the licensed
intellectual property rights or that they would prevail in the
related litigation. In that event, we would incur additional costs
and may deprived from generating royalties from these
agreements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">A
disruption in operations or our supply chain could adversely affect
our business and financial results</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are subject to the risks inherent in manufacturing our products,
including industrial accidents, environmental events, strikes and
other labor disputes, disruptions in supply chain or information
systems, loss or impairment of key manufacturing sites or
suppliers, product quality control, safety, increase in commodity
prices and energy costs, licensing requirements and other
regulatory issues, as well as natural disasters and other external
factors over which we have no control. If such an event were to
occur, it could have an adverse effect on our business and
financial results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We rely on third-parties to manufacture and to compound some of our
products, and we have no control over these manufactures and may
not be able to obtain quality products on a timely basis or in
sufficient quantity.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Some
of our products are manufactured or compounded by unaffiliated
third parties. We do not have any long-term contracts with any of
these third parties, and we expect to compete with other companies
for raw materials, production and import capacity. If we experience
significant increased demand, or need to replace an existing
manufacturer, there can be no assurance that additional
manufacturing capacity will be available when required on terms
that are acceptable to us, or at all, or that any manufacturer or
compounder would allocate sufficient capacity to us in order to
meet our requirements. In addition, even if we are able to expand
existing or find new sources, we may encounter delays in production
and added costs as a result of the time it takes to engage third
parties. Any delays, interruption or increased costs in the
manufacturing or compounding of our products could have an adverse
effect on our ability to meet retail customer and consumer demand
for our products and result in lower revenues and net income both
in the short and long-term.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">13</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OWNERSHIP OF OUR COMMON STOCK</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
We are subject to the continued listing standards of the NYSE
American and our failure to satisfy these criteria may result in
delisting of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
common stock is listed on the NYSE American. In order to maintain
this listing, we must maintain certain share prices, financial and
share distribution targets, including maintaining a minimum amount
of shareholders&#x2019; equity and a minimum number of public
shareholders. In addition to these objective standards, the NYSE
American may delist the securities of any issuer (i) if, in its
opinion, the issuer&#x2019;s financial condition and/or operating
results appear unsatisfactory; (ii) if it appears that the extent
of public distribution or the aggregate market value of the
security has become so reduced as to make continued listing on the
NYSE American inadvisable; (iii) if the issuer sells or disposes of
principal operating assets or ceases to be an operating company;
(iv) if an issuer fails to comply with the NYSE American&#x2019;s
listing requirements; (v) if an issuer&#x2019;s common stock sells
at what the NYSE American considers a &#x201C;low selling
price&#x201D; and the issuer fails to correct this via a reverse
split of shares after notification by the NYSE American; or (vi) if
any other event occurs or any condition exists which makes
continued listing on the NYSE America, in its opinion, inadvisable.
If the NYSE American delists our common stock, investors may face
material adverse consequences, including, but not limited to, a
lack of trading market for our securities, reduced liquidity,
decreased analyst coverage of our securities, and an inability for
us to obtain additional financing to fund our
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
The issuance of shares upon exercise of our outstanding options and
warrants may cause immediate and substantial dilution to our
existing shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
presently have options and warrants that if exercised would result
in the issuance of an additional 833,255 shares of our common
stock. The issuance of shares upon exercise of warrants and options
may result in dilution to the interests of other
shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
The price of our common stock may be volatile, and you could lose
all or part of your investment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Stock
markets have experienced extreme volatility that has often been
unrelated to the operating performance of particular companies.
These broad market fluctuations may adversely affect the trading
price of our common stock. In addition, limited trading volume of
our stock may contribute to its future volatility. Price declines
in our common stock could result from general market and economic
conditions, some of which are beyond our control, and a variety of
other factors, including any of the risk factors described in this
prospectus. These broad market and industry factors may harm the
market price of our common stock, regardless of our operating
performance, and could cause you to lose all or part of your
investment in our common stock since you might be unable to sell
your shares at or above the price you paid. Factors that could
cause fluctuations in the market price of our common stock include
the following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">price
and volume fluctuations in the overall stock market from time to
time;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">changes
in operating performance and stock market valuations of other hair
care products companies generally;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">sales
of shares of our common stock by us or our
shareholders;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">failure
of securities analysts to initiate or maintain coverage of us,
changes in financial estimates by securities analysts who follow
our company, or our failure to meet these estimates or the
expectations of investors;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
financial projections we may provide to the public, any changes in
those projections or our failure to meet those
projections;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">rumors
and market speculation involving us or other companies in our
industry;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">actual
or anticipated changes in our results of operations or fluctuations
in our results of operations;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">actual
or anticipated developments in our business, our competitors&#x2019;
businesses or the competitive landscape generally;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">litigation
involving us, our industry or both, or investigations by regulators
into our operations or those of our competitors;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">developments
or disputes concerning our intellectual property or other
proprietary rights;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">announced
or completed acquisitions of businesses or brands by us or our
competitors;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">new
laws or regulations or new interpretations of existing laws or
regulations applicable to our business;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">changes
in accounting standards, policies, guidelines, interpretations or
principles;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
significant change in our management; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">general
economic conditions and slow or negative growth of our
markets.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
addition, in the past, following periods of volatility in the
overall market and the market price of a particular company&#x2019;s
securities, securities class action litigation has often been
instituted against these companies. This litigation, if instituted
against us, could result in substantial costs and a diversion of
our management&#x2019;s attention and resources.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">14</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
We are an &#x201C;emerging growth company,&#x201D; and the reduced
reporting requirements applicable to emerging growth companies may
make our common stock less attractive to investors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are an &#x201C;emerging growth company,&#x201D; as defined in the
JOBS Act. For as long as we continue to be an emerging growth
company, we may take advantage of exemptions from various reporting
requirements that are applicable to other public companies but not
to &#x201C;emerging growth companies,&#x201D; including, but not
limited to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">being
permitted to provide only two years of audited financial
statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced &#x201C;Management&#x2019;s
Discussion and Analysis of Financial Condition and Results of
Operations&#x201D; disclosure;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">not
being required to comply with the auditor attestation requirements
in the assessment of our internal control over financial reporting
under Section 404 of the Sarbanes-Oxley Act of 2002, or
&#x201C;Sarbanes-Oxley Act&#x201D;;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">not
being required to comply with any requirement that may be adopted
by the Public Company Accounting Oversight Board regarding
mandatory audit firm rotation or a supplement to the
auditor&#x2019;s report providing additional information about the
audit and the financial statements;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">reduced
disclosure obligations regarding executive compensation in our
periodic reports and proxy statements; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 6%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 94%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">exemptions
from the requirements of holding a nonbinding advisory vote on
executive compensation and shareholder approval of any golden
parachute payments not previously approved.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Investors
may find our common stock less attractive if we choose to rely on
these exemptions. If some investors find our common stock less
attractive as a result of any choices to reduce future disclosure,
there may be a less active trading market for our common stock and
the price of our common stock may be more volatile.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Our executive officers, directors and their affiliates may exert
control over us and may exercise influence over matters subject to
shareholder approval.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
executive officers and directors, together with their respective
affiliates, beneficially own approximately 7.8% of our outstanding
common stock as of March 20, 2019. However, when issued, the
aggregate of 15,250,000 shares which are part of the merger
consideration, including following the voting rights vesting over
five years of 8,750,000 of those shares, may result in a change of
control of our company. In addition, the merger agreement also
provides that we may issue up to an additional 15,250,000 shares of
our common stock as part of the merger consideration upon the
satisfaction of certain aggregate net revenue criteria by cbdMD LLC
within 60 months following the closing date. A change of control of
the company may result over time in the event of, and as a result
of, the issuance of those earnout shares. Accordingly, these
shareholders, if they act together, may exercise substantial
influence over matters requiring shareholder approval, including
the election of directors and approval of corporate transactions,
such as a merger. This concentration of ownership could have the
effect of delaying or preventing a change in control or otherwise
discourage a potential acquirer from attempting to obtain control
over us, which in turn could have a material adverse effect on the
market value of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
If securities or industry analysts do not publish research or
publish unfavorable or inaccurate research about our business, our
common stock share price and trading volume could
decline.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">An
active trading market for our common stock will depend, in part, on
the research and reports that securities or industry analysts
publish about us or our business. We may be unable to attract or
sustain coverage by well-regarded securities and industry analysts.
If either none or only a limited number of securities or industry
analysts cover us or our business, or if these securities or
industry analysts are not widely respected within the general
investment community, the trading price for our common stock would
be materially and negatively impacted. In the event we obtain
securities or industry analyst coverage, if one or more of the
analysts who cover us or our business downgrade our common stock or
publish inaccurate or unfavorable research about us or our
business, the price of our common stock would likely decline. If
one or more of these analysts cease coverage of us or our business,
or fail to publish reports on us or our business regularly, demand
for our common stock could decrease, which might cause the price of
our common stock and trading volume to decline.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Public company requirements may strain our resources and divert
management&#x2019;s attention, which could adversely impact our
ability to execute our strategy and harm operating
results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are subject to the reporting requirements of the Securities
Exchange Act of 1934, the Sarbanes-Oxley Act, the Dodd-Frank Wall
Street Reform and Consumer Protection Act, which we refer to as
&#x201C;Dodd-Frank,&#x201D; the listing requirements of the NYSE
American and other applicable securities rules and regulations.
Despite recent reforms made possible by the JOBS Act, compliance
with these rules and regulations will nonetheless increase our
legal and financial compliance costs, make some activities more
difficult, time-consuming or costly and increase demand on our
systems and resources, particularly after we are no longer an
&#x201C;emerging growth company.&#x201D; While the members of our
board of directors have substantial experience relevant to our
business, they have limited experience with operations as a public
company upon which you can base your prediction of our future
success or failure in complying with public company requirements.
Our management may fail to comply with public company requirements,
or may fail to do so effectively and efficiently, each would
materially and adversely harm our ability to execute our strategy
and, consequently, our operating results.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">15</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Furthermore,
as a result of disclosure in filings required of a public company,
our business and financial condition will become more visible,
which may result in threatened or actual litigation, including by
competitors and other third parties. If these claims are
successful, our business and operating results could be harmed, and
even if the claims do not result in litigation or are resolved in
our favor, these claims, and the time and resources necessary to
resolve them, could divert the resources of management and
adversely affect our business, brand and reputation and results of
operations. Our new public company status and these new rules and
regulations may make it more expensive for us to obtain director
and officer liability insurance, and we may be required to accept
reduced coverage or incur substantially higher costs to obtain
coverage. These factors could also make it more difficult for us to
attract and retain qualified members of the board of directors,
particularly to serve on the audit committee and compensation
committee, and qualified executive
officers.</font>&#xA0;<br></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Some provisions of our charter documents and North Carolina law may
have anti-takeover effects that could discourage an acquisition of
us by others, even if an acquisition would be beneficial to our
shareholders and may prevent attempts by our shareholders to
replace or remove our current management.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Provisions
in our articles of incorporation and bylaws, as well as provisions
of North Carolina law, could make it more difficult for a third
party to acquire us or increase the cost of acquiring us, even if
doing so would benefit our shareholders, or remove our current
management. These include provisions that:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">permit
our board of directors to issue up to 50,000,000 shares of
preferred stock, with any rights, preferences and privileges as
they may designate;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">provide
that all vacancies on our board of directors, including as a result
of newly created directorships, may, except as otherwise required
by law, be filled by the affirmative vote of a majority of
directors then in office, even if less than a quorum;
and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: middle; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">do
not provide for cumulative voting rights, thereby allowing the
holders of a majority of the shares of common stock entitled to
vote in any election of directors to elect all of the directors
standing for election.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">These
provisions may frustrate or prevent any attempts by our
shareholders to replace or remove our current management by making
it more difficult for shareholders to replace members of our board
of directors, who are responsible for appointing the members of our
management. In addition, North Carolina has two primary
anti-takeover statutes, the Shareholder Protection Act and the
Control Share Acquisition Act, which govern the shareholder
approval required for certain business combinations. As permitted
by North Carolina law, we have opted out of both these provisions.
Accordingly, we are not subject to any anti-takeover effects of the
North Carolina Shareholder Protection Act or Control Share
Acquisition Act. Any provision of our articles of incorporation,
bylaws or North Carolina law that has the effect of delaying or
deterring a change in control could limit the opportunity for our
shareholders to receive a premium for their shares of common stock,
and could also affect the price that some investors are willing to
pay for our shares of common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
We have additional securities available for issuance, which, if
issued, could adversely affect the rights of the holders of our
common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
articles of incorporation, as amended, authorizes the issuance of
150,000,000 shares of our common stock and 50,000,000 shares of
preferred stock. In certain circumstances, the common stock, as
well as the awards available for issuance under our equity
incentive plans, can be issued by our board of directors, without
stockholder approval. Any future issuances of such stock would
further dilute the percentage ownership of us held by holders of
common stock. In addition, the issuance of certain securities,
including pursuant to the terms of our stockholder rights plan, may
be used as an &#x201C;anti-takeover&#x201D; device without further
action on the part of our stockholders, and may adversely affect
the holders of the common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
addition, the issuance of preferred stock may be used as an
&#x201C;anti-takeover&#x201D; device and may adversely affect the
holders of the common stock. If our board of directors and
stockholders approved the use of &#x201C;blank check&#x201D;
preferred stock, our board of directors would be authorized to
create and issue from time to time, without further stockholder
approval, a certain number of shares of preferred stock, in one or
more series and to establish the number of shares of any series of
preferred stock and to fix the designations, powers, preferences
and rights of the shares of each series and any qualifications,
limitations or restrictions of the shares of each series. The
authority to designate preferred stock may be used to issue series
of preferred stock, or rights to acquire preferred stock, that
could dilute the interest of, or impair the voting power of,
holders of the common stock or could also be used as a method of
determining, delaying or preventing a change of
control.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
USE OF PROCEEDS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Unless
otherwise indicated in an accompanying prospectus supplement, the
net proceeds from the sale of the securities offered hereby will be
used for general corporate purposes, which may include working
capital, capital expenditures, and development costs. We have not
allocated any portion of the net proceeds for any particular use at
this time. The net proceeds may be invested temporarily until they
are used for their stated purpose. Specific information concerning
the use of proceeds from the sale of any securities will be
included in the prospectus supplement relating to such
securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">16</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
DESCRIPTION OF CAPITAL STOCK</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
authorized capital is 150,000,000 shares of common stock, par value
$0.001 per share, and 50,000,000 shares of blank check preferred
stock, par value $0.001 per share. At March 26, 2019, there were
10,170,356 shares of common stock and no shares of preferred stock
issued and outstanding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Common stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Holders
of common stock are entitled to one vote for each share on all
matters submitted to a shareholder vote. Holders of common stock do
not have cumulative voting rights. Holders of common stock are
entitled to share in all dividends that the board of directors, in
its discretion, declares from legally available funds. In the event
of our liquidation, dissolution or winding up, subject to the
preferences of any shares of our preferred stock which may then be
outstanding, each outstanding share entitles its holder to
participate in all assets that remain after payment of liabilities
and after providing for each class of stock, if any, having
preference over the common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Holders
of common stock have no conversion, preemptive or other
subscription rights, and there are no redemption provisions for the
common stock. The rights of the holders of common stock are subject
to any rights that may be fixed for holders of preferred stock,
when and if any preferred stock is authorized and issued. All
outstanding shares of common stock are duly authorized, validly
issued, fully paid and non-assessable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Preferred stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
board of directors, without further shareholder approval, may issue
preferred stock in one or more series from time to time and fix or
alter the designations, relative rights, priorities, preferences,
qualifications, limitations and restrictions of the shares of each
series. The rights, preferences, limitations and restrictions of
different series of preferred stock may differ with respect to
dividend rates, amounts payable on liquidation, voting rights,
conversion rights, redemption provisions, sinking fund provisions
and other matters. Our board of directors may authorize the
issuance of preferred stock, which ranks senior to our common stock
for the payment of dividends and the distribution of assets on
liquidation. In addition, our board of directors can fix
limitations and restrictions, if any, upon the payment of dividends
on both classes of our common stock to be effective while any
shares of preferred stock are outstanding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Limitations on liabilities for our officers and
directors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Sections
55-8-50 through 55-8-58 of the North Carolina General Statutes
permit a corporation to indemnify its directors, officers,
employees or agents under either or both a statutory or
non-statutory scheme of indemnification. Under the statutory
scheme, a corporation may, with certain exceptions, indemnify a
director, officer, employee or agent of the corporation who was,
is, or is threatened to be made, a party to any threatened, pending
or completed legal action, suit or proceeding, whether civil,
criminal, administrative, or investigative, because of the fact
that such person was a director, officer, agent or employee of the
corporation, or is or was serving at the request of such
corporation as a director, officer, employee or agent of another
corporation or enterprise. This indemnity may include the
obligation to pay any judgment, settlement, penalty, fine
(including an excise tax assessed with respect to an employee
benefit plan) and reasonable expenses incurred in connection with a
proceeding (including counsel fees), but no such indemnification
may be granted unless such director, officer, agent or employee (i)
conducted himself in good faith, (ii) reasonably believed (a) that
any action taken in his official capacity with the corporation was
in the best interest of the corporation or (b) that in all other
cases his conduct at least was not opposed to the
corporation&#x2019;s best interest, and (iii) in the case of any
criminal proceeding, had no reasonable cause to believe his conduct
was unlawful. Whether a director has met the requisite standard of
conduct for the type of indemnification set forth above is
determined by the board of directors, a committee of directors,
special legal counsel or the shareholders in accordance with
Section 55-8-55. A corporation may not indemnify a director under
the statutory scheme in connection with a proceeding by or in the
right of the corporation in which the director was adjudged liable
to the corporation or in connection with a proceeding in which a
director was adjudged liable on the basis of having received an
improper personal benefit.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
addition to, and separate and apart from the indemnification
described above under the statutory scheme, Section&#xA0;55-8-57 of
the North Carolina General Statutes permits a corporation to
indemnify or agree to indemnify any of its directors, officers,
employees or agents against liability and expenses (including
attorney&#x2019;s fees) in any proceeding (including proceedings
brought by or on behalf of the corporation) arising out of their
status as such or their activities in such capacities, except for
any liabilities or expenses incurred on account of activities that
were, at the time taken, known or believed by the person to be
clearly in conflict with the best interests of the corporation. Our
bylaws provide for indemnification to the fullest extent permitted
by law for persons who serve as a director, officer, agent or
employee of Level Brands or at the request of Level Brands serve as
a director, officer, agent or employee for any other corporation,
partnership, joint venture, trust or other enterprise, or as a
trustee or administrator under an employee benefit plan.
Accordingly, we may indemnify our directors, officers, agents or
employees in accordance with either the statutory or non-statutory
standards.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Sections
55-8-52 and 55-8-56 of the North Carolina General Statutes require
a corporation, unless its articles of incorporation provide
otherwise, to indemnify a director or officer who has been wholly
successful, on the merits or otherwise, in the defense of any
proceeding to which such director or officer was a party. Unless
prohibited by the articles of incorporation, a director or officer
also may make application and obtain court-ordered indemnification
if the court determines that such director or officer is fairly and
reasonably entitled to such indemnification as provided in Sections
55-8-54 and 55-8-56.</font>&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">17</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Finally,
Section 55-8-57 of the North Carolina General Statutes provides
that a corporation may purchase and maintain insurance on behalf of
an individual who is or was a director, officer, employee or agent
of the corporation against certain liabilities incurred by such
persons, whether or not the corporation is otherwise authorized by
the North Carolina Business Corporation Act to indemnify such
party. We have purchased a standard directors&#x2019; and
officers&#x2019; liability policy which will, subject to certain
limitations, indemnify us and our officers and directors for
damages they become legally obligated to pay as a result of any
negligent act, error, or omission committed by directors or
officers while acting in their capacity as such.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">As
permitted by North Carolina law, Article 6 of our Articles of
Incorporation limits the personal liability of directors for
monetary damages for breaches of duty as a director arising out of
any legal action for breach of duty as a director.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Transfer Agent</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
transfer agent and registrar for our common stock is VStock
Transfer, LLC, 18 Lafayette Place, Woodmere, NY 11598.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Listing</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
common stock is listed on the NYSE American under the symbol
&#x201C;LEVB.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
DESCRIPTION OF WARRANTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may issue warrants for the purchase of preferred stock or common
stock, or any combination of these securities. Warrants may be
issued independently or together with other securities and may be
attached to or separate from any offered securities. Each series of
warrants will be issued under a separate warrant agreement. The
following outlines some of the general terms and provisions of the
warrants that we may issue from time to time. Additional terms of
the warrants and the applicable warrant agreement will be set forth
in the applicable prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
following descriptions, and any description of the warrants
included in a prospectus supplement, may not be complete and is
subject to and qualified in its entirety by reference to the terms
and provisions of the applicable warrant agreement, which we will
file with the Securities and Exchange Commission in connection with
any offering of warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
General</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
prospectus supplement relating to a particular issue of warrants
will describe the terms of the warrants, including the
following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
title of the warrants;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
offering price for the warrants, if any;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
aggregate number of the warrants;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
terms of the security that may be purchased upon exercise of the
warrants;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, the designation and terms of the securities that the
warrants are issued with and the number of warrants issued with
each security;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, the date from and after which the warrants and any
securities issued with the warrants will be separately
transferable;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
dates on which the right to exercise the warrants commence and
expire;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, the minimum or maximum amount of the warrants that may
be exercised at any one time;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, a discussion of material United States federal income
tax considerations;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">anti-dilution
provisions of the warrants, if any;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">redemption
or call provisions, if any, applicable to the warrants;
and</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
additional terms of the warrants, including terms, procedures and
limitations relating to the exchange and exercise of the
warrants.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Exercise of warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Each
warrant will entitle the holder of the warrant to purchase the
securities that we specify in the applicable prospectus supplement
at the exercise price that we describe in the applicable prospectus
supplement. Holders may exercise warrants at any time up to the
close of business on the expiration date set forth in the
applicable prospectus supplement. After the close of business on
the expiration date, unexercised warrants will be void. Holders may
exercise warrants as set forth in the prospectus supplement
relating to the warrants being offered. Until a holder exercises
the warrants to purchase any securities underlying the warrants,
the holder will not have any rights as a holder of the underlying
securities by virtue of ownership of warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">18</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
MATERIAL FEDERAL INCOME TAX CONSEQUENCES</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">A
summary of any material United States federal income tax
consequences to persons investing in the securities offered by this
prospectus will be set forth in any applicable prospectus
supplement. The summary will be presented for informational
purposes only, however, and will not be intended as legal or tax
advice to prospective purchasers. Prospective purchasers of
securities are urged to consult their own tax advisors prior to any
purchase of securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
PLAN OF DISTRIBUTION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may sell the securities from time to time pursuant to underwritten
public offerings, "at-the-market" offerings, negotiated
transactions, block trades, or a combination of these methods. We
may sell the securities in one or more of the following ways from
time to time:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">to
or through underwriters or dealers;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">directly
to one or more purchasers; or</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">through
agents.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
prospectus supplement (and any related free writing prospectuses
that we may authorize) will describe the terms of such offering,
including:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
name or names of any underwriters, dealers or agents;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
purchase price of the offered securities and the proceeds to Level
Brands from the sale;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
over-allotment options under which underwriters may purchase
additional securities from us;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
underwriting discounts and commissions or agency fees and other
items constituting underwriters' or agents' compensation;
and</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
<div style="text-align: justify; text-indent: 0px; display: table-cell">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
initial public offering price, any discounts or concessions allowed
or reallowed or paid to dealers and any securities exchanges on
which such offered securities may be listed.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Any
initial public offering prices, discounts or concessions allowed or
reallowed or paid to dealers may be changed from time to
time.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">19</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">If
underwriters are used in the sale, the underwriters will acquire
the offered securities for their own account and may resell them
from time to time in one or more transactions, including negotiated
transactions, at a fixed public offering price or at varying prices
determined at the time of sale. The offered securities may be
offered either to the public through underwriting syndicates
represented by one or more managing underwriters or by one or more
underwriters without a syndicate. Unless otherwise set forth in a
prospectus supplement, the obligations of the underwriters to
purchase any series of securities will be subject to certain
conditions precedent, and the underwriters will be obligated to
purchase all of such series of securities, if any are purchased
(other than securities subject to any over-allotment
option).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
connection with underwritten offerings of the offered securities
and in accordance with applicable law and industry practice,
underwriters may over-allot or effect transactions that stabilize,
maintain or otherwise affect the market price of the offered
securities at levels above those that might otherwise prevail in
the open market, including by entering stabilizing bids, effecting
syndicate covering transactions or imposing penalty bids. A
stabilizing bid means the placing of any bid, or the effecting of
any purchase, for the purpose of pegging, fixing or maintaining the
price of a security. A syndicate covering transaction means the
placing of any bid on behalf of the underwriting syndicate or the
effecting of any purchase to reduce a short position created in
connection with the offering. A penalty bid means an arrangement
that permits the managing underwriter to reclaim a selling
concession from a syndicate member in connection with the offering
when offered securities originally sold by the syndicate member are
purchased in syndicate covering transactions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">These
transactions may be effected on the NYSE American, in the
over-the-counter market, or otherwise. Underwriters are not
required to engage in any of these activities, or to continue such
activities if commenced.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">If
a dealer is used in the sale, Level Brands will sell such offered
securities to the dealer, as principal. The dealer may then resell
the offered securities to the public at varying prices to be
determined by that dealer at the time for resale. The names of the
dealers and the terms of the transaction will be set forth in the
prospectus supplement relating to that transaction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Offered
securities may be sold directly by Level Brands to one or more
institutional purchasers, or through agents designated by us from
time to time, at a fixed price or prices, which may be changed, or
at varying prices determined at the time of sale. Any agent
involved in the offer or sale of the offered securities in respect
of which this prospectus is delivered will be named, and any
commissions payable by Level Brands to that agent will be set
forth, in the prospectus supplement relating to that offering.
Unless otherwise indicated in such prospectus supplement, any such
agent will be acting on a best efforts basis for the period of its
appointment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Underwriters,
dealers and agents may be entitled under agreements entered into
with us to indemnification by us against certain civil liabilities,
including liabilities under the Securities Act of 1933, or to
contribution with respect to payments that the underwriters,
dealers or agents may be required to make in respect thereof.
Underwriters, dealers and agents may be customers of, engage in
transactions with, or perform services for us and our affiliates in
the ordinary course of business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Other
than our common stock, which is listed on the NYSE American, each
of the securities issued hereunder will be a new issue of
securities, will have no prior trading market, and may or may not
be listed on a national securities exchange. Any common stock sold
pursuant to a prospectus supplement will be listed on the NYSE
American, subject to official notice of issuance. Any underwriters
to whom we sell securities for public offering and sale may make a
market in the securities, but such underwriters will not be
obligated to do so and may discontinue any market making at any
time without notice. We cannot assure you that there will be a
market for the offered securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">20</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000"><!--page break line--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
LEGAL MATTERS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
validity of the securities offered by this prospectus will be
passed upon for us by Pearlman Law Group LLP, 200 S. Andrews
Avenue, Suite 901, Fort Lauderdale, Florida 33301. Certain matters
under North Carolina law have been passed upon for us by the Law
Offices of Jason H. Scott.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
EXPERTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
consolidated balance sheets as of September 30, 2018 and 2017 and
the related consolidated statements of operations, comprehensive
income (loss), shareholders&#x2019; equity and cash flows for the
fiscal years ended September 30, 2018 and 2017 incorporated by
reference in the registration statement of which this prospectus is
a part have been audited by Cherry Bekaert LLP, independent
registered public accounting firm, as indicated in their report
with respect thereto, and have been so included in reliance upon
the report of such firm given on their authority as experts in
accounting and auditing.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
INFORMATION INCORPORATED BY REFERENCE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
Securities and Exchange Commission allows us to &#x201C;incorporate
by reference&#x201D; the information we file with them, which means
that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is
considered to be part of this prospectus, and later information
filed with the Securities and Exchange Commission will update and
supersede this information. We incorporate by reference the
documents listed below that we have previously filed with the SEC,
except that information furnished under Item 2.02 or Item 7.01 of
our Current Reports on Form 8-K or any other filing where we
indicate that such information is being furnished and not
&#x201C;filed&#x201D; under the Securities Exchange Act of 1934, is
not deemed to be filed and not incorporated by reference
herein:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;width: 100%;">
<tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Annual Report on Form 10-K for the fiscal year ended September 30,
2018;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Quarterly Report on Form 10-Q for the period ended December 31,
2018;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Current Reports on Form 8-K/A as filed on February 22, 2019 and
March 21, 2019; and</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
description of our common stock contained in our Registration
Statement on Form 8-A as filed with the SEC on November 15, 2017
and any further amendment or report filed hereafter for the purpose
of updating such description.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
also incorporate by reference into this prospectus additional
documents that we may file with the SEC under Sections 13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934 prior to
the completion or termination of the offering, including all such
documents we may file with the SEC after the date of the initial
registration statement and prior to the effectiveness of the
registration statement, but excluding any information deemed
furnished and not filed with the SEC. Any statements contained in a
previously filed document incorporated by reference into this
prospectus is deemed to be modified or superseded for purposes of
this prospectus to the extent that a statement contained in this
prospectus, or in a subsequently filed document also incorporated
by reference herein, modifies or supersedes that
statement.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus may contain information that updates, modifies or is
contrary to information in one or more of the documents
incorporated by reference in this prospectus. You should rely only
on the information incorporated by reference or provided in this
prospectus. We have not authorized anyone else to provide you with
different information. You should not assume that the information
in this prospectus is accurate as of any date other than the date
of this prospectus or the date of the documents incorporated by
reference in this prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
will provide to each person, including any beneficial owner, to
whom this prospectus is delivered, upon written or oral request, at
no cost to the requester, a copy of any and all of the information
that is incorporated by reference in this prospectus.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">You
may request a copy of these filings, at no cost to you, by
telephoning us at (704) 445-5800 or by writing us at the following
address:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Level
Brands, Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">4521
Sharon Road</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Suite
450</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Charlotte,
NC 28211</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Attention:
Investor Relations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">You
may also access the documents incorporated by reference in this
prospectus through our website at www.levelbrands.com. The
reference to our website is an inactive textual reference only and,
except for the specific incorporated documents listed above, no
information available on or through our website shall be deemed to
be incorporated in this prospectus or the registration statement of
which it forms a part.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">21</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
16,000,000 Shares</font> </div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Common Stock</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424013.jpg"></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
PROSPECTUS SUPPLEMENT</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 24px; font-family: Times New Roman">
ThinkEquity</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
a division of Fordham Financial Management, Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 19px"><font style="font-weight: bold">Benchmark
Company</font></font><br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"> <font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
January <font style="color: rgb(0, 0, 0);">9</font>,
2020</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><br></font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ycbd_424000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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MG-)7//QE.4\P48.VPEKX)U*[C\Z:18689PYR3]:S-6T&^T<@SH#&3@2)T_\
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M7N%'2NMM?AK=2VD,CR;7>-69?0D=*O>"?A])#<1ZIK$84K@PVYZY]6_PKT_
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FZ*]@\)6-G%9+)':0(^W[RQ@'\Z**6,^ K!?&=0.E+117B(]T_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ycbd_424001.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -P JD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJSG\<>*2V!KMYU_OUHIIF;IM'TS17S1'XT\5%N==O,?[]6HO&GB7.#K=T?\
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M-FE\UO>FA:D6-FX"Y^E+F*2&^:V:FAF)/)IPLISTAD/OM-2)IEWG*VTI_P"
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M/K4E:(Z2S\6:O9X\K49@!V+9%=AHGQ0NTD5-019H^A8#!KQ^X^VV#@S)F/\
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M#?PT<U3XV%)FEJ.;<(7*@DA3@#O6S9F,EO((6VO(N[TSS5*ZUJWMXF93O('
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MBV26Y48ZFN<U?1UD$D>W(*\5Y<9.E4?8]E<M:FD]SQQ^M0/6GJME)8W;QL,
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M2[F+R')]/2G0)^50 =JOVR[8^E(HGC&U*[RP_P"/"#_<%<)GBN[L/^0?;_\
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MW/@R3^S5NX6(=B<+7*W$4ENQ25,$<'BO=K^.-(TMU "Q#'U-<9KNA174&\*
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M@R^#M$G.9+,'_@1JM)\/O#4JX?3P1_O&NGHHY(]A^TGW.6B^'?AF'[FG@?\
M S5N/P;HD7W+3'_ C6]12Y(]@]I/N9(\.:6%V_9^/J:BD\)Z-*,/: _B:VZ*
M/9Q[![2?<YR+P+X>AN4N([$"5.C;C5IO"VCNVYK4$_[QK9HJN5$N3>YF)H.G
M1#"6P ^M2#1['_G@/SJ_119!=E#^Q['_ )XC\Z/['L?^> _.K]%%D%V4/['L
M?^>(_.C^Q[(?\L1^=7Z*+(+LH_V39?\ /$?G2C2K,?\ +$?G5VBBR"[*7]E6
M?_/(?G5M45$5%&% P!3J9+-%!'YDTBHF<;F.!3L*Y@:QX(T'7;\WVH6AEN"H
M4MO(X%4/^%8>%/\ H'G_ +^&NH74;)SA+J%CZ!Q4OGP_\]4_.BP]3E/^%9>%
M?^@>?^_AH_X5GX6_Y\#_ -_#75^?%_ST3\Z:UU;K]Z:,?5J5D%V<];> /#EI
M)YD-CM;&,[S5S_A$]'_Y]O\ QXUJBZMSTGC_ .^A2BY@;I*A_P"!460[R,G_
M (1/1_\ GV_\>-+_ ,(II _Y=O\ QXUJFY@!P94!]-U+Y\7_ #T7\Z+(.:1D
M_P#"*Z1_S[?^/&E_X1;2/^?;_P >-:WG1?\ /1?SJ-[RVC^_/&OU:BR#FD9O
M_"+:3_S[?^/&G#PSI0_Y=_\ QXUI"Y@89$J$'_:I?/AS_K$_.CE0^:7<S/\
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M^==DG6N2^)W_ ")5Q_UT3^=6MB7N?.3^'X_X6K"O(?LMP8^N*[5FXQ7(:O\
M\?S4#92WXZBGAE/:HC3E..U D2@)U(IK! >*3>?2ESGM2&."1D9+4TQKV:I[
M2QN+^X%O:6\DTQ'W4&35]_#>KPC,FF7* =24/%.PTC/M(L7MN=PXD7^=?2R
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MM;XK'J$(R>P=?[U=O*DD<=2]SMHHHX4"1HJJ.@48 IXXXJC=ZA'9G9L=WQP
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M^\/0^U;RZ5%C:D\RKZ9I_P#9$;H5-Q*RGL:C4ZOW-[&19^#M#N4BNHTFC(/
MW5J^(Y/(\*ZI(%!*V[X!Z=*T;6V6VMUB3)"YZUD>-9?(\%ZJ_K#M_,U<4^IR
M5(^\['SBSS2+ND 11V JQ;W#Q88 XQBI1;SW:-Y:9"C\*B6%U^1B-Q., ]*<
ME8YF:D5VTGDJ\@P!P*GCNF$I _ 5F>4MJ<8\R7&,#H*NPMY,!PJO(5[CI5I7
M0T3R.92'<J%SQSG%,%PFYXUDW#&=S4SR271BP&1S@=*B>SVN5(X'/'4T1I,=
MBY _F2AVQY>*^D/A]M_X0;3-OW?+/\S7SAYT<,<*^2R<'''6OHWX=,'\":6P
MZ&,_S-*5EH*2L<O\3M4%CK-E$0?GA+9[=:XJ#4OM<4F^1-K9P3VKI_BU"9_$
M%A&)(T_T8MF1O]KTKSE$%O+^]E1HMWW5'\JX:M#5S/1PU1\J1OFZ>>+RK>%6
M8'[_ *UR'B+0)+!UU!(V\MCRR<%&KO["VC2)6"X4\\U<N+>&YMFAD0/&PPZ^
MU>7'$RISOT/0J4(U(V/([C5;NYM8F+[Y(VPDJCD^H85=2)O/E@A.R1E$BLO0
M-C/X5-J&B_V'JAVG$;G?#)CY3_LM5[1[BPN[N2"Y1DN+A&&.@4^U>PIJ:YH[
M'@U*<J;<9%/51=P7%EJD =)@5F1R>=W?/X@U] ^%]<@\2^'(;HA6\U/+GC_N
MG&&%>$7,DTOA5A<QY:P=D##JP[&M+X2^+#IVJOIMTVVWO&RK>C'I50,SO-:T
M>#POIB75]-<.K3;8UA;^('Y'W?PX'%5;^\OIM.:>344M%>("*. YDD'HS=37
M=Z_::9J>@RV>JW'EQ2 ?/GD$=,5A:5IEM9GR]&TAYYDP/M=[_,>U=4912N:P
ME&*VU.?_ .$=DUW3A!9:5]AMSAC=W+;2&ZY]379WES;-X:72V9[]S#Y$DD:\
M-Q@DUIII"7 B&HW#W,RKAE7A/RK06U2*V,=O%'"F/X1UJ9S<B9U'-GREH'AZ
M6?XAVVBO'GR[KY^/X5.:^I<"-=HZ* !7GL&DZ?X>\<WWB>Y!\EXUB7:,E78\
MG\A7;/?07NFSW&GS+/A#M,9R0<<<5C9L%%F9_P )C:_;;BQE@>)HY-J2%=P8
M>M)-:V6J!9(T5R,9DMY,-GZ5Q\-O&B>7<M/%<*,LX&[)SW':J\*&69GAW_NF
MVDQR8W '.<5JHZ#]BWK%GH-KH6JZ;E[?4))HV&1')U7VJ6;4]4M!B:S,F.X%
M'@V6YFT-9;BZ>Z\YV*.PZ*#C%;KGJ/PK-K4C;1F$?$$,.GFZO(I(1\V /05\
MWFUF\8^(M5O5D$8>1I%)/OQ^E>U_$2]M3HUU&D[+.^81@8 &.:\/\+B$:P%D
M9T#C"L&(Q]:N,=44D8[Q&":2)L$HQ4D'.<58TN_?2]6M;Z,<PN"0.X[BK^OZ
M=;V6IO#:J^U1\Y8YRQK-2VW'C/!K*349-#Y6SWO2-7BOK>.XL[@202?=VGE2
M>Q'K6[;W;2W)CY.!DD>M?.EE<WVFRE[.YD@(_NFO7?AM?7NK:7-=7IS()/+5
M_P"^!WIJ28G%K<[Q8P65L84=!4FT>AJ,':XR>E3_ &@>U40*#SSW _E4B'YO
MKWIH QGZ4\+Z&LC2X\ 9[5*JCKWJ(#@=L5,"!VIB';.<&I%4$8-"@FJ>HZMI
MVCPM-?W<4*J,\L,_E30%P#'TILT\%K"99Y4BC7DECBO,-9^,<)=K;P]8O=OT
M\UQA:Y&YB\2>)Y3+K6H/# QR((S@8K.=6,=V5&$F>@Z[\6-'TYFM]*B?4KKH
M!']T'ZUQ5[J7B[Q:?^)C>_8+,_\ +"'@D59T[1K'3%Q;Q*&[L>2:O,ZJI)(
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M?"DT,1^1G52?4YKQJ-A'M!_&G$Y9O4(R=Q!;Y3VJS*J$1*N0-N>>U+Y)^_\
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MJ5=?2N%FE(91UYK8\.1SOK,<L7!3DCU%:TW9F56*<3UU2&3(Y]#ZTN*;&NU
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MU$UA=]K2;_OV:]*Q*.YI/WOJ:S=5OH5:QY<^CWC]+.8_\ -"^'M1<86PF/\
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M-\N*SI'RQJY(.*J,HYH;N.P^"TNKA2T%M-*!W1":NP:'JTS8CTVZ;Z1&O8O
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M@.:6Q8?PU)]D;'2NA^RK2_95I-#,^Z>_V6ZVSR#$6 5Z U!_Q4@7Y;ABQ/&
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M/3N:LWK $Y&2>U9HL@S^9O(QVKDE*S.N,;H59(@X\ZX7;G 4'[M++8R.X"S
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MK%U%KC6HEAAB1%8"0<R9/:L(>*]1*W!+Q @$KD=/FQ_*K.2&%G)7N=O(<*S
M9(!P/4USPU2[<9,@C;)RI0\5$NLWTN@W]S'*F^T?:DH7Y9!]*S;K7-3@U%H
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MSI+':IP#\[X[^@K+\'W!E<X) &:O:[$?MRRGHZ8'X43D_9Z$Q2YR&VD60!2
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M+4LIXEBGN8P) =S8ZUT<3AUR.W6O/&\'+;W5O)%/(8Q("P![ UZ [P*=T <
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M9(2?>0>@-0^3JD(Q'\Y SCTKU671H8KW$D$B(WH*B.CPQ3[5PK-RI8\X]*+
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M,,VR3!X!J?S/>M#_ (0W6]V?LZ_]]U-_PB6N?\\%_P"^Z-A'I]%%% @HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "L[5M[?98U9U62=58KZ5HUEZRAD-F@<H3<+AA0
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KA4U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ycbd_424002.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -Q JH# 2(  A$! Q$!_\0
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MW_3_ 'O_ '^- &G169_8W_3_ 'O_ '^-']C?]/\ >_\ ?XT :=%9G]C?]/\
M>_\ ?XT?V-_T_P![_P!_C0!IT5F?V/\ ]/\ >_\ ?XT?V-_T_P![_P!_C0!I
MT5F?V-_T_P![_P!_C1_8W_3_ 'O_ '^- &G169_8W_3_ 'O_ '^-']C?]/\
M>_\ ?XT :=%9G]C?]/\ >_\ ?XT?V-_T_P![_P!_C0!IT5F?V-_T_P![_P!_
MC1_8W_3_ 'O_ '^- &G169_8W_3_ 'O_ '^-']C?]/\ >_\ ?XT :=%9G]C?
M]/\ >_\ ?XT?V-_T_P![_P!_C0!IT5F?V-_T_P![_P!_C4>G))!JUW;FXEEC
M6-&7S'R1G.: ->BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?#E<>-+;/]Q_Y40PCE1=1BJ8Y*NJ43UNY\4Z):7#P3ZA$DL;;64GD&HQXQT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M80<U!::/964OFPQ'S ,!F8D@>@J]0!F_VL?^?*Y_[YH_M8_\^5S_ -\UI44
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MGJ-%>6_\);K?_/TO_?L4?\)=K?\ S]+_ -^Q1]0JA_;%#LSU*BO+?^$NUO\
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M XP:EO+.6QNI+:=-LL9P1_6JC#G-;W-!M_?WFH$FZF+Y;<>V6]35W2AB"/\
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M##H1D5\Q./\ B;Z:N!Q*O\Z^F8AMA0?[(_E21.(I1A*R'YYK@?BP?^)'8?\
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M:&)J6G6^F1036(,$TKR>9M?<K 'CBJ(UJ-9?(N@(Y-N=P^Z176MHF@PZ4MU
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MO^![=KVLZ4_A[48X[VV=S;N%57')Q7S6\!).5)Y]*ZNT!:%F:QC8\E,_Q?\
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M.-=SR2' 44WAG%78+,8R=DBM_:\@& (^#G[HJ*76)I,[@GUV"K=SHIM9?*E
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M>!QTJ.I1TI,<3L7^^U-I9/OM25S&0GKSTXI00>AK1T5+26_2"YMVG:0JJ+G
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M<_X0K2?[C_\ ?5'_  A6D?W'_P"^JZ.BCV]3N'U2A_*CG/\ A"=(_P">;_\
M?5'_  A.D?\ /-_^^JZ.BCV]3N'U2A_*CG/^$)TC_GF__?5'_"$Z1_SS?_OJ
MNCHH]O4[A]4H?RHYO_A"-'_YYO\ ]]4?\(/H_P#SS?\ [ZKI**/;U.X?5*'\
MJ.:_X0?1_P#GF_\ WU1_P@VC_P#/-_\ OJNEHH]O4[A]4H?RHYK_ (0;1_\
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M_P"^Z3_A7NA_\\Y/^^ZZRBCZQ5_F#ZG0_D1R?_"N]"_YY2?]]TO_  KW0O\
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MRP6$$4[EY40!F]30!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHS0 4444 %%)D4M !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 44GXTM !1110 4444 %%)D4N: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ,XKGK[QAI=C</ ?.E=3@^5$6&?3-;S+O1E)ZC'%<_IFF7FE&<WES!
M)91*?* 3YO7+'UJ97Z&D%'[19T?Q-I^MRRPVCOYD0RZNI4BM:::.WB:65PL:
MC+,>@KS+32^A^++'59<_9]75@Y/16)R/\^]=EKB'4KNUTE3^Z<^=<>Z#H/Q-
M1&;L_(WKT(1FN7X6O^'#2_%=CJNIM8P1SAPN]7="%<>HK>R*Y+2M4NKZ_P!0
MAM;6T1;%O(67GYO84EQXBU.SNM+MY[.));QS&P).%(-.,U84L.Y2M!6^?S.N
MR/6L_5-8M=*16GWLS?=2-2S-^ K,BUR[?Q=)HIBB")$)3)DYQZ4]I;Z?Q)(L
M%O;M' @5IV)R,\[1[TW*ZT,_9<K][U+ND:_8:VKFTE.^/AXW&&7ZBC4]?T_1
M[BWAO93&9SA#M)'XGM7-ZC"='\?Z;>6ZA$U!##*!T9ASFK_C<13:*MJ54S3R
MJL9(^[@Y)_ 5/.TG?H:.E'FC;:1U ((R#D&EKE=/UC4M4@EFTR"-;.%=L4D^
M?WQ'IZ"J]QXT9?#46K0VR^8TWDM"YZ/G! JO:*Q'U:IS<J.RHR*YS^W;NVU>
MQL+V",&\0E&B).TCL?:J^G^*)KB_U.*X2".WL7V&4$G>WH*/:1$J$VF^QU=%
M9.CW.J7<9FO;>*")C\B G<1V)]/I6M5F4ERNP44E<]J&JW6C^)+47)!TF]'E
M*^,>3+VR?0T".BHKBAXIN9/[4U=!NTJW/V:SCQS<39QG/IG@5H2^*=G@]=:%
MM^\!"20$\H^[:5_ T[,=CI<T9XS61K^KR:/HC:A'"LK*R H3CAB!_6JEAK=U
MKC7#:9#$+2"0Q":4G]XP^]@#L/6E9VN(Z'(HR/6N2F\;+:6UY'<6;+J5M,D'
MV4-_K&?[A4^AK39-?^Q>:);4W/WO)V_)_N[NOMFBPS:R*6N1_P"$FFOK/2YK
M%#%+<7WV:XBD&3'M^^/P]:ZD7$)N#;B5/."[S'GD#UQ181+151]3L8QEKN$?
M.8_OC[PZCZT?VI8^:(OM47F$ [=W.#TH MT55&HV;.Z+<QEDSN ;ICK3%UC3
MG5F6]@*J0I.\8!/:@"[14$M[:P-MEN(T8$##,!R>GYTD]_:6TJQ3W$<<C@LJ
MLV"0.] %BBD5@ZAE.0>012T %%<YXS\66_@W0FU6YM9[B-6VXB'0GIGT%2>$
M_$8\2>&K'5I4CMGNEW"+?TYH WZ*9)-%%CS)$3/3<<4ID14W%U"^I/% #J*J
M7=_%;:?<7B@SK"A<K%R3@=![UQOA'XFV/B>UU?4)8?L&GZ>5'F3-R00<D_E0
M!WM%>>Z_\5M,T?PG:Z];V=Q=07;,D&  -P./F].E=CHVJ1ZGI-E=,422XA67
MR]W(R,T :-)D5Y_;?$V*_P#B)_PB=MI\JO%Y@GEE.#E1GY15KP/XPU/Q-J.K
MVNHZ0UBMG+MB9@1O&<=^] ';T5$;F!?O3QCG'+#KZ4]I(T7<[JJ^I.* '44U
M75QE6!'J#3J ,C5V'VNRBDN)(8I"X)5L9/&!3GTN**,R27MPJJ,DF7@4NO#.
MDR\#(*D<=/F%2ZG$]QI<D4:;I&4$+GKR.*I;(R>[*HT^7R/.L+^1F(RN]MRM
M[5<M=1BEM8Y)76-SPRENA'!%1Z/!+;V;+(@C+2,X0'.P'H*IZ@FFZ4?/EM3+
M).Y.!S]3]*'O85^5<QMK(CKN1@P/<&F-=6Z/M::,-Z%JQ;BSN(WA?27*0W6!
M(,\1C&=R^_:B6+2[&6*REMFD>3[TA&<9Z%C[FBR'SOL;9N(5.#*@/NU,:ZMU
MP#-&,]/FK,L_#MK;2SEU,RR-E/,.=@QTJLD.E1ZQ-8BU8O)RSM]T''W1[XHL
M@<IVU':? M^)1)=7*SQN0Z;BN.>,>U7=+D\JWN%FF)6.=E5G/..*K:78S66K
MWD;,S0E5,)/9>X_"H+;3MUU?7=^Q:W29FBC_ (0,#)/K5.Q$6TUIJ;\=S!+_
M *N5&QUP:D1U=0R,&4]"#7/Q06NIVDD]E&UK<)D*<8[9&1W!%:6C"$:3 ($V
M1@?=]#GD?G4-&D)-[E^BBBD:!14$E[:Q%A)<1)M^]N<#%,DNXF+Q0W$)G\LL
MJEAZ<$CTH M45FZ?=R0Z7"=5N[3[4%S*\380\]1GM5N:ZMX8U>6>-%;A69@
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M1^&..Y_F:Q[+2FN[&XO#<0PP0$*S2=R?2NBG2C*-V<E2M*,^5'KG_"PO#O\
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M>6_]!-<=XVT"\;P7X0\20PF:VAL8X9U"Y"X.03['I2 7Q-9?"U?"3KH=^O\
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M[^TT]IS<VK7'FQ&+ ?: #7315XLX\0[21O:I$G]IIXAA4"WN+83J>PF^Z5_
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M?2O]H67_ #]P?]_!1_:%E_S]P?\ ?P5\U;W_ +[_ /?5&]_[[_\ ?5']EO\
MF#^VG_*?2O\ :%E_S]P?]_!1_:%E_P _<'_?P5\U;W_OM_WU1O?^^W_?1H_L
MM_S!_;3_ )#Z5_M"R_Y^X/\ OX*/[0LO^?N#_OX*^:M[_P!]_P#OHT;W_OO_
M -]4?V6_Y@_ME_RGTK_:%E_S]P?]_!1_:%E_S]P?]_!7S5O?^^__ 'U1O?\
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MS_%.F6U@+.6 R1><A+6TKY:*M*>(FZG+(QJX6E[#VD#G#2445Z)Y?02DHHH
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M4=J!"4444P$-*%9F"JI9CT ZFDJYI/\ R%[;_?%)NR9<%>21'_9]Y_SZ3?\
M?%-_L^]_Y\Y_^^*DEOKSSI/]+G^\?^6A]:C^W7G_ #]S_P#?PU"]HT6_97ZA
M]@O?^?.?_O@T?V?>_P#/G/\ ]\&C[=>?\_<__?PT?;KS_G[G_P"_AI_O/(7[
MKS%_L^]_Y\Y_^^:@EBDA8++$\;'G##%2F^O/^?N?_OX:BEFDF.Z65Y#C&68G
M H7/U)DJ;V.A\'Z-%J=[+-=1;[>)<8/0L:BLM.@U3QA);PQ!;5)22HZ;5_\
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M.NUTL:8O"PI8126LFS ) .">:;N&:T8-8N[>%88A#L7@;HE)_.G_ -OW^?\
MEW_[\+_A77S5>ECS%&FU\3,O(S3<CUK6_M^^QTMO^_"_X4W^W]0]+;_OPO\
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MRVV[NF:NZ3_Q[ZK_ ->9_F*51WA<5*+C4LS)'6M31_NZC_UYO676IH_34?\
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M;&#MQS@]/Q]J%43$Z,T4Z#]TYHH/W35N^I";+^L?\?<?_7!/Y5'I7_(6M?\
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MX&:NW.EW5K#YTB1E!CE'SP>,_G5,^GI6D$M[W,JKN]K&GI?_ ""]7_Z]U_\
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M3>L0E*25U(@:ZF,;1LWRL@0CV!S_ #JN:4GG-(>E:V2V,')MZFII?_(+U?\
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MJ!K^ZN"X9R[.IC/')!/2KT&H6PTJ&WE+[XI"3QPV3FISK%@)5DA@\H+(&VA
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MY,+I+EB&D3IQ@5 .3Q5BQLY-0O%M864.X^4MTJ)1C%79I&52;44Q3?W)93O
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M*#-E#P,-SGG(I3IUGY#/O(^;:?G'R<?K5)=.NLKA N1D?-@\\4[^S+D6[NP
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M_"F^M<<HJ5KBA4<%H7_M>F_] QO^_P :7[7IO_0,/_?XUG8I:7LH]V5[>?\
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M!>K_ /7NO_H0K)]*UM+_ .09K'_7NO\ Z$*R>U90UG(WJ?#$UM+_ .03K/\
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M2 Z=_P \[C_OH57-Y$.%MVBF:2KC-I_&(KC_ +Z%3V-G:ZA/Y-O#.6 RQ9P
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M<U7;5]/1RC7<08'!&[H: +M%0R75O#")I)D6,]&)XJ.'4K*XD$<-S&[GH :
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M]!TV*99$ME#*<CDD#\*TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BCH.:* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_5;F-+*:$-NED0JJ
M+R2<5?/0UF:3!&T#7&W,K.P+'KP2*:L3*^R)]/NH9;:.-6 D10&0\$&KM9FI
M0HJQW"KMF610''N:TJ&$>S%HJLMT#?M;8^Z@8'US5FD.X4444#"BBB@ HHHH
M **** "BBB@ HHHH **** "BC-% !1110 4444 %%%% !1110 4444 %%%%
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MDMH/,BMWG;.-B=:J6>K/<7YM)K.6WDV>8-YZC.*S.BYJ4444#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K'\3?\@C_ +:Q_P#H0K8K'\2_\@C_ +:Q_P#H0H$]B74]
M%M=3D263>DR<"2,X;'I]*=IVD6VF1L(0SR/]Z1SEC]36C13YG:Q/LX<W-;4B
M6")68B- 6ZG:.:!!&!@1J >H"CFI#65J.LK8ZA%:")GDD3>,' ZXH5V*3C!7
M9IHB(,(JJ#Z"F>1$)#(L:!SU8+S^=9D_B"UBN5MDRTI)!P.%(&2,TEMXCLID
ME+%D,2J7..#GL/6JY);D^TI;7-8QIV1<Y]*8L$:LS") 6ZD*!FJ3:Y9':(G,
MLCH75$') J6#4[:ZDEBA<L\7W^.E3:2Z%<\&]RUY$00H(DV'JNT8-*L:J!A5
M&..!BL%/%,4D;GR&4[69-Q'S '!^E6YO$%G%%*P8NT8!8+T'(SS^-/DD2JM-
MZW-)88E!"QH,G) 44>4A<L8U#'@G'-5[;4K:ZD586+%@2"!P<=>:NTG=,T7+
M):$0AC086-0,YX'>G"-,Y"*#G/2GTG>EJ.R,;P[]S4/^OR3^E;58OAW_ %>H
M?]?DE;55/XA0^$*RHO\ D9[C_KU7_P!"-:M947_(SW'_ %ZK_P"A&D@>Z-6B
MBBD44M1OUL4C_=F225]B(.YJM)J L=,ENY;3R2K ,HQR2<9S5J_L$OXE4R-&
M\;;DD3JIJM-I,EQI;V<UT\K.0?-8#C!STJURZ&,^?6WR(X=9ANK6\=X<BV&7
M7(8'C-.M=9$DT,$ELT)F3=%D\''44EMH,<%O=1M,[M<+M=L 8X]!2V6BK;SQ
M337,ES)"I6/?@!1]!WIODZ&<?;:7'0ZC:22,X@VS"3RR=HR??Z5)-?*UZUGY
M:M@#=D^M)_9$'[CYGW0R;U;/7V/M3GT]FOS=+,JYQE2@/3WJ=#1J=K#)+V.Q
M>2&. ".)03@@=?043W"R72QK;"5@GF G'R_2GW.EP74TDK_ZPA0#_=QTHEL'
M>Y6>.X:-MFQL#K1H-J6RV$DU1([6*14.9&VX/&TCKFKL3^9&&( )&< YJHVG
MXM5MXI-N#DLP#9]<U/9VJ6END*9*KW-)V*7-?4L5C>)O^0,W_76/_P!"%;-8
M_B;_ ) S?]=4_P#0A3A\2"I\#-BBBBI18C?<;Z5C^%_^0!!]6_\ 0C6PWW&^
ME8_A?_D 0?[S?^A&GT)?Q(FU32_MYBEBD,-S"<QR@=/4'V-4Y=*U2\MIX;R]
MC*R1E J)@?6M^BFI-$RI1EN<PWAB>2V;?=JUR3& ^WY0$Z#%:>F:5]BDEN)Y
M3-=2\/(>F!T ]!6GCBEH<VUJ*-&$7=(S=3AU*0(;"6)" 0PD&0:S9/# .FVL
M*2C[1;Y82%>&)Z@CTK=EO+:!]DLR(QYP6Q34O[62.61)5*PG$A_NTTY+8B=.
MG-M29SPT#4I+5K9Y+:&)DVMY:\L>V:U9]*,\FG,' ^R-EA_>XQ5JWU*SNMWD
MSJVT9/M4S31+@M*@!&1EAS1*4GN$*=)+0Q[G2+R&_DO--G1&E&)(I!\K$=_K
M26^BW$]T;O59EFD"&-(T'RJ#U_&MJ&:*>,21.KH>A4YI]+G97L(?(YV/3-9L
M$^S65W$]L.(_-'S(/3WH_P"$>GAMXF@N%:\6;SWED7.]L8_E71T4<[!4(=2&
MV$RVZ"X96E ^8J,"L]_^1KC_ .O0_P#H5:U9+_\ (UQ_]>A_]"I&IK4444AA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5C^)?\ D$?]M8__ $(5L5C^)?\ D$?]M8__
M $(4UN)[&QVJ&>Z@M@OG2JF>F3UJ:N>\1Z7<W]Q:26Z[A%NW , >1CO3BDWJ
M14DXQNE<WEE1T#(X96Z$'K67J&F076H0W+73PRA?+7:1SSGN*Q8M!U:-[0>>
M5BC0*1&^-A!Y^M+'H>H^9"\L>\0W <!I268=SFM%",=5(YW4E-6E T9]$TZ&
MZ$LUTZ;F9PA< ;B,$U'_ &3I?F-&MZX8[-H##*LO0CCK4U_I]TVJ+=I!%=1M
M&(S'(V-ASU%94FA7YU=IUB 1IUD!W_* !R,4XMVW(G!1V@:VFZ?IMM=![:X\
MR<(5(+ DY.2?KFE@L;&RU*64W1\Z8%=C. .?;UJA8Z1?K-:"2".$6\S.TP?)
MD!)P,?C4ESI-^-0N)((H9!/(KB:0\Q8QD8_"I>^Y45:*?)L74\.V$5FULB%=
MX(,@^]US3#X<M&BFB$LODRY+1 C;DG)_.LZ32]9<-"&"JJRA9!(<ON((X[5+
M'H=Y!<J\<K_+,",R'[FW!_6GJOM"]UZ>S\C4L=*AT[:L,D@B7(2(L-HS5^*>
M*4%D<$ E3]17+?\ "/Z@L/RS-YHA7_EH<>9NR3^5%QHNKO*ACFP@D<D*^TC)
M&#2Y4WK(M5)P5HP.M!!Z&BL/1K"^L]0N&N#NA8?*S/N8FMRLY))V6IT4Y.4;
MM6,;PY_JK_\ Z_)*VJQ?#G^JO_\ K\DK:ISW"G\*"LJ+_D9[C_KV7_T(UJUE
M1?\ (SW'_7JO_H1I(;W1JU7O;I;*RFN6!*Q*6('>K%07=M'>6DMM+GRY%*MC
MT-)6OJ.5[.QD6WBBSE25I08E0*<GOGH*L_\ "06&5$<I<LA<*H[54_X1:P2!
MQ(\C#:OSLW*A>E%OHVFW0@FMYV=8/E&UL GWK6T#D3Q&VA;76[=M(&I;7$;
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M>V*TM#DN'O+7RGN&C,/^DB7. WMGOFIG3^U<VHXA-\G*SJZ*.U%8G8%9+_\
M(UQ_]>A_]"K6K)?_ )&N/_KT/_H5-"9K4444AA1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5C^)?^01_VUC_ /0A6Q69K]M/=Z6T=LF^4.K!<XS@YH0GL:=%97]H:GC_
M ) Y_P"_X_PH_M#5/^@.?_ @?X4[!<U:*RO[0U3_ * Y_P# @?X4?VAJG_0'
M/_@0/\*+!=&K165_:&J?] <_]_Q_A1_:&J?] <_]_P ?X46"Z-6BLK^T-4_Z
M Y_[_C_"C^T-4_Z Y_\  @?X46"Z-6BLK^T-4_Z Y_[_ (_PH_M#5/\ H#G_
M ,"!_A18+HU:*RO[0U3_ * Y_P# @?X4?VAJG_0'/_@0/\*+!=&K165_:&I_
M] <_]_Q_A2?VAJ?_ $!S_P!_Q_A2LPNB/PY_J[__ *_)*VJR= MKBWMK@W,7
ME/-</*%W9P#6M3EN33^%!65%_P C/<?]>J_^A&M6LJ+_ )&>X_Z]E_\ 0C0A
MO=&K1112**VH0R7%A/#$P5W0J"16/HFE7VEV]PC-$%9?W4:G.UO<]ZZ&D(XJ
MN=J-D92I1E-3>Z.1/A6\$$T?VI)/M*8FW# W9R#_ #J5O#,\?G&%H<O*KA#D
M!@!C!_'FF1IJTNKW<L>]8HIS\S-P5"_="_7O36U75X[6V=P5DD3?Q'G<V?N>
MW%;\T]DSCY:2WBR:/PW>"&4/=#S3 (T;)P#G)_PJ >&]0-K,F^%#-(7*(3@?
M+@<TG]N:I]O,+C;(=_[H+D#"Y&#WYJ2;5-6@EL$(+LZHTOR<-NZ_E1[Z["?L
M7LGI^HB>&]0\\,98QNV%I03N^48(_&ID\.W?F(QE3[L:MSU"YS_.H'O]< 9P
MW!220+Y?3:V OXBKVF:E?76JO%,K"/8& "\+]3ZTFYVN.,*+?+9F;;Z%?07-
MK9+N$()$SIPK1YR/QSQ79    =!TI:*QE)RW.VG25-605C^)O^0,W_75/_0A
M6Q6/XF_Y S?]=4_]"%$/B0ZGP,V****DL1ON-]*R/"__ " 8/JW_ *$:UV^Z
M?I7,:%K5A9Z4EO<3>5*C,&4HV1R?:FD[$-I-7.HHK*_X232?^?L?]\-_A1_P
MDFD_\_8_[X;_  HLQ\R-6DK+_P"$DTG_ )^Q_P!\-_A2?\))I/\ S]C_ +X;
M_"BS#FCW-:DP*RO^$DTG_G['_?#?X4?\)+I/_/V/^^&_PHLPYX]S5P*,#TK*
M_P"$ETG_ )^Q_P!\-_A1_P ))I/_ #^#_OAO\*+,.:)JX'H*  .@K*_X232?
M^?P?]\-_A2_\))I/_/V/^^&_PHLPYHFK165_PDFD_P#/V/\ OAO\*/\ A)-)
M_P"?L?\ ?#?X468<R-6LA_\ D:X_^O0_^A4[_A)-)_Y^Q_WPW^%5;6^@U#Q,
M)+5C)&EJ0S[2 #NZ<TTF)M/8WZ***DL**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LJ+_D9[C_KV7_T(
MUJ'I65=Z5<2ZC]LMKTV[&/RV&W.1G--$LUJ*QO[-U7_H+M_W[%+_ &;JO_07
M;_OV*+!=]C8HK&_LW5?^@NW_ '[%']FZK_T%V_[]BBP[OL;-)BL?^S=5_P"@
MNW_?L4?V;JG_ $%V_P"_8HLNXFWV-%+*V2<S)"BRGJX'-6*QO[-U7_H+M_W[
M%']FZK_T%V_[]BG:_4%IT-FBL;^S=5_Z"[?]^Q1_9NJ_]!=O^_8I67<=V;-%
M8W]FZK_T%V_[]BC^S=5_Z"[?]^Q19=PN^QLUC>)_^0.W_71/_0A1_9NJ?]!=
MO^_8J&XT*^NU$<^J,\6X,R[ ,X.:%8F5VMC?HHHI%A28'H*6B@!,#T'Y48'H
M/RI:* $P/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&!Z#\J6B@!,#T%&
M!Z#\J6B@!,#T%&!Z"EHH 3 ]!2X Z"BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ycbd_424003.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -K J4# 2(  A$! Q$!_\0
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M;GZ?E124$MBY^GY4W/T_*D)I*I";%W?3\J0L?;\J;FE"D]!3);#/T_*FY)Z
M?E4HBQU-*2J=J:(;&A&[X_*G95/3\J8TA/M45-")6F/;'Y5$78GM29I*8B]
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MW9ZVTO\ WS2PW\QZWDG_ ']_^O4AOIO^?N3_ +^__7JN21G*=/I<0Z?<A?\
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MJQU2ZX)O)O\ OZ:1]7NB/ENYO^_AI\T_(.2EYDLVFWS#/V6;_OBJ_P#9M_\
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M-OS1IV!KOC<?)@C) S]:\RO]7U*YTB];39([0W,K!N/F&#CB@#O;;2[:*3S
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M$L<KVQ:52,8;''XYKSOX7<>+N?\ GW:M88F<J4F]T85<#3C7A%/214/PS\2
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M_P"OE:BI\#-**O40NN1)%XBU%$4*@G=0H'09K-D4 5J>(6'_  DFICO]I?\
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M5N#^M>GZMX?LY_"$^DQ1Q^=%;#& -V0.#^E<L\8H*+74[88"<W)7VV/#%Z
M'.>% R::^[)#*0>N",5VGPQTG[;KTUW<(#%:1X(8<;S6#XANGUKQ7=?9E&))
MA#"JCJ <"M%73J.*VL8/"N--3ZMZ&/R5W+&<>H7BF89F"@$D\@ 9->\65CHV
MFVUGX8F2,SS6S'!4$M_>.?K7D>)/"/BUP\ F-I(P5'Z,#T/Y5G1Q7/=):_F;
M5\$J*B[Z/?R,3RI"3F"7K_<-.$<@.?*<?5#7LW@GQ.OB>XNXYM,MH/)56!4
MYS^%<OK?CAKJ>]T?^RK:-&E:W\X8R!G&>E0L14<[<NQ<L)24%-3WV. \N21R
ML:/(?1%)_E2.CQG$D;(3V=<?SKVC5G7P5H5F-%T9;K( =PN2..I/O7$^(/'*
M:UHLMG<Z1%!>;A^\"]!W[9JH8F4WI'057"PIQ:E+WOS.-"J>, 9.!QUJ7[-,
M@WF"55'.XH0*]+\+:)I?A[PN?$NL0K-,Z[HU<9V@] !ZFH(_BA!-=*EUHT8L
MF..H)4?3%'UF3;Y(W2$L)%*/M)V<MD>;-MVX&,>M(ZD '80IZ-MP#^-=]\0?
M"]E:V46N:2H6UGQYB+T&>0PKM].T&PUKP'8VMU"G[VV7#A0"&QP:4L7%14K#
MIY?-SE"^JU/"<%L#!)/8"E<$#YD(..C#!KL- T2XT7XDV.G7J!MKG:Q&0ZX.
M#3OBA&D7BW;&H1?(7A1BM8XA2FH+J92PLHT>=]&<52]J3H:7/%=".-B5K^%_
M^1LTK_KX6LBM?PO_ ,C9I7_7PM35^!FM'XUZH37E!\2ZGG_GY?\ G5'  J]K
M[8\3:G_U\O\ SK.WY'%.G\"]"*Z?M&1MUJ>TLYKTRK" 6BC,I&>PZU">N:MZ
M5?G3=5@N]N]$.'3^\IX84IWMH%.SEJ6HM$OBUFWE!?M<9DB)/4#KFEDTRX\X
M1PH\Q*!R8U/&:TV\5+-;:A"L!4R?+:<?ZE"-I'Y5!=>) ;6:&%98G>*",.IP
M1LZ_G64:E5=#:5.A?1F8=.NIE8Q6TS;"0Q"G@]Q59;2X>!IEA?REX+A>,UTQ
M\6(]Q$\<<J(MZ+EU!QN& ,'\J>?$T;Z8ULL+12!7C4*!M92<Y/O3YZCZ$\M)
M+XCE)K>>!AYT+Q[AE0R]15RST/4+V^BMDMI$>0;@74@8 Y-7K_4S=Z\NH[2R
M1E"D;G@!1TK3_P"$HMXIAY27+AI'D=I&Y1BN-J^U$G4LM!Q5*[UV.>MM'FN+
MN6!)8E:)MNYVV[CZ"KB>']0>)OW05E9E",WS.5ZX^E.T2[L+.[:YOXY99%&8
M=H!VMZG/6KT.OVRM;RR17$UQ9M(UNY.!)O[O]#0Y54[)!%4I*[*/_"/W $!,
MD"I,F]&+X'7&/KFH4TB\EU-M-2+_ $M2<QY]!FM&TU;352P74+:646B2;0O0
MNS9!(]!5:WU<6^NS:BKS2;@^UWP'R1U_.G&5770AQI::E)+"ZDLYKI8F\F!P
MCGT8]OK36LKM95B^S2B1^0NTY(K7D\2_:+62WGMP$<QLR1G =@<LQ]S5V7Q9
M9M+:B%)XTB9]QX)VM_#]*7M*J6Q2IT9;,YBZTR]2V^UM;2"%7\LMC^*J_P!A
MNQ.(3:R^85R$V\D>M=$WB>S5V,=I*J178N88R^5; P0V?SIESXJC>Y:2$3E#
M;RHNX ,C/Z'T%1[6I?8U5.DE\1SLEI<1P^<\$@CSC>5P*@K=N=:MKKP\EC(D
MTMU& JR,<! /YYK".,\=*VIRD]S*I&,7:(4E%%:&84444 %*.M)2CK0#'/TJ
M/M4C?=J.DQ+8*2BBI&%/CZTRG)UIH'L!^\:U/^67X5EG[U:G_+/\*&8U>AJZ
M[_Q\6?\ UYQ?RK+-:FO?\?%G_P!><7\JRS44OA)K_&Q***6M3$444@HI%'H\
MA_>'_/:HZ=)_K#_GM3,UXY]<V&:0FC--IDW*\5R=/UBVNL?*'VM]#UKT%2."
M#E3T^E>=WL7F0D8KI_"^I&_TP0N<SV_R.,\X[&N:K'6YUX>>G*= 3\O6L#Q7
MK9T;2R(<?:9CA!GE?>KFM:[;:+:[GP\Y_P!7$.I/J?2O+=4O[G5;Q[BY;<QZ
M#L*R.HQ-2\1:NSGS+Z5L= 3D?E69#K\I?;==&XW+5W4;<21MP!CI[USTL!#$
M=<4 ;,MTK1Y+"5".&]*RIK2*8].3R#ZU5226([DY3N.QJ_!*L@W(?JIZT 5+
M>RLUU6TCORR6SS*DA4]1FOIC3[&RT^VCCL;:.&$*,;%'S#US7SAJ%E+=2VLL
M6W;$WS G''K7T%X8U*#4-#LU6XC>=(@KIGGCB@"#Q[@^"-3]?*_K5KPXV?#.
MFG_IW7^55?':C_A"M4_ZXFK'A@Y\+:6?6W7^5 &MVI#T-)FE/(^M &??7D>G
MZ?<7DAPD,9<UX/YSW-Q+<R??E<L?QKT'XEZV$@BT2!_GE(DGQV7L/QKS]%"J
M/6O4P5*RYF>!FE92DH+H.I*7!/2C!KTCQP%.!Q2 4$<T"9)O.W%2V=Q)9WD-
MS$</"X<'Z&JU.!^4CUI/4<7RM-'O[Z5:Z]?:)KP*_P"CH9 #_%N''Y5RNB>)
M_M7Q/OHR^;:Y7R$&>,KT_/FN6TOX@:IIFBKI<<4;(BE%D;J :Y^SO);*]ANX
MC^^BD$@/O7FPP<FGS?(]BKF$;Q<.^I[#>V</@OPQK=Q&PWW,CM'[%N *XWX:
M:)]NUQ]3G4&&S7(8]"Y_PK-\1>-=0\264=K=0QQHCA_D_B/O3=-\87NDZ%-I
M=I;Q*LH;=+_%S51P]6-)KJR*F+H2Q$9/X8[>IWU]I6FW?BN/7_\ A)$CEB8;
M(A@@ =1UK'^*>DI+'::];%6C;]U*R]"#]TUYD>P[_6NCA\97J>&CH$T$4UOM
MV!GY9?\ ]5"PTZ<E*+O8'CJ=6$HS5CIOA%S?ZJ?^F:?UKA=8&=>U 9.?M3]/
M]ZKWAKQ1=>%YKA[6*.4SJ V_MBLJ:Y>XOY;P@+))*93CH"3FMZ=.?M)/N<TZ
MT70A#L=O9>+_ !5X?BCM+_3C<PA1CS4)./J*Z#5(-,\6^![C5+C3?L%PB,RE
MA@@CW[@US5M\3=6AMECN+:VN=O 9EY-9>O>.M5U^V^RR"*WM>\<0QN^M<SP]
M5RVL=BQ5&,&N;F\FCMI83XM^%UO%8D-<1(A,8/.Y>JFO-K?0M3NKH6L=C/YQ
M.W!4X!IVA^(M0\/7'FV,V%;[\;<JWX5U+?%;53&?+LK5)",;\<UI&%:BG&"N
MF9SJ4*W*ZC<;&OX]EBTCP'::-(X:Y<(NW/\ =Y)JSK%W<Z?\+=-O+60QS1K"
MRD&O+-3U.\UBZ:ZOIFEF/&3T ]JU;_QE>W_AJ+0Y((A!&% 8?>^6LWA9<J7G
MJ7''0YI6[61ZGX<O],\9PV6INBIJ-B^64=5;&#^!K@/BGQXP&>GD+7-:'KEY
MH&IK?6;?.!AD/W7'H:D\0ZY<^(]2^WW,:1OL";5]JNEAY4ZUUL36QD:F'Y9?
M$91%(.E+GC%(*] \D!UK7\+_ /(VZ7_U\K60.M:WACCQ9I?_ %\*:SJ_ S6A
M_$7J,\1D_P#"3:I_U\O_ #K,!Q6EXC_Y&;4SV^TN?UK-"FB%^5>@5OC89S4]
MM;371E\E QB0R,,]%'4U"5(J[H]\-.U:"ZD4M",K*H_B0\$43O;05-)RL]AZ
M:5?E[3%NW^EH7ASQN ZFB>PF61$"^:S*&_=Y(&:VY_%5O-9WT:0N' \O3SC_
M %2$;6SZ<5&/$<*VTT=J)(YGA@C5PHXV?>_.LHU*NUC:=.BMF8:6\F&*0R-M
M/.%/%-C$K(TBHVS."V#@?C73W'B:V2YB>W\V.+[=]HF4(/F3 !'YYJ(>);$:
M0UK'"T4H#IL\L%7#'(8GL:?M:B>PO94FKW,)D>/&]77/3<,58MM.N[V]BMH8
M'\V3[H88X[GZ59U/6H[K6X[X*9+>(ILB88X &16F/%=E#.CPFZDW.\A=U ,8
M9<!![9JY59VV,X4J=W=[&-#I5U<SRP0*KO$<,=P S[9ZTY-'OY(9)!;MMC)!
M4G!R.H [TS0[[3H+Q[G5'N"R?-$(EW#?ZL,C-:,7B*R5[:>=KJ6XLVD:)@H
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MD3?:]$_Z!MQ_W_\ _K4?:M$_Z!EQ_P!__P#ZU0_8D_O&C[&G]YJ/9A]:1/\
M:M$_Z!MQ_P!__P#ZU)]KT3_H&W'_ '__ /K5#]C3U-'V-/[QH]F/ZTB;[7HG
M_0-N/^_W_P!:D^U:)_T#KC_O_P#_ %JB^QI_>:D^QI_>-'LUU#ZRB?[5HG_0
M-N/^_P#_ /6I/M.B_P#0-N/^_P#_ /6J'[$G]XT?8T_OFCD7</K*)OM.B_\
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M\/\ W\HY9]A<\"V-)O0>+5_RI?[+OO\ GV?\JI_;_P#I\_\ (E'V_P#Z?/\
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MWT(@$W]W_P!^A5 6<AZ.*&LI",%Q2<6^K&JT4]D6/L^@?]!"\_[]"C[/X?\
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MY-+M?^X__?)K2_X2+5O^?L_]\BC_ (2+5O\ G\_\<%%Y^7WART^[^XS-C?\
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MHN[NT>=1K1I8E2C=)FE\0=%_L?Q3,T:8M[K]\F!P#W'YUZ/X.L(_"_@EKNY
M21T-Q*3^@_E6EXB\.6OB>.PD=AB&59<C^-.Z_C7-_%+6?L>E6^D0-A[@Y<#M
M&.W^?2N/VKK*%+[ST716'E.N_D<'I5_)JOCZUOIB2\]T'/L.PKUOQKX=G\2Z
M3':6\JQNDH?+=*\;\+C_ (JS3,_\]AQ7K7Q$U'4M,T&*72Y)$F,P!9%R<5MB
MHM581B8X%J5"<IZW./\ ^%2ZF>?ML'X@UQ.J:<^DZK<:?*P>2!MK,.E;?_"6
M^+Q_R^77_?JL&_EN[FZ>YO1(9Y3EF=<9KJH>U<O?::.#$^QY?W<6GYE8T4=J
M*Z[W. 2NGU\?\47X;^DE<S73Z]_R)?ASZ25A5^./J=-#X)^AR1ZTVE/WC25H
M9=!1QS5FRL9[^Z6VMU&YLG).  .235?%7-.OVTR\\]8EE4H4>-CC<K<$>U3.
MZ6A4&KZDDFCS">*&VFANV<' A;.,=:8-,OPL[&UD"P-ME)'W3Z5;L]5TNPO/
M-M=,E"&-E;S) S GN.W%6M0\5->M(T=MY1>YCN,,V0=@ P?KBL4ZG1&\H4K7
M95M]!OI;F.&:%H/,1F5W'' SCZU$^C7DKQK:1//NB61L#&W/3-:P\5QJSF&R
M<>;(TTN^3=\Y7'R^@JA<>(&:PDM4A9"\,,6\-T"'/ZT.57>P*-'8STTJ^E$V
MRU<^2<2#'*XJ33M+;48+F?SHH(K< N\G3DX%;MOXSBBNY[DZ<3)(^X$..<IM
MP?RS6-INKRZ997T$,:E[HKAF 94P<]#UIWJ-,=J2:$FT+48)YHA;F4Q*'9DY
M!4C((_"HQI&H"T%T+23R" P?'&#W^E:^E>+6L6>6ZM3<W+2>9YH8#(VX"GV'
MM5<^)'^7]PVU;)K4+NXY.<X]JE2JK2PW&B^I*/#&I*US"\8$T$2S!!@[PQ[5
ME+I5]-<30QV<A>+_ %BXY7VJ_=>(EN(KOR[>2.:[MHX9&\SH5[CTS5V/QB4D
MG,EHVR4QN"C#<&5<=3VIN=6VPO9T;[F$FE7\D221V<A61MJ$+U(ZBGVFCW=Y
MK,6F"+9<R'D,>GO^57%\1R>?82,DO^C&1FV/@L7.?IQ33KB#Q)!JL-H(EC '
ME@\M@$$GMDT[U.P<E):W*]UHUW!).(XS+#%(8C*!@%O2G?V/J"SBV-G(963>
MJXZCUIT.M&*TMK=K?S$ANC<NI;A\]OTK4NO%:W"*L-H\:K;RP EAD;R#GCTI
M<U1:6"4*3ZF"ND:@][):+:2&=!N9<=!ZYJ9O#VH)IL5\D#.K;PZ@<IM.#FK@
M\11O$+>ZM)'A-O'"YCDVN2G1L^AIL'B0V\MB8X'$5H93L,F=P?\ PI-U7LBE
M&EU92;1;MRAMHGF4Q+*QQC;GWJ!M-O%L_MC6L@M^GF;>/_U>];5MXICB 66S
MD=!"L1C#C:VW/7\Z;=^*GNM(%D+=HI1#Y!9"-A3/<=<TU*IV&XTNYC)IU[);
MK<1VTC0N^Q6 X9O05(VC:DMRML;.03N-RKCJ/7-7;+Q!)8)I8BB#&PE>3#'Y
M7W?_ %JM2^*DDFDC>VF:SDB:)D+@.N3G*D4W*IV(C&FU>YDQZ-J3M+MLY#Y)
MQ)QT_P :<-*U"00[;20K.,Q<?>'J*T[7Q+!;F+_0I2+:5I;8&;H2,?/ZTT>)
M7-S$\T#-"+0VDB*^"0>25/8TN>KT0*%)O5E2[T.YLKVPMIV59;M%;!'W,G&#
M1>:+J-C=_9WMG+-(4C(&=Y'85+>:Q'<WVGSQ6[I%9(J*CON9@ISUJU;^*989
MWD,'F;[II_G?HK*00#Z\]::E56MA.-)MHI)HEYNNDG0PO;P^=AA]X9[4YM!U
M"/36O)8&3$B1K&5^9BV>E7!XF6&,16]HPAC@,<8EDW-DL&R3^%3_ /"7)'(T
MMO8NLTERMS)YC[ER <@#L.:3E5>R*4*/5F,='U+[1Y'V.3S=F_&/X?6J)RI(
M88(.#717'BII'F\J.54>W>$!F&5+')(Q]*YLC Q6U)R?Q(PJ1@G[I)VIGK0I
M[4M;&&PT<&GMR*;3@>,4#$C^^/K6B>GX50C_ -:/K6B>AH,JCU1J>(N-9DQ_
MSSC_ /016:"#UK3\1?\ (:D/_3./_P!!%976HI? B:WQL=131UI:T,1ZT4U2
M1FB@+&_(?WK?6F$^]+*?WC?6HZ\ZQZ[9(&XJ.0\4H-,;VJK$-ZG>?#&3]SJ4
M?I(I_2NKUW7],\.Z>]]JERD$*],GECZ =S7EGA;Q-9>%KJ_N]2E\NV-ON'^T
MP/ 'N:\G\9^,[[QCK3WMRQ2V4XM[?/"#W]_>O)KJTV?2X*2=&)WWB;X\W]T7
MMO#ME]FBZ?:9^7/T'0?C7E.J:G?ZS=-<:E>37,A.29')_+TJEN[4N161UB#@
M<G%-;_(IYZ=:;SG@9I :FE:DT0CMI7P@;Y"?X<]171S6I4;' '2N'8>G2M>U
M\2SP1"*YC\]5&%;HPH N7FEP2?>0'Z5F)I\,<^2ORCUJ_'KMG-GS-T3#IGD&
MJ.HZC X"6[%L]6[4 -U"]$@B1/E\LG!%=/X3^*?B/POLB2?[;9@_-!<'.!['
MJ*X8MN8'WIT0PN*8'U9X,^*>A>+P( YLK_O;3'&?]T]Z[OC%?#BLT;K)&S)*
MIRCJ<$5ZKX$^,.J:7=6^G:Z_VK3V8)Y['YXAZD]Q0!]'5X=\6I5D\90HO6.U
M&?S->W1R)+$LL;!D8!E8="#7SQXWO?[0\<ZG*#E(W$2\_P!T8/ZUUX*-ZIYV
M9RM0L8:CY<U+%*T4D<B@%D8, PR"140X.*><8Y/%>U9/1GS5]3T[3OBU&MNL
M6IZ62P&"\+ @_@:NO\5-"B0M;:=.9?0(%_6N(T;P+K.L6@O$6&WMF^X\[X+?
MA577O"FI^'E26\\EH)&VI)')D$UY_L<.YV3U/6CB,8H7:T)?$OBR^\43HTZB
M*WB.8X5/ ]S[UEZ5>)8ZQ9W;@LD,RN0!R<&KNJ^&-4T6QMKV[C3[/<XV.C9Z
MC(S69!;2W=U%;0(7FE8*B@=S77!4^3ECL<%1U?:J4]SN?&7CS3_$FA_8+>WG
M23S%<,XP.*\^;O\ TK:U'PQJ6E:K;:=="(7%SCRPKY')QS5IO VLIK!TMC;"
MY\KSN9,#;G%94Y4:<+19K65>K/FDM3KM(^)^EZ=H]I926MP[0Q*C$#@XJY_P
MM70?^@9/T_N"N3'PR\1;/, L]N.3YU4F\#:PFL0Z5_HQN9XS*H$F5VCKS7/[
M/#-MW.R-?&127*=!XG\>Z5KF@SV%K92Q2RXPS* !@UYV0#Q4][:2Z??36D^T
M3P-M?:<C/UK2U3PQJ.D:;:ZA=>5Y%UCR]KY/(SS773C3I))=3AK3J59.;6QV
M?AWXFVVF:';65_!/)-"NS>G(([5Q?B36W\0:[-?D,L9^6-6[**RD1GD$:*6=
MCA57J3Z"NOM?AMKTUNLDC6MNS#(CED^;_P"M4*%&A+F;W+]IB,3#D6J1SNC7
MJ:?K-I>R*2D$@<@=<5Z<_P 6='< /8W+CW45Y[-X5U2VUV'1IEB2[FY3]YE2
M/K6N?AEXBSR;,>WF\TJWL*EI39>'^M4DXP6AU?\ PM30L_\ (,G_ .^!7&^-
M/$UCXCGM'L[=XA"&#;@!UK"U72;_ $6Z^RZA 8I,9!Z@CV-4,U5+#4HOFB9X
MC&5:B=.HAS'FBHR??BC?BNM,X;#ST-=-K_\ R)/ASZ25R^[(XKJ/$'_(D^'/
MI)6-7XH^IT4%[D_3]3DJ!UH[4J]*T,N@X=:GM;.2_EDBB(WI&9 #U8 9('O5
M?CO4UK<RV%W%=0.%FB;<I/2E+FMH.%KZFLOAF\@GA%T$$3"-VPV,AS@+_O9Z
MU;7PO;B[TX/>*5O+AXC I^9 I(Z]_>LIM>U"9$1YLA+C[2H(_CSG\O:G+K]\
MHB.Z,M%*T\;%>59NN/:N>U7>YU\U%:6%U#2FTU8Y?/BN+:1V59(6R,J<$'W%
M7QH.FMJ5M:F>](NH4D3:JG8&ZECTP,5BRWDTUFEL[ Q)(T@'H6ZU=@\27]KN
M5/)?="L!WID[!T%5*-3E5F9PE3YFV,T[3;:\N;^V:=R]O&[QR1@;6"YZY]?:
MMB3PM8PV+WDE[,+>#89I54$.&'\'T/'-8G]KNBQBWBCA<121R,HQO#=?RHEU
M>YEL$L\1I ""41<;\=,U/+5>MRN>FEL2:MIMK9&Q6VDF,ES'YC1S8R@)^7I^
M=64\(W\EW-;K<VQ\@A9)-WRJQZ+]:R+N]GN[PW<[@S$C\,=!]!5N'Q!?VUQ<
MS)(C&Y8/*I&02.]4U4459@G2<M422>'[J"W:2YFMX'+,L<3O\TI4X.VKJ>$;
MV"XMC=B)XY'V21)( R$KD9K,&LW?V4V[&-UY*EU!9,\G![5(_B3499(9'D4R
MPG(?').,<^O%*4:VUQKV*U'1^'[@S([-&;9D64.&P&5FVA<_WL\59?PM<2R,
MT,UO&'DD2""1_G<H>0*S!K-ZMA%9>=BWBF\Y5 Z-UZ^F>U2?V[?_ &B&7S$\
MR%Y'0@="_P!ZBU6^X[TNB+2^&;PVK2M<VRR);FX: M\XC]:ALM'N;ZVAFA:,
MQR,R.<_ZO:,Y;\*O)XH$6CO:+;LUU)"8#,Y'"GKCO52SU=;+0[NPMXW$UUA9
M9"?E 'H/4T)UK:DR5+04^&+XVEO=1RPNDTBQX4\H6/!/M4MOX7D>]$=Q>VJ0
MK<" N'_UC]U7W%02>)M3:".$R)MB*$8 Y*?=J"TUZ^M=Y01OOF\X"1 =K_WA
MZ5-JS+3H]BQJ'AV:SM)KT3Q>0LKHD9.7*J<9/I6(3S6F?$%\;&>TRBQSDF0A
M<ELG)K*K2GS)6D9U>1N\$+GVHS0.E)6Q@.SS3JC[T\4T#0_I13<TN:=R!U%-
MI<T78"]J0]**44P0@-.IA&#2JU -"TM--.'/%"%8<GWQ]:T6Z?A6:N0Z_6M(
MD%3]*;,JFZ-;Q%_R&9/^N<?_ *"*RNE:?B$_\3J0_P#3./\ ]!%9IZ5-+X$1
M6^-B8P:#10:LR%6BD!(Z44KCL;LI_?.?>HN]/E_UK_6HF-<-CTVQ<TE)FE!I
MI$-F1KUI]KT^:+&25^7/KVKRP@JY4\$'!KV.Y4,E>:^)]/:RU$W$8_=R]/9O
M2N'%P^T>SE==.\&8V2O.:-V.M1[N]!?(YZUP'MD@.1GWJ3)(/L*C7MCUJQ#;
M7$T4DL2%HXAESZ4"(CQP.]1/&<<]JGX/K3#RPVYS0!#MI .WK5B6,P\2*RMZ
M-4/*@$]Z %Z4]<=:9BG$\4 29 '%-W=<]^M,)XZ^])GOUR.: />/AI\347PG
M=Z5J<G^E:?;L]L['_6KV7ZBN'21YW>:0Y>1B[$^IYKF]"M2Q\]@1G[M=,@VJ
M!7KX"DTN9GSV:5U*7(AU.VDID4WM3@W&,XS7?):'DJZ:L>K276D>,O#]A:1:
MO_9UU;J 8=VW)QCGU%<IXI\,:SHEC%)<W;7M@K?(X8D(35J*T\#:A9Q.]Y<6
M=PJ@.I&<GN:F\1^)=+3PK%X=T=Y;F-2-TTGIG->9!.,_=5_D>U4Y)P;JV3MI
MJ=Y>I8:GX?L-#O,"2\M086/9E4=/>N.\):'_ ,(U->:WK2;3:R>1;J>K,>,C
MZYJAXO\ $5G>6>@MIER3<V*@M@8*L *H^(/&DWB.YTY9(_)@MF5Y%SG<X/)J
M84JG+R]&74KTN93>KBE8Z/QT=WQ#T%L$;O+_ /0JS?BE++#XMA:*5XV-J 2C
M8.,TSQ9XATW4?%^C7UM<;X+?9YC;>F&S6?\ $#5['6_$$5SI\WFQB (S8QSF
MM*%-\\+HSQ%6+A-Q?5'2P7%P?@Q-*9Y3)N;Y]QW?>]:QOAG++/XSB,TSR,+=
MP"[$_E1!KVGI\+IM'-Q_IK$GR\>K9K.\":M::-XF2[OI?*@$3*6QT)H5+]W/
M34EU$ZM-WZ:G3:[X*TN\UR^N9/$=O"\LA9HV(RM6?B7"MMX1T:%'$BQ,JAQ_
M$ O6O._$EQ;W_B#4+NW(>*:4LC8ZBNH\7Z_IVI^%-(L;6X\R>VVB1<=,+BA4
MIQE!MW"5:FX5(Q5CF-$O8]/UNSOIEW1P2AV'M7I6LZ78>-+J._TKQ&(I2@ A
M,F /P[&O+M->UCU&W:^5FM0X,JJ>2*[3^SO +W"7D6J7$ #;O*'45IB5:::_
M*YG@Y-P<79K[A-/TK5M)^(NE1:N[2R,W[N;.0Z@$<5>\7^'_ !3>>+;B?2X[
M@6[A-DBRX4''/%0W_C2PU#QII-RA:/3[ D>:PY;(QGZ5!K/CV\B\7&[TV^>7
M35*_NOX2/XJR4:W,GRZV.CFP\(R7,[7Z%[XG2QQZ/I%I<2*^HH,N0<D<8/ZU
MYD37:^)[SP_JOB&SU6&Y=X9V7[9!SD>XK)\6'0VU1#H(*VXC^?KC=[9K?#2Y
M8J+1QXR*G-S35D<\:3-#4VNLXA<D5UGB#GP5X;_[:5R-==KP_P"*)\-_22LJ
MGQ1]3HH_!/T_4Y7;Q1TI6ZTUCQ6UCF0A.:UO#5M;7FOPPWD9DMRKLZ@X. I-
M8]2QRR1L7B9T8 _,IY&>M1-71K#1W.M?PO:265B;>X5XKJ:5XYE.6:-5SMQ_
M>ZBJS>'K*."2]F>YCMA:_:/)8 2CYMN#7.+/-&B!9I$5'W)AB K>H]Z?)=W$
MSR/+<RR-*NUV9R2P]#6"I5$M)'3*M3O\)T\GAZQAN_+MKB5Y86@E;S%&UDD/
M3ZBF/X?LI;I8WGD2YN[B>.+:!L78>,USHN;IY/EFE:1\ X8Y..@I'N;F.4;Y
MI5DC8[<L05)ZGV-'LYM_$3[2FU\)T</A>W72XKVY:565HC+'D897;'%3GPQ8
M/>:@WF306\%QY"(1EAWW'VKE?M=[);_9OM%P\ Z1;B5'X4JZE?AWF6\N@Y4(
M[AVSCL"?2ER5/YA\]-_9.IL_#ME#'*TGFW3-8RSK*J_NAC('XU0T&SL[G0KC
MS$'VJ:YCMUE?[L>[O6(EYJ$<36T<]TL3<F)2V#GV]ZA,DBHT6Z0*6!*<CD=.
M/6FJ<VG=BYXIK0ZB/PO:27$(\RYABWR1R+,N';8N=R^HJGX=L]-O=1OA=I(U
ME%:O(#_$N.A^M8[W][)*KRW<[2(I4%W.5'<<TQ9)820C2(77:P (W ]O?-"A
M+ELWN#J14KI':P>'K"UGT]93!*DEG//YQ.4<#[K'\.U9<]C;W6EZE<6<,<\D
M,L*QM:J2,'.>#6 )[H+M$DX1%*8Y 4'J/;-/M;V\LE+6ES/ K]60E0V*E4Y+
MJ5*K%]#7\.Z?97<VH1ZGE%CMOE?_ )YON !_6M+_ (1NVCL+6VW^9>_:BERT
M;<*-N[:#WXKD6N)MTC><Y:7ASNY;ZT^&:>)5\N=T"MN&UL8/K5RIS;YKD1JP
MC&S1T=]X:L;"2YFFN)FMH[6.Y4)]X[F(VU1'A]3XI_LE;C$>W>'/5EV[@![U
ME37=U.6\ZYFDW#:Q9R21G./SJ)YYFF64RN91C#[N1CIS0H3[@ZD'HD=?::1I
MME9W-_+%,^^S:6*&8 /&0VW)%95AI]G/X>:\:&5[I+U(\K]U5/K[5D/>74SN
M\US+(\@VNS.26'8?2FQW$\2ND4TD:2??56(!^M+V<DMRG4C?8ZV]\-:??ZS/
M%8SO;JMZ+>4/C:,@GY?RK#U[2[73)8?LTSN) =R.,%2#6<;B=MV9W)9@[?-U
M8=#]:)[JYNI ]S/),P& TC;CCTIPA)/5BG4@UHB*E!XIM%=!SCJ,TWO2YIBL
M.%.S2)S3R*:)>XS- S2'BDW\XI7'8D[4T\<T*XZ&I 0PJD)Z#<Y% /-!&#Q2
M4M@T)4Y=?K5]N :SHC\X^M:+<J:KH8U/B1K>(C_Q.9/^N<?_ *"*RP<5H^),
MC6I/^N<?_H(K+W ]ZBD_<1-9>^R0\=*3.:9DTA..:NYE8D&>:*8CYS12'8WI
M^97Z]:A-6)B/-?ZU&2M<9VMV(^:09J1F%-R,U21#D,?D5BZOIT=];/$X'(X/
MH:VG/%5Y &7K4S@I*S*I5G3DFCR"]M9;&Z>"52"IX]QZU""6/TKT?6M$BU*#
M#C#CE7'45Y]>6-QITYBE7'HW8UY%6BX,^JPF*A6COJ;%N-+T[3XI;N(W5Q<<
MA%8@(O\ C5_3O[/?3=4\MY(K5MA)/+?05A6UY:-:);7D#,$;*R*<'![5<M]1
MTU(KJV6VE2WFP%^;)&.IK$ZRU-IUG>Z=]JTPN"D@22%^O/0U*=$L;>ZBM6OP
M;Y6&5V\?3ZU#%J%KI%IY5I*9Y)95>1B. !5J2VLYM734A?QB%W#E6^\&]* )
MKVUM[W4-1DN0HVL(T)_A.*Q=)TX3RM-=(1&K%54_Q'UJWK-YYC7R1;2&NMVX
M'(P *KKJLMS>1K$ NR,J!VSW/UH 1DT^VAC,\)D:0L?E/W1FJ]]:1+:QW=H2
M87.U@3]PU-/:2R65J8DW$@[FS5>>Y-MIWV%\'<^]\=J=@,XMQTZ]*MZ?:/>3
M!1]P?>--L["6[D  (CZ%JZZSL8[>-41>!^M=6&P\IRNUH>?C<9&E&T7J36MN
ML2*JC"@<5;-(  .E+^%>W&/*K)'S,Y.4N9B=J<I X(S24M58D 5]*.0<TE%)
MKL&P9H)XI*3-'2R ;WI0<4A-)DTFB]QW&,TF<FDY-&,46\@L+G@TH'&:;1DT
M6&//!XHXSC'/K31FEYIK8FP[Y@.E-X/6CG&*,'-&ST ,,/NTW+9YIQSUIG-'
MH4A">:;3CFDYI6 51QFNLU__ )$KPW])*Y49QS4KS2/$D3N[(GW%+9"_2HE#
MF:?8N%3E37<B[4PTXG--YJ[D)!5_2;O[#JD4CJKPR'RI4;HR'@C^M4.:.:4E
MS*Q479W.XA_L2XN[NU,<+QV;+%:H[$*T?5WXZL:A33]#DT.[D4PAMDCPDN?,
M5@?E4]CQ7&\TM8*@^C.CZQY'07W]GIK]A%:11QVZ>5OD1SEB<%B3VK26/1?M
M$,<T,$WVJ\F669Y#E(Q]TBN/%-88JY4;VU(C6:;T.C\*),-1G:*]CM[>([G#
M8W2XZ*,UKVUY;[48/:V]FIF.H6_!W,<E<>O;&*X3FD -1*AS.]RXU^56L=Y:
M:F&GLY5=)9GTX1.WF!&4[SR">X%9=C]DC\:3.UVMQ%'N9'D('FMC[N>F?>N8
MP:3%"P]D[,'7NT[;'1>)XH/[:@NK.XBD:?&4'2)AP Q[GU-;\LP@>TBN[JUN
M;M(9/*O"5P)F'RKC^Z.WO7GU(<=Q1*@VDK[ J]FW;<[F;4(/(NK6YN8GF;3,
M793&))0W;_:QWJ+Q1+83Z4S6ESMA0Q_9HE(VN,<_*!P1ZUQ=+BFJ%G>X_K#M
M:P=ZE'W347.:D&=M=".1HC.:;3SFF<TKE)!]*,<TO-)SF@8F*.E+S1S2 * .
M:.:>HXIH+#<48YIV&[5*JX&35)$M@JX'-!IV:3@U1GK<A:HS4K YIO?!%0T:
M(;S3@V*7;1LYZTP) V101FD4$4_GO5(AK410?,7US5_=\IS5./[ZY]:T'V[3
M]*3T1E4W5S3\0L#K,F?^><?_ *"*R2J]>*T_$2_\3F3_ *YQ_P#H(K)Q40^!
M!52YW84\#KFDW#\Z0@4TCTJC-(<,9)HI$/6BD4;TQ_>O]:9FEF/[UOK49-<R
M-Y,=F@&HZ!P:I(QDQ[GBJ[&I)&^6H.M6D8N8IP1R*R=0TZ*]0I)&&4^O:M8*
M33O) 7D U,Z2FM2Z.(G2=XL\[O/#LUNY:VQ*O]UAR*RWW0$":$HPZY%>H26Z
MMD@<51N=.BG'SHK#'\0K@JX'^4]W#YR[6J(\Y,L93 C(;.:;N3*G!%=?<>&[
M9SE(]I[XJH?"RYXD:N9X6:/1AF="2.=9XL8#.OK4J)" #YI4]ZWQX54=68U:
MB\-QJ!\N<>M..%F]PGFE"*T.:B1Y441R2$^@SQ6IINA6<A+:C-/NSPD:Y_,U
MT$6C;/NE5'L*NQ:7M_C'/M752P*^T>?6SA-6AH)9Z?H$:*#<WRJ.RPBKXB\-
MJ,?:M1_[\BJHL".!(/I1]@8?\M!7=&BHK1GERQD9.[2+8C\.'I>:C_WY%+Y?
MAW_G[U$_]L151M/*X(D%"V#8^^/RJO9ON3]8AV1;\OP[_P _6H_]^11Y7AW_
M )^]1_[\BJOV!O\ GH/RH^P-_P ]!3]F^XOK,.R+7E>'?^?O4?\ OR*/+\.?
M\_>H_P#?D54-@W_/04GV!O[XH]F^X?68=D6_*\._\_>H_P#?D4GE>'/^?O4?
M^_(JK]A;^^*:;%O[XI.#[C^LP[(M&+PWWN]1_P"_(H\OPW_S]ZC_ -^15,V#
M'^,4W["W]\4N1]RUB(=D7O+\-_\ /WJ/_?D4>7X;_P"?O4O^_(JC]A;^^*/L
M3?WQ1R>8?6(=D7O*\-_\_>H_]^12>5X;_P"?O4?^_(JE]B;'WQ1]B;^^*.3S
M#ZQ#LB]Y7AS_ )_-1_[\BD\KPY_S^:C_ -^15+[$W]\4W[$V?OBCV;[A[>'D
M7_+\.?\ /YJ/_?D4OE^'/^?O4?\ OR*S_L3?WQ3OL1S]\4>S?</;P\BZT?AO
M_G[U'_OR*;Y?AK_G[U+_ +\BJ363!OOC\J3[&W]\?E1[-]QK$0[(O>7X;_Y^
M]2_[\BD\KPW_ ,_FI?\ ?D52^Q-_?%*+%O[XH]F^X?6(=D:"Q>&_^?S4?^_(
MI#'X<_Y_-1_[\BJ?V)A_&*8;1L_?%'LWW$L1#LBZ8_#?_/YJ7_?D4>3X:_Y_
M=2_[\BJ'V,_WZ/L9_OBE[-]ROK$.R+WE>&O^?O4O^_(H\KPU_P _FI?]^15'
M[&?[XH^Q'^\*/9ON'UB'9%[RO#7_ #^:E_WY%/$7AO\ Y^]1_P"_(K.^Q'^\
M*/L3?\]!3Y'W#V\.R-18O#?:[U'_ +\BF/%X:[W>H_\ ?D542R;^^*9)9G/W
MQ3Y'W(6(A?9%SR?#?_/YJ/\ WY%'D^&O^?W4O^_(JA]C;^^*=]A;'WA2]F^Y
M;Q$/(N>5X;_Y^]2_[\BCR_#?_/WJ7_?D53^PL3]\4/8$#.\?E1[-]P^L0+GE
M>&O^?S4O^_ I/+\-_P#/WJ7_ 'Y%4/L9Q]X4HM&_OBCV;[C]O#LB]Y?AO_G[
MU+_OR*7RO#?_ #^:E_WY%9_V1O[XIPLV_OBCV;[A[>/9%_R?#7_/YJ7_ 'Y%
M/$?AO'_'YJ/_ 'Y%9_V0_P!X?E2K9MM/SBFJ;[D_6(]BV8_#7_/WJ?\ WY%)
MY7AO_G[U/_OR*H-:-G[PI/LA_OBDZ;[EJO'LC0\KPW_S]ZG_ -^12>5X:_Y_
M-3_[\BL_[(?[XH^R'^^*7(^X>WCV1H>5X:_Y^]2_[\BCRO#7_/YJ7_?D5G_9
M#_?%'V1O[XHY'W#V\>R-#RO#6?\ C\U+_OR*E$7AK'_'WJ/_ 'Y%9BVC?WQ^
M52?9B!C<*:A;J2\1'L: A\-_\_>H_P#?D4_R_#G>[U'_ +\BLT6IS]X4_P"R
MM_?'Y5?)YLCV\>R+_E>&_P#GZU'_ +\BD,?AS_G[U'_OR*H_8V_OBFM:L/XA
M1R>8_;1[(T/)\.'_ )>]1_[\BFF'PYG_ (^]1_[\BJ0M'/.\4ILW[L*7L_,7
MMX)[(M^5X<_Y^]1_[\BE$/AO_G[U'_OR*I_9#_>%!M/1J?LGU;'[>/9%WRO#
M?_/YJ/\ WY%'E^&_^?O4?^_(JC]D/]ZE^R'^]3]GYB]O'LB^D?AS>N+O4>O_
M #Q%7FBT C'VG4/^_0K"%L58'=WJP3FAT_,SJ5E>Z2+NKW4-[J,EQ &$)"JN
M\<\#%4&P12TAII65C"4^9W8TT;1GFEI15"N*H7FBE4446'S&G/\ ZUOK49-.
MG/[YOK4)-<J1K*5AV::33=U1M,B-ACBK2,6[[$A!9P!R3P![UJ_\([>1MMDD
MM0W=3, 161%>0^;$!G[X[>]7=?N8!KUYG^_Z>PH=^:R'&#Y;M%S^P;K'$UH/
M^VXI/["N\D^=9_\ ?\5@_:8&/ 'Y4>?;@<X_*CEEW#ECV-S_ (1^]/2:S_[_
M (I1X?NL<RV?_?\ %8HN+<#']*!<V_M^5/EEW"T?Y3:/A^X_Y[6?_?X4G_"-
MW.<^=9_]_A6+]I@'8?E3A=6^>2?;BER2[AI_*;(\.W6/]=9_]_A2_P#"/7(7
M'G68_P"VPK&-U;D8S^E)]H@P,G]*?++N+3^4VAX?N@/]=9_]_A2_V#<X_P!?
M9\?]-A6'Y]ON_P#K4GG6_.2/RHM/N.R_E-S_ (1^ZSD3V@_[;"F_\(_=8XGL
MR?\ KN*Q5N80V#C'TI1=0*V<#\J.67<++^4VO[!NL@F>SY_Z;BD.@W@;_7VG
M_?\ %8AN;;KQGZ4W[3 1R!^5'++N'*OY3?&@7?0SV?\ W_%+_8%U_P ][3_O
M^*Y\7,&1G'7GBG?:H/08[<4<LNX<J_E-W^P+K_GO:?\ ?\4'P_=_\][3_O\
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MCJ.#6>V4+1N-KJ2&'H10IQ;LF-TYQ2;6Y"!SS2D =#S3CMQ@=J%4L0J@LQZ
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ME\;A.NW^M.<?J]=1ALR5/ZSA7*>ZZESX=#'@>TSU ;^=>'ZCG^UKPG_GN_\
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MR6Z5;F-5#3!0B,N3SWQ5.I3[$QI3OHSGF\0ZD7CE8QA5B:)5$0"E">5Q3?\
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M43NP&(A1FW,V7^%^OM*["2WPSDCYO4UG:QX$UC0=/:_N9(#'$0?E;G.>*/\
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M?DQ[^)6(!<YSVKC.>]&#Z_C5>R=MR55C?8ZK^S=,-O</8VJ7!69TD6:<*8$
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MUS<+#86>(WE)]!D@5I?#ZSA6VU*96.W[1Y:'U KSW^T+N2.9//D6*:0R.@.
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M.SN65G!5EB)!X'-8PCE_ND?A5H7NIA0!=W6!Q_K#4.+O='=&4+68G]E:D?\
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MTK4<?\>%U_WZ;_"C[?J7:\N@/^NII?M^I?\ /Y=?]_#3_>$\U/S#^RM2R?\
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M7?\ WY:C^R-2_P"@;=_]^6IO]H:G_P _MU_W]-+_ &AJ?_/[=?\ ?TT>^#<
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M6G'&$6O2PF&M[TCPL?C^;W(;#P,+12YI*]-;'AA1110 4444#'*.M%(#UHH
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M$U3J,Z(ZO;?] >S_ "-+_:]J?^8/9_K7-F=\_>--\Z3^^:7LX!^\.F.K6O\
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M.H ]:T+#Q7IYLM+35;2>2XTQV>!XGP),\_-^-:=G\1K98(?M>GB2<7,D[/\
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M%Y\9A<E,Y7TIL.OZK:_84CG,?V!B]N"OW">OUI5:=5RO&15*I245[2%SK_\
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M-,D::8:?3#2+0E%%%(8Y/]8OUJZ?NFJ2?ZP?6KI^Z:"*FZ-;Q%_R&I?]Q/\
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MUW3A*&,S3-^^*RB(+Y:LN!'[US::;?2>;LM)3Y)Q)\OW32'3[P0)/]FD\IR
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M692[BM)+61$&48?P?EWK@Z*/JU,/K50[6/QK \^@W$\'E'3YF>:&! L;Y_B
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MP?:J]OKL=G#I]N;Z&;_3Y7NW RK1M_0T>WG?8/80MN<<5;!.QL8SD#BDVL2
M58$C(&#S7;66MV%F=)MXYH!:BYG-T"@.4).T'VZ8IEKJMA>+8R7]TD=Q%<3
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MMP8AAR"#0>N:3/M19;,[4VM4*6+N69F9CU+')HSSTI.O3K3@W'3FA)('=B9
M]*DCMI9HI9$B9HXAEV4<*/>HNIKI/#&I6VF66JO<!'\V)$\IO^6B[N0/?'-9
MSDXJZ-*:3=FS"AL;FY17BA=XV<1A@.-QZ#ZTTF6W,D+%EYVN!TX]:[6+4-'3
M3[?3[615M(-0B=3)PTB]68^PZ56GGM'TR7[!-IZ)F7[2LX^=SNX*^V.E8>VE
MU1T.A'HSE+FUGM)C#<Q-&VT-@^A&1^E1 !1Z&NWU'5;+4)KZTFDMOLRV,7DR
MA?F\P 9P>YJS?2>'S%9FXEM9EBNTPT9&YHL<D@=!GM36(:^R+ZNGM(X6WM)K
MN;RX(FD;:6( YP!R:FMK+4-4+_9H9KDQ@!B.=J]J[26_TR/4XMKVBMY,X$T3
M@\%?E4X%8OA66&+2M8MI)+<22^48TFE,8?!.>11[5M<U@5&/,E?<PCI][!]H
M+6[QM;X,F[@KGH:9-/-.J---++@<;R3@5VNIWVF337CM<6LDAMK9-F_*!E;E
M0>XQUJZ@L+G4FEBGL3(MG*WE !HXNFTDXJ?K#M=K4OZNF[1D>?00W,RW MPQ
M2--\V#CY?I4!QG !X[^M=I)/IP2;S;BS>];3MLSP?ZMY-XQM]\4V]U#3;B34
M[=A;-;1>4UMY:C+G(W 'N<9JE7EV)>'6USC/^ _I0>&]<5WVKPQ?\(YK$NZU
M,8:+[,J1;'C!/W2?7%<"Q["M*=3G1C5I^S8B\XR.E*/]H=.E"G/'I2@<_2MK
M&5QIY8]LTF .!2G@Y%*<%L=J -3PS_R,%O\ [K_^@FLGG;6QX7/_ !/H/0*_
M_H)K'SQT[FH7QOT1J_X:^8H((QWI0,9I#R1Q2'@<=*LR%Z<FE7..]:.AZ+)K
MEVT"S1P(B[WED^ZO8#\3Q1!HFJW5Q<Q6UJSM;OLEP1\ASCFH]I%2LV:*G-QN
MD9V>>G7I30#G/Y5J76@:O90^=<V+Q1AMI)(X)Z9^M#^'M7BF@B>QD#3DK%@@
MACCI]:.>'</9S[&8  U)@ ^HK3N-!U6VN+>WDLY%EF/[L#!W$=>?:K5QX4U&
M"UL6\DFZNGD'D[A\H7'.>_6DZD%U&J4V86WC H7(/3I5N33;ZWU$6,UNRW;,
M%6-N^>E7;S18;4R0IJ<5Q?1,$:VC0\L>RGN:'4B@5.;,?/7 /-(:UG\.ZRMS
M#;MI\OG3 [%&#G'4?440^&M9G5VAL'8*Q0X(^\.H'O3=2'1A[.?8QR.*;5\Z
M3?M+#&+63?,K.@Q]Y5Z_EBJ..2*%)/83BUN)2CK24O>J6XC8U'_D6-$^LW_H
M58U;.H_\BQHGUF_]"K&J*7PFE;XA1UI<4T=<UJZ'HD^O:@UE!(J2"(R#=T..
MU5*2BKLB,7)V1FE<_6FA0.*UO["O1;0LJ'[1)</;_9R,%649/6IXO">LSW%Q
M#]F$3V\/G$.P 9?;UJ/;0M<T]E4O:QAX_(48[XK=N/"M^NF6E_;1//%+ 99,
M8RA!Y'OBJ+Z+J4>GK?FT?[*<?O 00 >!352#6XG2FGL9M '2M*]\/ZMIUN;B
M[L7BBR Q)!VYZ9],U-9:+#-HJZG=7S01M,8E582YR!G/'2I=2"0U2F]#(QNZ
M4(<&MIO#MT[VJ6*O<FXM_//& @W$<Y^E5AX>U4R72?89 ;4 S;B!L!Z&J52%
MMP=*>UBI^%+5XZ!JT-M#/)8RK'*P5"?4],^F:==Z!J]@(S<V,J;Y/* &"=_8
M?6J56'<R=*?8S\<4$ CFM)_#VL1W$5NUE)YTN=BC!Z=<^F*J7EG<Z?<_9[R%
MHI0-V".H/?Z549PEHF)PG'5E,_*W-/R"M*P##WJ,<9!IM"O=%[2O^0S8_P#7
MQ'_Z$*7601KE\?\ IX?^=,TD_P#$YL1_T\1_^A"GZR<ZY??]?#_SK/\ Y>&C
M^#YE(&G9IN*,UL9-#\T4VEIH5A:?&[PR++&Y1U.0P."*9FK%G%;3S%+FY-O'
MC(8(6)/IBIF[1NRHIN5D1,3(6=V+,3DD]3431@]JZ'4?#BZ>)U2Z>XDCMUE9
M4CQLW' 5O0U3F\/ZM (?-L9!YK!%QC.X] ?0FLU5IM&CI5$]3$:(CMD&F8YZ
M=.M;.H:/J.EQJ]Y:-$KDJ">1D=N.]7;3PI/?WFGPQ3*8[V!IA,1PF,Y!J93@
ME<N$9O0YD Y.!1BMM/#&H26^Z*,R7!N&MT@ ^9BHRQ_"HW\/WK16RPV\TEW-
M*\9C &T%?0_SJ?:P+]G/8R,9I,#MVKH++PCJ4U]]EN8'@:2"26$Y!$A7T-1P
M>$M8GFGA:V$,D,!G(=AAE]CWH]M3#V4S#Q3T&3TI"/FV]P>:D5<"M5KJC&3M
MH.IU HK1&3"BB@TQ$D7^L7ZU<-4HO]8*N&F95-QR]Z*1>]%!F7)6S._UJ%F^
M5N.QJ28CSV[<U&Q&QOI61FMS,)XZ49!H')Q2D8'O0=@W&T]*!SS0<]Z.E Q>
M"*50\C!(T9F)P !DFD I5EDA<20NT<B_=93@@TGM<:6MB22VN(4#2V\L:YP"
MZ$#-0;ATX!]*[B>7^UM5M=,N9GF2ZL(TC)8L(YL<-]?6JUP=)MM/U'R[2WD>
MVEBM%=NI[._OS7.L0]FCJ>'6Z9R?&,'GM35V\D8XKN;O3M,6&56AM$M5>(64
M\;Y>;)&X-^&<U1UM=-N-/U9K>SM[9[.[6.!HCRZ'KGUIJO=VL2Z%E=LY?9)\
MH$;9?[OR]1[4A4D,2APG#''3ZUV6AWUNN@0ZE</&;G1BXBC;JX8?*/?!JW=+
MI N;2-I(FBU2<WLJY^4?+\J'T&XFD\0T[6*CATU>YP V^U/CF>-7,4C(&78Q
M!ZJ>HKMDL-->:W:\M;.'4S%*1:I)^Z8C&S/I2FRT_P B22*RLFUCR%+V3/\
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M/^OA_P"=9_\ +SY&_P#R[*@.:4&HQQ2YYK0R:)@:6HP:<#D529%@I<T8IIH
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MH3/&*53M!!IN3@]/RIY/ Z?E0 SEB1VI2,# -.!/M^5,).>WY4 +U&!U%!Z
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@\YI9#\O;\JAR<CI^52V7%7)ED%%1 _3\J*+LKE1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ycbd_424004.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "W 2H# 2(  A$! Q$!_\0
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M_P"^13*6@!^\^B_]\B@.?1?^^13:* '[SZ+_ -\BEWGT7_OD4REH =O/HO\
MWR*7>?1?^^13*6F [>?1?^^11O/HO_?(IM+0 [>WHO\ WR*-Y]%_[Y%-HH =
MO/HO_?(HWGT7_OD4VB@!V\^B_P#?(HWGT7_OD4VB@!V\^B_]\BC>?1?^^13:
M*!#O,/HO_?(I-Y]%_P"^13:* ';SZ+_WR*3>?1?^^124E QWF'T7_OD4F\^B
M_P#?(IM% "[SZ+_WR*"Y]%_[Y%-I* ';SZ+_ -\BDWGT7_OD4E)0 [>?1?\
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M^'6M8O+.W(\FWBCD5W5D=BV<@H0",8'/?-='&.M",:^95JU-TYVL_(?5U/\
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M^59]N(Y$4LJL2.]+2^I3O;W2:74884WG>R]"57IR!_6H/[6AN ZQI*%R4#L
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;9/[OZT44"$\F3^[^HJZD,GEK\O8=Z** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ycbd_424005.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %, ?4# 2(  A$! Q$!_\0
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MP>6/>H=48KK[X)^8 87O6C/HGEZ!<7=YO1@,H@[#WKGPS;HVB:3LI)LX1_\
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M2^[&0,X/IFGS75D91Y>;0Y6D-*:::S9L(:2BDJ6R@HHI*D8M)112N 444E(
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MNAV,MK'\DDPE,2D^P;(-5*IRKWC..&=25H/4[#4KC43JDL5E?"2Y\U(HY5
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M=TIW-G^\>OZU&LL ZBI5T]6CS*Y5^W>J[VIC."1]:'"^Q@W8G^T6_0+4RWD
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MG'3/OW_"GOJ0,J,874A-JS'G?QUJXR:V!I'+_P#"2>9=PV>IQO;_ &=-A1@
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M&NKVYCR<B")E7^%?_KUD_'2Z5[G3]'@YR3-(N[L*[WX3:%]@\"V08LC2@R$
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M<SA9"[$QQ]%(/0GT_P#K52EDEG:-(Y4,8=74J0RE3VR.]6GD5,)$2@<D9"#
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M9><_S_3I6'J,3W$+2X,EQ:[9$D8CJ#R/<8_E6J8Q/;M*)/)$\6W>&^4^WO\
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MSO=CW%-6E9LU&6P*Y8H[4M"*Y<8XKEM<LCJ$T:BZD@,>?N=\^M=!,V6))XK
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M_P!",''O7LUG=0WD(EA;([CN/K7J>TBTHQ/ K8>I3?//6YR_COX>:9XWLLR
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MM/N8+>:WC$X$G)8@\ ?CQ72M>20P-YB[&Y#*>JGN*P/!6JG2/$UE>^81#O\
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MK18J/],4\XG;9G^ X'(IE'/W%LDEDK;E621L@&/DC/\ *JUO%+8D/OCE9-S
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ycbd_424006.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "G A@# 2(  A$! Q$!_\0
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M;3!'BBFCR0<9-<5=N#<&&%K*M.2[&C&S;0, CZ5/M$@[''MTJ"V4L!CJ*O!
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M]>A235F)Q:=T:?EQW*;-JNA'((JS:07L4B""1)X8F1Q;W(RIV]%S].*R-/\
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MJ- ?NR'>A]^XKFG!3;(.GK6Q;2":$8/*\_0UX>9X;7G1G[1T*BK+YG4V<15
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M#O[T#1SGBOQ"^NZD74LMI%E8$/I_>/N:R+,???U^4?U_I521^:NK ?)C .&
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MY*OC&" .!52=!NW4,1-*F] U0*2*L6[[DV&HY$PU,"*6(.,CAOYTV.9X3M8
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M^]G< /7_ #[YK;^(UBNF^,KL*@5)P)57!QSWYX_G]*YF%_)G0YX[$GKGT_\
MK"M$9V.GAN&6:QNP<')A9AV]#W]J]RTR\6_TRVNE.?,0;O\ >'!_4&O!+<>?
M:W-N".GF(?0C_(_*O5?AYJ?VW1Y+<G+1$./H1S^HJ"UN4_BUHO\ :?@Y[N-,
MS:>XF&.NP\-_0_A7@5G>G3-6LM15%<V\JR%6&0V#R"/I7UI=6T5Y:S6LZ[HI
MD,;@^A&#7R?K.G2:7J=YITPQ);2M&?P/7\J!/N>JN^C7WB;6K2RE06.L0CS"
M0 J3%!(C?GW_ -HUY/+%EV'&,XJYX?F@"FW+OYLVY&4@!0.-I'?/6HI%*,R,
M"&4[3FDF4U<I!#;H5C9L-C=SUHJ9QD8HH$==-)QP,<5DW,A45<GFY))[5D7,
MOWB2  ,Y]*\^*.YLS]0NUM[=Y6.2>%'J:Y.8^;^\8_.6^;W]ZM:C>&\N-PSY
M:\(/ZU%;21QR_OD#QMPP/\Z[Z<.5'!6FWJC0TZ$QJ\A&-YPGT[FK,[;IPO9!
M6E#IES-;3720DPVX4N .<'I@>E9;KAR<?>.>37;E\HSJ2L]4>>E)SYY*P\=*
M0T#I17O1>@21:MRKJ5) ;'&:]BN-+CU_PA9P,RK.;>-X&/\ "X4?H>AKQ.O2
M]3U&XTOP1X9O[9L2Q-']&&PY!]B*^9XDIUJD\-[!VGS.S\[?\ [L!*,5/G6E
MCHQID6D^"[JQ4J9%M7:7'\3$$D_I@?2LFTUVZT?X<Z7=6HC9MWED2 D8RWO[
M5'X=U=_$$'B6ZD4IYB )&3G8NQ@!6<O[SX10$_P3C_T,_P"-?.T<+)5?8XSW
MFZL.;_MZ+N=TJB<>:GI[KM\F:/B.^DU7P3IFJ3!1<"X4ED&,<L./R%;7B31(
M]=%NT5R(]2A3S(59OO+D$_KW'2N=_P!=\*%.,^5-_)__ *],\?WD]G-H5[:R
MM%,D)9'4\C[M:0P]3V\*.'ER.,ZJ7;9.WH2YQY'*:O=1+_B2UCO/'N@QW48D
MC=.4;IP22*=JNK:+:ZK-:W'A)IO*?;YL5NI5QQR.*I^,;N^C\0Z!/81"6^6%
MG2/;D,QZ\?G6GX>UWQ+=ZO';:GIQM[8HQ+^2R<@<<DXK-PK+!TJ\M8Q@].=Q
M=^9ZJVX[Q=64%NWVOT,KP]-X9O[[^QYM$;[7YDK;I(]NU<E@#SG@<4E['X6E
M\06FFVFEA;D7PAF5P2K)@YQSZXK/T$D_%6ZW,6_>W')_&JUL2WQ5P/\ G_8_
MEFO3E1:Q%24:DDE2Y[<SM=W_  ,%*\$FE\5MC9U/1/!%O>7,"WDME>0@_N]Y
MVEL9 !(^G>H[/PHFM>'M.O9=?EB5U)$-V^Y W0[<GCI3_%.O:$T^JV$^E#^T
M%4HMT(U.6P,'/6K5IH@\0?#_ $BWBN$MV1BX+C(/+#'ZUC#&8NAA*52I5G#F
MDDW*TM.5NZ\G]Y3I4YU)144[+IIU,74?"3V&K:3;27,=S:WTX02Q#&.Y'?MW
MK5U#3O UC?36<\UU;31G#J&8@9&>N#5W4K?[!=^#=.>9&F@GPVW^(!<9QZ5A
M>*_"^N7WB2]O+2Q:6"5@48.O("@=,^U70S"IC*E-8G$N"Y9:IJ-[2LM]-A3H
MJDFX0N[K3?H<MXBM]*M]4*Z/,9K,QJ=[-D[N_85D*V*N:KI][IMU]GOX6AFV
MAMK$=#TZ50)K[/#VC2BHSYE;?OYGE5+\STL6; ':[#^_UK=MY,@<UA:1=QM-
M)9/@,3N1O4]Q6O =KXQ7S6.UK29ZN&^!(UX6[5,Z$J2!FH(%W.!FM0(-N*\_
M8ZC#AD_>;9-P<=>,5+J%I#K%@UE-P3S$YZHW^%17R^7>,&&Q&8?-[>M,W^6Q
M 8DKW-=U.6APU(ZG RVTEM/)!,I62-BK#WKI/!^K7.CSW!MTB=90N]) ><9Z
M$=*G\1Z?]J@&I1+\\8"S@=QV:J&@R10RRF1"P( X[5H]A0DXNZ/3=/\ &=B[
M!;M)K-CW.73\Q_A7407$=S&)+6>*X0CDHP/_ ->O*P]LS*T3!FR!L/!YKO+:
MUM[FTBE$11MN%;[K\>XYJ.6YV1QLE\2N:QN1 _SV\@]=N?Y5YIXWU,2ZY(84
M)$>(@/<#)_4UMS^+-0TK498ECCO+2-@N)20_O\PZ_B*XR_NEFEN+J9MK2.S!
M1W)SQ^M+8=>O&I"T2C:Q&>YWS/\ ,2!G^@J[*X:1W[$GK5"TW2W(=LJB*6PI
MQC_.:MNP4 M\RCJ#WI/<YH["(N^,"3GU!Y%7MZS:<873_42*8VW?WLC'Y#]*
MHKPH Z5- Q\DY[R$=>@ _P#KTAL<S.OE;./,DZ]\#K].E-\D/'-YAV+)+NR>
MX[4>>"\*_>PAPPZ "H!YDZ6I?YB7W$XZ"D(N_:%$DX5<,B<MZU6_?7&FQ@%B
M[ODG/UJ01K%]HEE8;7Z_2B2X6.& 1E8T?H2O3Z"EZ#]2Q)!&\L#R-C9@*,]3
M1/>E;U;94&2,EB?8]*A;:VJ1[BN548!Z]>U$]M*=2-Q@>6J=2>O!H6^H/R)?
M#?V@Z]:_9)I89P24DB"%E.#T#D*?Q-:6N:MK&C>*;J2WU2Z2Z=(S+*,1LYV@
M_,JY'?IS7.6EY<V%S'<VEQ)!.G*R1MAA3M0U"YU.]EO+N3S+B4@N^T#<0,9P
M*V("\O9]0O&NKEPTSD;F5 N?P  K8M[EFNFA<*3@L&4YXST/H:YW-:]I!-'J
MCSMS&ZG!!Z=\5$K#CN6(;6%;6Z2V?<LH/&[.#561I[31;=LM')%+@X/;)_,4
MW2N+^_0<')(_,U8ANA+ILK7BB14;#;5ZCCG'XU.J&73<(]ZUJ\?WX=P?V[BH
M8H-LUC)"PDCC5HRP/8]*41++>VUW&_RK'MQZJ>]58VDLK7^)-ESCIU4FD,G@
MG\Z"&.==TLHDAW].1ZUS73@]174-)"TS>8/+:WF!# \$D<?G61'ICW=[/'%+
M$K*[85VQFJB3(IQGGKC/>KMM.J7$,T@P\3K(".,X;-4=CQ[=ZD9&1GN*G*$9
M*G?'_+_.:L1]%:]HVA^*(_M-[(5U'RG2VV2%0>Z''ON7TSFO".4E*%<-T*C^
MH'/YFO9O"NH?;/"]A<Y4++:"&>1E9A^[)7:0O.257GMGWKRWQ59_8O$VH1&)
MHT,OFA3R%#C<!V'&<=ZT0FB?3+@QW44I;(;&[^1KM/A]J(L_%\UB3\KDH<G'
M7D>YY_"O.K2;$(!/&[[V1_/C]*V$NYK77]/OH,%ID48(/WU.>0.OXTFA+8]N
M\0^(/[#EMQY"RH_^LRQ!7TQ^1KPSXF2V]YXE75+:%XH[N(%P^/OKP?S&#7L/
MBV**]L8;V,Y\^%6&#D?*=PY_$UY=XTL_.T R!1FV<2 CN#P?\^U'0ER?-8X;
M17NQJ@M+&!9KB[(AC4H"V<@C:3T/'7TK8UG3KFSO)FGCVL&V2 ,#M?N.*YJ.
M9[6ZANHCB2)U=?J#FNY\7HD/D7%G&!::A%',@1<*%QD?SQ4=31/0Y0T5-]G)
M .0<]LXHIW$V6YIG';=]*YO7+\MFTC.#_P M2#^E:&J:C]D3RXSF=A_WP/7Z
MUR[<DDG)[DUE1I?:9K5J?91$1@4W/%/:HS72<YZ!X7>XEM;01,WF%FC1P3E2
MJAESZCJ,>]4]=A7[2MW''LAN1YBC'0_Q#\&S6QX*_P!&BMI\'RXYX\MZ%U9?
M\*-9@'_"%V<KC]X;R8K],\_J*\W#5_8YBK;-V^^__ (D^>DGVN_R1RH'%!H0
M\4-7VT&<TEH-!YKT/Q""?A?H)QT9,_\ ?+5Y[&-SBO1O$)V_##1!V)C_ )-7
MBYM_O&$_Q_HSHPWP5/0B^'(/V36UQUB7C\&J;PUJN@MX)&FZO=Q+LE9GARP8
MC=D8QR?PK*\-Z3XHGLY8],8V=O<,"]PWR$@#& >I'/:NAM?!.@:':R7NLWIN
M?)&Z0;MBCVV@Y)->'FCPBQ%55:CYI2BTH:R3BK>B.S#^TY(\L=$G>^VIFZSX
MMT:70Y=$TFPDAMY"!YA&P Y!X')R<=ZYK7?%%SKALXKJUAB6T&U1&6Y''!)/
MM4^N:F^JM_H\$=E81D^1;1J!@?WF]6-80_UF\KNV]1[5]%EV4T*-*,W!J5V]
M7=W:L[OO8X:^(G*35]#H;KQ5J%]J%IJSI!!-:Y6!40E<>X)YQ5X>/O$&-QDM
M&QZP?_7KG'MI)PKK@1X!'M3O*95V\9^M:3RW*YI0G"+Y=%Y&*QTTW:9=TG7)
M++79=::W2XF.\O&&V#+=2.OY4_3M<M5\7_VU+!*D0F>5D3YV&X$>W<UE+#)'
M)O4'W%,FA,,@GBR$/W@1TK:> PM5R:WE'E=GT".*EHK[._S.YN6\%:[//=_:
MY(;QPSG>S1[VQZ$$?E575,Q_"S1SR/W^0?Q:N&WF.;<IX/6NCL]$U35-",>F
MW;7,*D--8E\-&><$ \$8[BO(JY9#"*FYUGR1DG[VRT:M?IOU.N.(=3FM'5KH
M;?C*ZF&A>&;T2N+LQ;O.!PP.U><UF:%XEUF?6["V;5+ETDG165GR",\BF>(K
MZ34-.TRPELIK2YL$,;K(.&&  1GG/%9_A48\5Z8&'(N%IX?!0CE<O;03:4VM
M$^K:L$ZLGB%ROL3>.Y1-XQOL?P;$_)17--6YXNR?%^J>TY_D*Q&KU,MBHX*D
ME_*OR.:N[U9/S,@LZW!D4D,&R".QKKM-NQ?V_FXVS(<2*.Y]?QKEW7#'ZU:T
MN]-C>K(<F-OED7U%>+6AS7.VE*S.ZM6P1GM6H&RHK'C(PK*<HW(([BM&.3*B
MO-EH=Z(=3"R0#G#$[:R(G)?+'G.&_P :V;N,R19!PRG*U@2']]N&,'GI711>
MAS5EK<THI DA#?-&PVL#T(KGIK!]-OK@1QO)!@,K@'A3TS6VC"1>/QK2TT-,
M'3SO*V\%L<8]#72C*G'FE8X\2&4;5SEB ,^IKT:Q_=01P13R(MNF90&XP!W!
M]369-HT<DBN]LDC@Y5[=L-['((_E2#16DG=X-1DAF8?-'>(W(_WE']*>VII+
M#SZ'.RZB;F61&3YMQ<L#6;-"6D\QC\O8FM.^T6[T>3_2A&?.R4>-PP;!Y]_3
MJ*HW!&57.Y@.!V%00TUHQ\ V6[87"G !]?6FM(4(QGYCBG\K$ 3G+$]?PJ%F
M)=1V[U(^A,&R:?N8VJY^^RLVT>I)_P !5<G"L<XP*=)*! 1&WW0B C\*5@;)
M$"Q(-S<)$%(%.$NV:*%5 4KN.>HJ!E=S< =\ &I@J++YA;E4QCVH!$8W2V,V
MS+.[8ZU9:V\Q+<,<"(#/UJ![@0V@>),;FP P_6I),O=Q#)(502,\9I:AH6A+
M#]L5#S,?0=!]:CFN93<31 J(T4\ <M\M0(\AU<[59D YVC/.*F>%PT[R21Q+
M)S\W+>G04)!<?_95CY>[_A(+'=MSM\N7.?3[M6!HNC_Q^*;/J/NV\A[<]O6N
M=GWPR,JE74$@,!C.*C\V3;G;6MR+FX^F:>MO)(->M&=5)6,0R9?'09Q@9HMK
MR0W_ -G+*R$9'&"O%9$ $IP\H3) !VY_K5Z&(K?)<HZR*1R$X.,8Z&IE9C3-
M6*>WDNW11B=<AOEQD?7O4'V$PV%U#"Y;S.5SQ@U;N)-/*Z<UN0MT5D%PI!!S
MQ@\_TK.LI"+F^C0D;22 3P#S46*N*Y:*'3&8%75]C<]*M/<#-VDRB2.+#  <
MXJNEZK:<L]PH(#[3L&1]:GDACDDF"N!)+%@C/Y&EZ@$T*RB=H9/GF16 )].A
MJ@\<;:K(DH.&PW'TJQY,BRPDYS]G:)F'8]JH2*]Q+9L' D>+EF/4C^M4@9-=
M6T:/M65R5^Z&&0?QJN28)OW;=#R#5J0;(\2,ID5N2ISD?6F/:/<#SH@S$C^'
MGH/2K6PF>F?#36%ETJ?26$Y^=]D=N2CG> >'Z#E3P?4U!\1M)(EMM6.+=S"L
M36TBJC8!P&7^$C! ..161\-+NZM_$+VB^5LGC#N78@$(W)4CJ<%OUKL_&>FV
M\GAIFD2\N9EEW6\F[YER",X!;@G (." 5JD+H>4Q'DDC+8X)'?ZG_"M:96NK
M&V$>TRK,&7.,<C_]=5'T34+6W,\MN5R< !AN_'J<5+!M>RD1QN &2O/.#G^1
M-4_(270]BT>\75O!"P,VZYT]@)/F!RASSQ_3TKA]9N(T2XT^5X8U,90-*'8O
MG( 4*/IR2!S3O".IS1ZE"D?E6\#[8W1 2I1CM8,3U.>1]*WO%E@MOJJRQQ A
MHN.,D,#@_P!*F+N["G&SN>&.I7<A'*GG-=C9Z_87G@NUTN[E,=]92M%%E21+
M"YR #V*DGKVK \00K#K5QL)*2'>"1CK5&QMX[BY>.6\AM (V=9)L[20,A<CH
M3V]Z&K.S!:%YO-=S#P)-VS('.<T4W[29;I)HU8Y(8OC:H(Z]>M%(K0Y62=I'
M+NQ9FY)/>HB],R33@N>M:F0F<T8IX6GA:0SU!)(=,\!:?!%@W-[Y<RXZY!!S
M^& *;XP7R[6"S PL4DK8]-^&'\S^55/!EL^N26,LW,&FH$(]2"2H_7/X5KZN
MBZ]J>N-!\T<$"NC#H63@_GEA7SL&J&+5]>5N3?J[+\!5;SI.VE]$O35_B>?(
M#L#4X\BD7@E?>E/I7Z-&SU1Q]!85+-BO5DU?1-.\':+_ &LJ3R1P++#;8W,6
MP0#CICW->6#]W%_M&HF<GJ:X,SRN&/5.,Y-*+OIN]+;]#7#XAT;V5[G3:YX[
MU?5F:.*4V5MT$<)PQ'NW4_A@5A6A+2EF^8GJ6YJGG)J_; *N:ZL'@L/AH\E&
M"2,ZE:=1WD[EBY?$>!6=GEAGFK$[9J&,#)..M=K,F>R_"7:VA7P*J?WJ=0#_
M  UW4FG6DPS)96S_ .]"I_I7!_"3_D#ZA_UUC_\ 032_$[5M1TE]-DL;N:#<
MDFX1R%0W*]<5\VU>;2[DPDHTKVO_ ,.=;-X?T>3_ %FDV39_Z8*/Z5C:OX$T
M;4;*2.ULX[.YVGRWBR!GT8="#7F,7CWQ(K #4[CDXY?=_,5[CI327.F6,\Q+
M220H[L>Y(!)ISI2INTE9CCRS;BXV/FB2V-OJ+P2+CRV((/;VK3L=5N-%U*/4
M;4@NHVNA^[(O<&F:PN/$%\3_ ,]G_P#0C527F/\ "O9A3AB,/R55=-:CI3E%
M*2>IW(\?Z/K)-KK&CD6K<+)NWF/WZ C\*=;^$6L_$>F:KILHO-+:8-YBL"R#
MWQU'O^=>;(=DF*V]!\2W_ANZ_<DR6CG,ENQ^5O<>A]Z\#$Y+4PU&2RZ5DTTX
M-MI^E]F=]/%1J27MU\R+Q/\ \C3JC'_GX:L1CS6IKMS%J6LWE];;Q%-*7"N,
M$9]:RI.$)]!7M8>,J>%A&2LU%?D<LVI5&UW*4N*8*#SUH"D]*\35G7L=)X=U
M$<6,[<?\LF/8^E=-O\I22#\OH,FO/(XG4[AD8KL-*U/[;!Y4IQ<(/^^QZURX
MBE]I'50J?99<,OVI3OE5$(^X&Y/U_P *S9K)D8X(VU>D=.C*I^HJE*RC."<=
MANXKGC)IZ&TH7W)K2$X#!QD]!BM)4N[4">W53G[X9F'ZBL^V.%&3BI-6GG\J
MU:WF>-E+9*G&>E;TZFNIFXJ/O(W(]0T^6-3<*L$IX)8':?\ @0&/S%61!"56
M6'RGCQ]X2,1^8/\ 2N*^W763YRQSYZGH?TQ4]KJT$+!C%-$0>65S_3%=%XOJ
M6J_<D\27$;ZO'%YCF.*, X;=@DYXR![5A2MF7Y1M4'J3S4UW=>=J<TP(<.Y*
MEAU'8U ZY;>[YR<8 ]>U9O<YYRNVR5_E5$!X"C_&J[R%)/7BK-PR&X?Y#@#
M"MC^E5+L&."(F/!?D/ZBDA-CT@N)XWD"G8JEB3P*LM"+0Q1D[VD"L>,8)&:O
MMLBTM0QR/+5& 'L!BL^\=?M>7E&8SC'4],4;B(GF=XQ@XS)MX]*</FDN"H)8
MC P*C66,!5CA+Y.5+F@M.]M(Y?:L9QM%%@N3-%F"-)G2+:<GG)IYGA,@*JTL
MAX&>!^51/;(CVF2?WA&[WJ8O##JX<[0BKU [XHL,5)[FYN3 G[K') &,#/\
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?)CL> .>@YHHIJ3M8F<FJ;B<URLJL!T(-%%%(Y4S_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ycbd_424007.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Q )D# 2(  A$! Q$!_\0
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M2J0H4^6+U,HQE4GS,ZC1]/72='M+!7+BWB";CWQ5VBBO*;OJ=H4444 %%%%
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-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ycbd_424008.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 *4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ I#
MBH;J\M[.(R7$JQH.[&N=D\375_)Y6C6,DPZ":0;4JE%LPJ8B%/1[]NIU!( R
M2!6?=ZWIMGGSKR)2.V<FL?\ X1_5M2(;5-4=4/6*WX'YU>M/"ND6N&%J)''\
M4IW&G9+<R]KB)_!"R\W^A4?QI8[MMM!<W+=O+CX_.H?^$DUF=L6VA2 =C(V*
MZA+>&(82)% [!:?@>E'-'L'L<1+XJGW(Y47GBV8?+96T6?[S4;/&3=9+)?\
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M.) D:*J@8  Z4^N;%ZJ>([RXDF*V]O&%(R<9/7BGK(GEIX>UEN=+14$EY!%
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MU9@H &?ZTR^TL:C;1RY\F\C^:.5>JG_"JWW.>,.1\U+1=4;%%4-)O'NK=DG
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AF@V6EKF)-\I^]*_+'\:U***3=SIA3C!6BK!1112+/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ycbd_424009.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !? )0# 2(  A$! Q$!_\0
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M1J/91Q7NE]^SEH$\^ZSU:^MH\?<*K)^IQ5ZV_9Z\() JSSZA-(.K^:%S^&*
M/&_ ?Q8UCP+836%K;6]W:ROYBQS$C8W<@CUKK6_:0UTJ0NAZ<I]=[G'ZUZ-:
M_ GP/:[]UI<SEAC][.3CZ5$GP#\#HZO]GOFVD':UT<'Z\4 ==X$\32>+_"-G
MK,MJ;9YP04SD$@X)'MG-%;=A96VG6,-E9PI#;0J$CC08"@=J* ."\?:4/[8T
M:Y&K:E"]W?I 88KK8BJ5P2J@=?E!YS5K7?%&J>$+[3+"/1;G5+&=EMTNO/!G
MDDP>"./S..]6/%6@^)]9U.V;3[W2X;*UF2>)9H"TA=1W.>!]*@UC0O&NI'3G
M34](CELY5N-WV9L-( 1C&>F#CK0!2/Q(U2VM6M]2\/C3]8DNS;VT%S<!89 !
MDOYF.F/3J>E:&@Z\_C.'4-+OU^P7]E*I9]/NMX(/*LKX_,$5>USPQ=:VNEWC
M2V<>IV626DM_-BD###)M)Z'UZBH-.\/Z]ID-Y<PW6G?VA<NFV-+?RX(D'48!
MRQ/J: ,7PEXDDTCP%K>I7TM[JD>F7]RB_P 4I16&!^IYK<\.>-5\07R6OV!K
M?S;3[7&ZW$<@*Y P=IR#SW]ZP/\ A"?%QTZ\T[^T=*CM+JY:[D5(I,NY()1C
MN^X<8/M5S3/ ^KV&NPZK#<:18[8/L[P6%EY89"5).[/7([CI0!!)\2=5^U:I
M86_AF66^TIR]YB=1$D.,[M_=B.0OM5^^\8W.JV]E;>'M(?49KZT6[E5YA"(8
M'X!W?WCS@>U.T[PKK-M<>(Y+J;3YX]78MY:1LA V[<$^FWVZU#IO@[7=&BL;
MG3]0M$O8;/[#+$8R8'C4DQMC.X,N3GGG- %SX;W%W<^$8S>1312QW$T6RX;=
M(H5R &/<^]4?BEI>I7VB6L^DZA<6M]!<IY82Y$2,.K9]3@<"M+P/X<U7PQ83
MZ??7D%W TSS)*B%7+.Q9LC.,<U=\4:+>ZW!9PVLT$*PW"SN94W;]N<+^.>M
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@S8,6LK$12SXZ*QR=H]<=: .W0Y7(HI5Z<C'M10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ycbd_424010.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !D &P# 2(  A$! Q$!_\0
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MJQ%7$YG"I5=W_P  YWPEX(;Q19S7*7@@\M]A!3.>/K70GX/39!754'K^[_\
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/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ycbd_424011.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- $T# 2(  A$! Q$!_\0
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MAIRR;H;"%4"@\;V&X_S%0^&/BE'::;#IFJP2VZ1(D27ECP_EH<[&0\'/<]:
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B6VGPFXNGPT\W\4K?T KJ[65IK=9'B:)C_ W45+@4M '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ycbd_424012.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) 04# 2(  A$! Q$!_\0
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M367FAI%VMO;/%;U%7[2?+RWT,O84^?GMJ<YK'@O2];OC>77F^:5"_*V!6?\
M\*TT/_IO_P!_/_K5V=%5&M4BK)F<\)1F^:43C/\ A6FA>D__ '\_^M3XOAQH
M,<FXQ3/[-)7844_;U/YA+!T%]E&?I^B:=I<>RTM(HAZA>?SK0HHK)MO5G1&$
*8JT4%%%%(H__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ycbd_424013.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !B 8L# 2(  A$! Q$!_\0
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M&*G'E-LCG*5.5WU%HKQCQ-XSUZQ\1WUM;WQ2*.3"KM' K)_X3_Q)_P!!$_\
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M_P"N=>0]J]O*_P"'(^6S[^+'T+6FVIOM1@MA_P M'P?I7LEM EM;I#&H"(,
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JQ1]AM/\ GU@_[]BBBA%#U@A3[L4:_10*DHHK">YM3"BBBH-0HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
